<SEC-DOCUMENT>0001564590-20-044842.txt : 20201026
<SEC-HEADER>0001564590-20-044842.hdr.sgml : 20201026
<ACCEPTANCE-DATETIME>20200928192442
ACCESSION NUMBER:		0001564590-20-044842
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20200927
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200929
DATE AS OF CHANGE:		20200928

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			METHODE ELECTRONICS INC
		CENTRAL INDEX KEY:			0000065270
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTRONIC CONNECTORS [3678]
		IRS NUMBER:				362090085
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0501

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33731
		FILM NUMBER:		201205680

	BUSINESS ADDRESS:	
		STREET 1:		8750 WEST BRYN MAWR AVENUE
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60631
		BUSINESS PHONE:		7088676777

	MAIL ADDRESS:	
		STREET 1:		8750 WEST BRYN MAWR AVENUE
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60631
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>mei-8k_20200927.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml  version="1.0" encoding="utf-8"?>
<!-- DFIN ActiveDisclosure(SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2020-09-28T21:47:58.2523740+00:00 -->
<!-- Version            : 5.0.1.513 -->
<!-- Package ID         : ed84c0b5956d4413a5407535331b86cf -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:mei="http://www.methode.com/20200927" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:dei-std="http://xbrl.sec.gov/dei-std/2019-01-31" xmlns:dei-ent-std="http://xbrl.sec.gov/dei-ent-std/2019-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html" />
<title>
mei-8k_20200927.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body><div style="display:none">
	<ix:header>
		<ix:hidden>
			<ix:nonNumeric id="F_000005" name="dei:EntityCentralIndexKey" contextRef="C_0000065270_20200927_20200927">0000065270</ix:nonNumeric>
			<ix:nonNumeric id="F_000006" name="dei:AmendmentFlag" contextRef="C_0000065270_20200927_20200927">false</ix:nonNumeric>
		</ix:hidden>
		<ix:references>
			<link:schemaRef xlink:type="simple" xlink:href="mei-20200927.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef>
		</ix:references>
		<ix:resources>
			<xbrli:context id="C_0000065270_20200927_20200927">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000065270</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-09-27</xbrli:startDate>
					<xbrli:endDate>2020-09-27</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
		</ix:resources>
	</ix:header>
</div>

<p style="border-top:Double 2.25pt;padding-top:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES AND EXCHANGE COMMISSION</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">WASHINGTON, D.C. 20549 </p>
<p style="text-align:center;margin-top:9pt;line-height:4pt;border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-top:9pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FORM <ix:nonNumeric id="F_000000" name="dei:DocumentType" contextRef="C_0000065270_20200927_20200927">8-K</ix:nonNumeric> </p>
<p style="text-align:center;margin-top:9pt;line-height:4pt;border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-top:9pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CURRENT REPORT </p>
<p style="text-align:center;margin-top:9pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 </p>
<p style="text-align:center;margin-top:9pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Date of Report (Date of earliest event reported): <ix:nonNumeric id="F_000001" name="dei:DocumentPeriodEndDate" contextRef="C_0000065270_20200927_20200927" format="ixt:datemonthdayyearen">September 27, 2020</ix:nonNumeric></p>
<p style="text-align:center;margin-top:9pt;line-height:4pt;border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-top:9pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:24pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000002" name="dei:EntityRegistrantName" contextRef="C_0000065270_20200927_20200927">METHODE ELECTRONICS, INC.</ix:nonNumeric> </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Exact name of Registrant as Specified in Its Charter) </p>
<p style="text-align:center;margin-top:9pt;line-height:4pt;border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:33%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000003" name="dei:EntityIncorporationStateCountryCode" contextRef="C_0000065270_20200927_20200927" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></p></td>
<td valign="bottom" style="width:33%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000004" name="dei:EntityFileNumber" contextRef="C_0000065270_20200927_20200927">001-33731</ix:nonNumeric></p></td>
<td valign="bottom" style="width:33%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000007" name="dei:EntityTaxIdentificationNumber" contextRef="C_0000065270_20200927_20200927">36-2090085</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="bottom" style="width:33%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(State or Other Jurisdiction</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of Incorporation)</p></td>
<td valign="bottom" style="width:33%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Commission File Number)</p></td>
<td valign="bottom" style="width:33%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(IRS Employer</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Identification No.)</p></td>
</tr>
<tr>
<td valign="bottom" style="width:33%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:33%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:33%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="width:33%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000008" name="dei:EntityAddressAddressLine1" contextRef="C_0000065270_20200927_20200927">8750 West Bryn Mawr Avenue</ix:nonNumeric>,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000009" name="dei:EntityAddressCityOrTown" contextRef="C_0000065270_20200927_20200927">Chicago</ix:nonNumeric>, <ix:nonNumeric id="F_000010" name="dei:EntityAddressStateOrProvince" contextRef="C_0000065270_20200927_20200927">IL</ix:nonNumeric></p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:33%;">
<p style="line-height:2pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="width:33%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000011" name="dei:EntityAddressPostalZipCode" contextRef="C_0000065270_20200927_20200927">60631</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="bottom" style="width:33%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Address of Principal Executive Offices)</p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:33%;">
<p style="line-height:2pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="width:33%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Zip Code)</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:9pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Registrant&#8217;s Telephone Number, Including Area Code: (<ix:nonNumeric id="F_000012" name="dei:CityAreaCode" contextRef="C_0000065270_20200927_20200927">708</ix:nonNumeric>) <ix:nonNumeric id="F_000013" name="dei:LocalPhoneNumber" contextRef="C_0000065270_20200927_20200927">867-6777</ix:nonNumeric></p>
<p style="text-align:center;margin-top:9pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Not Applicable </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Former Name or Former Address, if Changed Since Last Report) </p>
<p style="text-align:center;margin-top:9pt;line-height:4pt;border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-top:9pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000014" name="dei:WrittenCommunications" contextRef="C_0000065270_20200927_20200927" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </p></td>
</tr>
<tr>
<td valign="top" style="width:4%;">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000015" name="dei:SolicitingMaterial" contextRef="C_0000065270_20200927_20200927" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:96%;">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </p></td>
</tr>
<tr>
<td valign="top" style="width:4%;">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000016" name="dei:PreCommencementTenderOffer" contextRef="C_0000065270_20200927_20200927" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:96%;">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </p></td>
</tr>
<tr>
<td valign="top" style="width:4%;">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000017" name="dei:PreCommencementIssuerTenderOffer" contextRef="C_0000065270_20200927_20200927" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:96%;">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </p></td>
</tr>
</table></div>
<p style="margin-top:9pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Securities registered pursuant to Section 12(b) of the Act:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Title of each class</p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:15%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Trading</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Symbol(s)</p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:45%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name of each exchange on which registered</p></td>
</tr>
<tr>
<td valign="top" style="width:38%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000018" name="dei:Security12bTitle" contextRef="C_0000065270_20200927_20200927">Common Stock, $0.50 par value</ix:nonNumeric></p></td>
<td valign="bottom" style="width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:15%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000019" name="dei:TradingSymbol" contextRef="C_0000065270_20200927_20200927">MEI</ix:nonNumeric></p></td>
<td valign="bottom" style="width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:45%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000020" name="dei:SecurityExchangeName" contextRef="C_0000065270_20200927_20200927" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></p></td>
</tr>
</table></div>
<p style="margin-top:9pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8201;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8201;240.12b-2 of this chapter).</p>
<p style="margin-top:9pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Emerging growth company&#160;<span style="font-family:Segoe UI Symbol;"><ix:nonNumeric id="F_000021" name="dei:EntityEmergingGrowthCompany" contextRef="C_0000065270_20200927_20200927" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></p>
<p style="margin-top:9pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;<span style="font-family:Segoe UI Symbol;">&#9744;</span></p>
<p style="border-bottom:Double 2.25pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:2pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:2pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item 5.02</span><span style="margin-left:36pt;">Departure of Directors or Certain Officers&#59; Election of Directors&#59; Appointment of Certain Officers&#59; Compensatory Arrangements of Certain Officers.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%;">On September 27, 2020, the Compensation Committee of Methode Electronics, Inc. (&#8220;Methode&#8221;) awarded performance-based restricted stock (&#8220;Performance-Based RSAs&#8221;), performance units (&#8220;Performance Units&#8221;) and time-based restricted stock units (&#8220;RSUs&#8221;) to our executive officers.&#160;&#160;The Performance-Based RSAs and Performance Units were awarded pursuant to a Long-Term Performance-Based Award Agreement and the RSUs were awarded pursuant to a Long-Term Time-Based Award Agreement.&#160;&#160;All awards were made under Methode&#8217;s 2014 Omnibus Incentive Plan (the &#8220;Plan&#8221;).&#160;&#160;&#160;&#160;&#160;&#160; </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%;">After a comprehensive review of various design alternatives and market practices presented by the Compensation Committee&#8217;s independent executive compensation consultant, Frederic W. Cook &#38; Co., Inc., one of the critical determining factors the Compensation Committee considered in granting another five-year, long-term incentive program was the performance of the two prior five-year, long-term incentive programs which concluded as of the end of fiscal 2015 and fiscal 2020.&#160;&#160;Consistent with our prior five-year programs, the Compensation Committee currently expects that these Performance-Based RSAs, Performance Units and RSUs will be the only equity-based awards made to our executive officers during this new five-year period which ends on May 3, 2025, i.e., fiscal 2021 through fiscal 2025. The Compensation Committee believes the mix of performance-based and time-based awards supports Methode&#8217;s operating performance and retention objectives.&#160;&#160;The Performance Units represent an opportunity for participants to receive a cash payment based on the price of Methode&#8217;s common stock to the extent that fiscal 2025 EBITDA exceeds target performance for the Performance-Based RSAs.&#160;&#160;At the discretion of the Compensation Committee, the Performance Units may be settled in shares of &#8206;Methode&#8217;s common stock. &#8206; The Compensation Committee determined that EBITDA is the appropriate performance metric for the program.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%;">The tables below set forth details regarding the awards to the named executive officers.</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;width:18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Executive</p></td>
<td valign="top" style="background-color:#FFFFFF;width:21.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Target Performance-Based</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">RSAs</p></td>
<td valign="top" style="background-color:#FFFFFF;width:20.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Time-Based RSUs</p></td>
<td valign="top" style="width:20.1%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:20.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Maximum Performance</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Units*</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#C6D9F1;width:18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Donald Duda <br />Chief Executive Officer</p></td>
<td valign="top" style="background-color:#C6D9F1;width:21.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">375,000</p></td>
<td valign="top" style="background-color:#C6D9F1;width:20.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">375,000</p></td>
<td valign="top" style="width:20.1%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="top" style="background-color:#C6D9F1;width:20.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">187,500</p></td>
</tr>
<tr>
<td valign="top" style="width:18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ronald Tsoumas <br />Chief Financial Officer</p></td>
<td valign="top" style="width:21.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75,500</p></td>
<td valign="top" style="width:20.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75,500</p></td>
<td valign="top" style="width:20.1%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="top" style="width:20.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37,750</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#C6D9F1;width:18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Joseph E. Khoury <br />Chief Operating Officer</p></td>
<td valign="top" style="background-color:#C6D9F1;width:21.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">144,000</p></td>
<td valign="top" style="background-color:#C6D9F1;width:20.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">144,000</p></td>
<td valign="top" style="width:20.1%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="top" style="background-color:#C6D9F1;width:20.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72,000</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;width:18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Anil Shetty</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">President, Dabir Surfaces</p></td>
<td valign="top" style="background-color:#FFFFFF;width:21.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68,000</p></td>
<td valign="top" style="background-color:#FFFFFF;width:20.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34,000</p></td>
<td valign="top" style="width:20.1%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:20.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,000&#8206;</p></td>
</tr>
</table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&#160;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">* Executives will only begin to earn Performance Units in the event Methode&#8217;s fiscal 2025 EBITDA exceeds the Performance-Based RSA target performance goal of $300 million.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Performance-Based RSAs </span></p>
<p style="margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%;">The Performance-Based RSAs may be earned based on fiscal 2025 performance relative to established goals for threshold and target performance.&#160;&#160;The executives will not earn any shares of Performance-Based RSAs if threshold performance is not met. For Messrs. Duda, Tsoumas and Khoury, performance will be based on Methode&#8217;s earnings before net interest, taxes, fixed asset depreciation and intangible asset amortization (&#8220;EBITDA&#8221;) for fiscal 2025, subject to certain adjustments, including adjustments for non-accretive acquisitions and divestitures.&#160;&#160;</p>
<p style="margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%;">The performance goals and corresponding percentages of Restricted Stock eligible to be earned by these executives are set forth below.</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80.88%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;width:35%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:6pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Performance Goal</p></td>
<td valign="top" style="background-color:#FFFFFF;width:30%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:6pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fiscal 2025 EBITDA, As Adjusted</p></td>
<td valign="top" style="background-color:#FFFFFF;width:34.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:6pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Percentage of Restricted Stock Earned*</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#C6D9F1;width:35%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:6pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Threshold Performance</p></td>
<td valign="top" style="background-color:#C6D9F1;width:30%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:6pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$270 million</p></td>
<td valign="top" style="background-color:#C6D9F1;width:34.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:6pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50%</p></td>
</tr>
<tr>
<td valign="top" style="width:35%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:6pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Target Performance</p></td>
<td valign="top" style="width:30%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:6pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$300 million</p></td>
<td valign="top" style="width:34.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:6pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100%</p></td>
</tr>
</table></div>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*&#160;&#160;Payouts are interpolated for performance falling between established performance measures.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%;">For Mr. Shetty, performance will be based on the fiscal 2025 EBITDA of our Dabir Surfaces subsidiary, subject to adjustments for acquisitions.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%;"><span style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%;">Dividends will not be paid on the Performance-Based RSAs until the shares have been earned.&#160;&#160;At such time, the executives will be entitled to a dividend equivalent payment based on the dividends declared during the restricted period and the number of shares earned. </span></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%;">In the event of an executive&#8217;s death or disability, the executive will earn all of the shares of Performance-Based RSAs.&#160;&#160;In general, in the event of an executive&#8217;s qualified retirement, the executive will be eligible to earn a prorated number of shares of Performance-Based RSAs based on the number of months elapsed since May 2, 2020 (the first day of fiscal 2021), and the fiscal 2025 EBITDA for Methode or Dabir Surfaces, as applicable.&#160;&#160;If Mr. Duda retires after fiscal 2023, he will be eligible to earn all of the Performance-Based RSAs subject to the Methode fiscal 2025 EBITDA achieved.&#160;&#160;In the event Messrs. Duda, Tsoumas or Khoury are terminated without cause (as defined in the Plan) after fiscal 2021, the executive will be eligible to earn a prorated number of Performance-Based RSAs Stock based on the number of months &#8206;elapsed since May 2, 2020, and Methode&#8217;s fiscal 2025 EBITDA&#8206;.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%;">In the event of a change of control of Methode in which either (i) the successor company does not assume or replace the Performance-Based RSAs or (ii) the successor company assumes or replaces the Performance-Based RSAs, and the executive is terminated without cause or resigns for good reason within the next two years, the executive may earn a prorated number of shares.&#160;&#160;The proration for Messrs. Duda and Shetty will be based on the number of months elapsed since May 2, 2020.&#160;&#160;For Messrs. Tsoumas and Khoury, if the change of control occurs in fiscal 2021, the executive will not earn any shares, and if the event occurs in fiscal 2024 or 2025, the executive will earn all of the shares.&#160;&#160;If the change of control or termination occurs in fiscal 2022 or 2023, the proration for Messrs. Tsoumas and Khoury will be based on the number of months elapsed since May 2, 2020.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Performance Units</span>&#160;&#160;</p>
<p style="margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%;">If fiscal 2025 EBITDA for Methode or Dabir Surfaces, as applicable, exceeds target performance, the executives are eligible to earn Performance Units based on performance relative to goals for target and maximum performance.&#160;&#160;The performance goals and corresponding percentages of Performance Units eligible to be earned by Messrs. Duda, Tsoumas and Khoury are set forth &#8206;below.&#8206;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80.88%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;width:35%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:6pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Performance Goal</p></td>
<td valign="top" style="background-color:#FFFFFF;width:30%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:6pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fiscal 2025 EBITDA, As Adjusted</p></td>
<td valign="top" style="background-color:#FFFFFF;width:34.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:6pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Percentage&#160;of&#160;Performance&#160;Units&#160;Earned*</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#C6D9F1;width:35%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:6pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Target Performance</p></td>
<td valign="top" style="background-color:#C6D9F1;width:30%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:6pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$300 million</p></td>
<td valign="top" style="background-color:#C6D9F1;width:38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:6pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</p></td>
</tr>
<tr>
<td valign="top" style="width:35%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:6pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Maximum Performance</p></td>
<td valign="top" style="width:30%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:6pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$330 million</p></td>
<td valign="top" style="width:38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:6pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100%</p></td>
</tr>
</table></div>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*&#160;&#160;Payouts are interpolated for performance falling between established performance measures.<span style="font-size:11pt;"> </span></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%;">The &#8206;Performance Units shall &#8206;&#8206;be &#8206;settled and paid in cash based on the number of Performance Units earned and the price of Methode&#8217;s common stock at that time.&#160;&#160;At the discretion of the Compensation Committee, the Performance Units may be settled in shares of Methode&#8217;s common stock instead of cash. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%;">Dividend equivalents will not be paid on any Performance Units settled in cash.&#160;&#160;If the Performance Units are settled in common stock, then the executives will be entitled to a dividend equivalent payment based on the dividends declared during the period between the date of the Committee&#8217;s decision and the end of the restricted period, and the number of Performance Units earned.&#160;&#160;Dividend equivalents will not be paid on any Performance Units that are not earned.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%;">In the event of an executive&#8217;s death or disability, or a change in control of Methode, all of the Performance Units will be forfeited to Methode.&#160;&#160;In general, in the event of an executive&#8217;s qualified retirement, the executive will be eligible to earn a prorated number of Performance Units based on the number of months elapsed since May 2, 2020 and the fiscal 2025 EBITDA for Methode or Dabir Surfaces, as applicable.&#160;&#160;If Mr. Duda retires after fiscal 2023, he will be eligible to earn all of the Performance Units subject to the Methode fiscal 2025 EBITDA achieved.&#160;&#160;In the event Messrs. Duda, Tsoumas or Khoury are terminated without cause after fiscal 2021, the executive will be eligible to earn a prorated number of Performance Units based on the number of months &#8206;elapsed since May 2, 2020, and Methode&#8217;s fiscal 2025 EBITDA &#8206;.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Time-Based RSUs</span></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%;">The RSUs are subject to a five-year vesting period based on continued service, with thirty percent (30%) vesting on April 29, 2023 and May 4, 2024, and forty percent (40%) vesting on May 3, 2025.&#160;&#160;Dividend equivalents will not be paid on the RSUs until the units have vested.&#160;&#160;At such time, the executives will be entitled to a dividend equivalent payment based on the dividends declared during the vesting period and the number of vested RSUs.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%;">In the event of an executive&#8217;s death or disability, all unvested RSUs will become immediately and fully vested.&#160;&#160;In general, in the event of an executive&#8217;s qualified retirement, a prorated number of RSUs will vest based on the months elapsed since May 2, 2020. If Mr. Duda retires after fiscal 2023, all unvested RSUs will immediately vest.&#160;&#160;&#8206; In the event Messrs. Duda, Tsoumas or Khoury are terminated without cause &#8206;after fiscal 2021, the executive will earn a prorated number of Restricted Stock Units based on the &#8206;&#8206;number of months elapsed since May 2, 2020.&#8206;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%;">In the event of a change of control of Methode in which either (i) the successor company does not assume or replace the RSUs or (ii) the successor company assumes or replaces the RSUs and then the executive is terminated without cause or resigns for good reason within two years, all unvested RSUs will become immediately and fully vested. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8206;<span style="margin-left:36pt;">The descriptions of these awards are qualified by reference to the full text of the Form of 2020 Long-Term Performance-Based Award Agreement (CEO), Form of 2020 Long-Term Performance-Based Award Agreement (COO and CFO),&#160;Form of 2020 Long-Term Performance-Based Award Agreement (Dabir), Form of 2020 Long-Term Time-Based Award Agreement (CEO), Form of 2020 Long-Term Time-Based Award Agreement (COO and CFO) and Form of 2020 Long-Term Time-Based Award Agreement (Dabir) attached hereto as Exhibit 10.1, 10.2, 10.3, 10.4, 10.5 and 10.6 respectively, and the Plan which was filed as Exhibit 10.1 to Methode&#8217;s Form 8-K filed on September 22, 2014.&#160;&#160;</span></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item 9.01</span><span style="margin-left:36pt;">Financial Statements and Exhibits.</span></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8206;(d)&#8206;<span style="margin-left:36pt;">Exhibits.</span><span style="font-size:10pt;"> </span></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&#160;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1<span style="margin-left:36pt;"></span><a href="mei-ex101_38.htm"><span style="text-decoration:underline;">Form of 2020 Long-Term Performance-Based Award Agreement (CEO)</span></a><span style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.2<span style="margin-left:36pt;"></span><a href="mei-ex102_37.htm"><span style="text-decoration:underline;">Form of 2020 Long-Term Performance-Based Award Agreement (COO and CFO)</span></a></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.3<span style="margin-left:36pt;"></span><a href="mei-ex103_36.htm"><span style="text-decoration:underline;">Form of 2020 Long-Term Performance-Based Award Agreement (Dabir)</span></a><span style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.4<span style="margin-left:36pt;"></span><a href="mei-ex104_35.htm"><span style="text-decoration:underline;">Form of 2020 Long-Term Time-Based Award Agreement (CEO)</span></a><span style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.5<span style="margin-left:36pt;"></span><a href="mei-ex105_34.htm"><span style="text-decoration:underline;">Form of 2020 Long-Term Time-Based Award Agreement (COO and CFO)</span></a><span style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.6<span style="margin-left:36pt;"></span><a href="mei-ex106_33.htm"><span style="text-decoration:underline;">Form of 2020 Long-Term Time-Based Award Agreement (Dabir)</span></a></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104<span style="margin-left:36pt;"></span><span style="color:#000000;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">SIGNATURES</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Company Name</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: September 28, 2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;Ronald L.G. Tsoumas</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ronald L.G. Tsoumas</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Financial Officer</p></td>
</tr>
</table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>mei-ex101_38.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
mei-ex101_38.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Exhibit 10.1</font></p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">METHODE ELECTRONICS, INC. </font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FORM OF 2020 LONG-TERM PERFORMANCE-BASED </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">AWARD AGREEMENT (CEO)</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Long-Term Performance-Based Award Agreement (the &#8220;Award Agreement&#8221;), effective as of September 27, 2020 (the &#8220;Award Date&#8221;), is entered into by and between Methode Electronics, Inc., a Delaware corporation (the &#8220;Company&#8221;) and [_____________] (the &#8220;Grantee&#8221;).&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">WHEREAS, the Company desires to reward Grantee for services to the Company and to encourage Grantee to continue to work for the benefit of the Company in a manner that will benefit all Company stockholders.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NOW, THEREFORE, in consideration of the premises and the mutual covenants and obligations hereinafter set forth, the Company agrees to award to Grantee (i) shares of Restricted Stock of the Company (the &#8220;Restricted Stock&#8221;), and (ii) Performance Units (the &#8220;Performance Units&#8221;) under the Methode Electronics, Inc. 2014 Omnibus Incentive Plan (the &#8220;Plan&#8221;) on the terms and conditions set forth herein and in the Plan (collectively, the &#8220;Awards&#8221;).</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">General</font>.&nbsp;&nbsp;This Award Agreement and the Restricted Stock and Performance Units awarded herein are subject to all of the provisions of the Plan applicable to such Awards. Unless the context otherwise requires, capitalized terms used herein shall have the same meanings as in the Plan.&nbsp;&nbsp;Grantee hereby acknowledges receipt of a copy of the Plan and that Grantee has read the Plan and fully understands its content.&nbsp;&nbsp;In the event of any conflict between the terms of this Award Agreement and the terms of the Plan, the terms of the Plan shall control.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Awards</font>.&nbsp;&nbsp;The Company hereby grants to Grantee (i) a total of [_______] shares of Restricted Stock and (ii) a total of [_______] Performance Units payable in cash.<font style="font-size:12pt;"> </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Vesting</font>.&nbsp;&nbsp;Subject to the terms of this Award Agreement, the Restricted Stock shall vest and the Performance Units shall be earned on the date (the &#8220;Vesting Date&#8221;) that the Committee certifies performance under this Award Agreement, subject to the Grantee&#8217;s continued employment by the Company or a Subsidiary or Affiliate through the end of the Performance Period.&nbsp;&nbsp;Any Restricted Stock that does not vest and any Performance Units that are not earned pursuant to this Section 3 shall be immediately cancelled and forfeited to the Company as of the Vesting Date.&nbsp;&nbsp;Except as provided in Section 3(d), 3(e) or 3(f) below, all Restricted Stock and Performance Units shall be immediately cancelled and forfeited to the Company in the event Grantee ceases to be employed by the Company or a Subsidiary or Affiliate at any time prior the end of the Performance Period.&nbsp;&nbsp;To the extent Restricted Stock vests pursuant to Section 3(e) below or the Restricted Stock or Performance Units are forfeited pursuant to Section 6 below, such Restricted Stock shall not be eligible for vesting pursuant to Section 3(b), 3(d) or 3(f) and such Performance Units may not be earned pursuant to Section 3(c) or Section 3(d).&nbsp;&nbsp;Any fractional shares created by the vesting calculations described below will be rounded down to a whole share number; no fractional shares will vest pursuant to this Award Agreement.&nbsp;&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><a name="_AEIOULastRenderedPageBreakAEIOU3"></a><font style="text-decoration:underline;font-size:11pt;">Performance Period and Fiscal 2025 EBITDA</font><font style="font-size:11pt;">.&nbsp;&nbsp;The &#8220;Performance Period&#8221; is the fiscal year of the Company ending on or about May 3, 2025 (&#8220;Fiscal 2025&#8221;).&nbsp;&nbsp;Except to the </font></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">83633513</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap"></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:11pt;">extent provided in Section 3(d), 3(e) or 3(f), the number of shares of Restricted Stock that shall vest and the number of Performance Units that shall be earned will be based on the Company&#8217;s EBITDA for the Performance Period (&#8220;Fiscal 2025 EBITDA&#8221;), subject to the Grantee&#8217;s continued employment with the Company or a Subsidiary or Affiliate through the end of such Performance Period, and provided that a Change of Control has not occurred before the end of the Performance Period.</font></p></td></tr></table></div>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:15.38%;text-indent:-7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For this purpose and subject to Section 4 below, Fiscal 2025 EBITDA shall equal the Company&#8217;s earnings before net interest, taxes, fixed asset depreciation and intangible asset amortization (&#8220;EBITDA&#8221;) in Fiscal 2025 adjusted as follows: (A) all positive EBITDA from acquisitions that close during the period from the Award Date to the end of the Performance Period and that are not accretive (as defined below) in Fiscal 2025 shall be excluded; and (B)<font style="font-size:12pt;"> </font>&#8206;to the extent not otherwise included in 2025 EBITDA, all EBITDA from business unit &#8206;divestitures or spinoffs that were approved by the Company&#8217;s Board of Directors and close &#8206;during the period from the Award Date to the end of the Performance Period shall be included.&nbsp;&nbsp;&#8206;The amount of EBITDA to be included for a business unit divestiture or spinoff shall be the &#8206;actual EBITDA of the business unit for the four full quarters immediately preceding the &#8206;divestiture or spinoff, or if greater, the amount of EBITDA that the Committee reasonably &#8206;determines more appropriately reflects the amount of EBITDA the business unit would have &#8206;contributed to Fiscal 2025 EBITDA.&#8206;&nbsp;&nbsp;In order for an acquisition to qualify as accretive, (Y) the EBITDA in Fiscal 2025 from the acquisition must exceed Fiscal 2025 interest expense related to any debt assumed or issued in connection with the acquisition, and (Z) the net impact of the acquisition on Fiscal 2025 earnings per share (&#8220;EPS&#8221;) must be positive (i.e., Fiscal 2025 EPS with the acquisition is greater than Fiscal 2025 EPS without the acquisition).&nbsp;&nbsp;<font style="text-decoration:underline;">Exhibit D</font> hereto includes an illustrative calculation of the net impact on EPS.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:15.38%;text-indent:-7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Threshold, Target and Maximum levels of Fiscal 2025 EBITDA are set forth on <font style="text-decoration:underline;">Exhibit A</font> attached hereto.&nbsp;&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="text-decoration:underline;font-size:11pt;">Number of Shares of Restricted Stock that Vest</font><font style="font-size:11pt;">.&nbsp;&nbsp;</font><font style="text-decoration:underline;font-size:11pt;">Exhibit B</font><font style="font-size:11pt;"> attached hereto sets forth the formula for calculating the vesting percentage applicable to the Restricted Stock based on the Fiscal 2025 EBITDA achieved.&nbsp;&nbsp;Pursuant to </font><font style="text-decoration:underline;font-size:11pt;">Exhibit B</font><font style="font-size:11pt;">, if the level of performance achieved is greater than or equal to Threshold Fiscal 2025 EBITDA, then the number of shares of Restricted Stock that will vest under this Award Agreement shall be determined by multiplying the number of shares of Restricted Stock by a percentage (subject to a maximum of one hundred percent (100%)), equal to (i) fifty percent (50%) plus (ii) fifty percent (50%) multiplied by a fraction, the numerator of which shall equal (x) Fiscal 2025 EBITDA achieved minus Threshold Fiscal 2025 EBITDA, and the denominator of which shall equal (y) Target Fiscal 2025 EBITDA minus Threshold Fiscal 2025 EBITDA.&nbsp;&nbsp;If the level of performance achieved is less than Threshold Fiscal 2025 EBITDA, then no Restricted Stock shall vest pursuant to this Section 3.3(b).&nbsp;&nbsp;Except as provided in Section 3(d), 3(e) or 3(f) below, if the Grantee experiences a termination of employment or a Change of Control occurs, in either case, prior to the end of the Performance Period, no vesting shall occur under this Section 3(b).</font></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-2</a>-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><a name="_AEIOULastRenderedPageBreakAEIOU4"></a><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="text-decoration:underline;font-size:11pt;">Number of Performance Units Earned</font><font style="font-size:11pt;">.&nbsp;&nbsp;</font><font style="text-decoration:underline;font-size:11pt;">Exhibit C</font><font style="font-size:11pt;"> attached hereto sets forth the formula for calculating the number of Performance Units earned based on the Fiscal &#8206;&#8206;2025 EBITDA achieved.&nbsp;&nbsp;Pursuant to </font><font style="text-decoration:underline;font-size:11pt;">Exhibit C</font><font style="font-size:11pt;">, the number of Performance Units earned shall be determined by &#8206;multiplying the number of Performance Units by a fraction (subject to a maximum of one (1)), &#8206;the numerator of which shall equal (i) Fiscal 2025 EBITDA achieved minus (ii) Target Fiscal 2025 &#8206;EBITDA, and the denominator of which shall equal (a) Maximum Fiscal 2025 EBITDA minus (b) &#8206;Target Fiscal 2025 EBITDA.&nbsp;&nbsp;If the level of performance achieved is less than or equal to the Target &#8206;Fiscal 2025 EBITDA, then no Performance Units shall be earned pursuant to this Section 3.3(c).&nbsp;&nbsp;Except as provided in Section 3(d) below, if the Grantee experiences a termination of employment or a Change of Control occurs, in either case, prior to the end of the Performance Period, no Performance Units shall be earned under this Section 3(c).</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="text-decoration:underline;font-size:11pt;">Effect of Termination of Employment in Connection with Death, Disability or Retirement</font><font style="font-size:11pt;">.&nbsp;&nbsp;Notwithstanding Sections (b) and (c) above, the following provisions shall apply to the Awards in the event of Grantee&#8217;s termination of employment in connection with death, disability or retirement prior to the end of the Performance Period: </font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">if Grantee&#8217;s employment with the Company and its Subsidiaries and Affiliates is terminated due to total and permanent disability as determined by the Committee or death, then all of the Restricted Stock will become immediately vested and no Performance Units shall be earned and payable; and </p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">if Grantee&#8217;s employment with the Company and its Subsidiaries and Affiliates is terminated due to retirement on or after Grantee&#8217;s sixty-fifth birthday or retirement on or after Grantee&#8217;s fifty-fifth birthday with consent of the Committee (in either case,&nbsp;&nbsp;&#8220;Retirement&#8221;) then, the shares of Restricted Stock and the Performance Units shall, as of the Vesting Date, vest and be earned based on actual performance on a pro rata basis based on the date of Grantee&#8217;s Retirement.&nbsp;&nbsp;The fraction to be used to &#8206;determine the number of shares of Restricted Stock to vest and the number of Performance Units to be earned hereunder shall have a denominator equal &#8206;to sixty (60), and the numerator shall be determined as follows: (A) if Grantee&#8217;s &#8206;Retirement occurs on or before April 29, 2023, the &#8206;numerator shall be equal to the number of fiscal months elapsed between May 2, 2020 &#8206;and the date of Grantee&#8217;s Retirement (rounded up to the nearest whole month); and (B) &#8206;if Grantee&#8217;s Retirement occurs after April 29, 2023, the numerator shall be sixty (60).&nbsp;&nbsp;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(e)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="text-decoration:underline;font-size:11pt;">Change of Control</font><font style="font-size:11pt;">.&nbsp;&nbsp;Notwithstanding (b) and (c) above, the following provisions shall apply to the Awards in the event of a Change of Control prior to the end of the Performance Period&#8206;: </font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i) </font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">in the event of a Change of Control, the surviving or successor entity (or its parent corporation) may continue, assume or replace the Awards on substantially the same terms and conditions (with such adjustments as may be required or permitted by Section 15 of the Plan), and such Awards or replacements therefor shall remain outstanding and be governed by their respective terms, subject to (iii) and (iv) below; </p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-3</a>-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii) </font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;"><a name="_AEIOULastRenderedPageBreakAEIOU5"></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">if and to the extent that the Awards are not continued, assumed or replaced in connection with a Change of Control, then a pro rata portion of the shares of Restricted Stock will become immediately vested based on the date of the Change of Control and no Performance Units shall be earned and payable.&nbsp;&nbsp;The fraction to be used to determine the number of shares of Restricted Stock to vest hereunder shall have a numerator equal to the number of fiscal months elapsed between May 2, 2020 and the date of the Change of Control (rounded up to the nearest whole month) and the denominator of which shall be sixty (60); </font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iii)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">&#8206;if and to the extent that the Awards are continued, assumed or replaced under the circumstances described in Section 3(e)(i), and if within two years<font style="font-weight:bold;"> </font>after the Change of Control, Grantee experiences an involuntary termination of employment or other service for reasons other than Cause or Grantee shall terminate employment with Good Reason, then a pro rata portion of the shares of Restricted Stock will become immediately vested based on the date of termination and no Performance Units shall be earned and payable.&nbsp;&nbsp;The fraction (subject to a maximum of one (1)) to be used to determine the number of shares of Restricted Stock to vest hereunder shall have a numerator equal to the number of fiscal months elapsed between May 2, 2020 and the date of the termination (rounded up to the nearest whole month), and the denominator of which shall be sixty (60); and&nbsp;&nbsp;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iv)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">Notwithstanding whether the Awards are continued, assumed or replaced in connection with a Change of Control, if Grantee experiences an involuntary termination of employment or other service for reasons other than Cause or Grantee shall terminate employment with Good Reason during the period beginning on the date an agreement is entered into by the Company with respect to a merger, consolidation or similar transaction of the Company, which would constitute a Change of Control, and the effective time of such merger, consolidation or similar transaction of the Company, then a pro rata portion of the shares of Restricted Stock will become immediately vested based on the date of the Change of Control and no Performance Units shall be earned and payable.&nbsp;&nbsp;The fraction (subject to a maximum of one (1)) to be used to determine the number of shares of Restricted Stock to vest hereunder shall have a numerator equal to the number of fiscal months elapsed between May 2, 2020 and the date of the Change of Control (rounded up to the nearest whole month), and the denominator of which shall be sixty (60).&nbsp;&nbsp;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(f)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><a name="_AEIOULastRenderedPageBreakAEIOU6"></a><font style="text-decoration:underline;font-size:11pt;">Effect of Involuntary Termination of Employment Without Cause</font><font style="font-size:11pt;">.&nbsp;&nbsp;Notwithstanding Sections (b) and (c) above, if Grantee experiences an involuntary termination of employment for reasons other than Cause after May 1, 2021, then shares of Restricted Stock and the Performance Units shall, as of the Vesting Date, vest and be earned based on actual performance on a pro rata basis based on the date of Grantee&#8217;s termination of employment.&nbsp;&nbsp;If the involuntary termination of employment for reasons other than Cause occurs on or before May 1, 2021, then no shares of Restricted Stock and no Performance Units &#8206;shall be earned and payable. If the involuntary termination of employment for reasons other than Cause occurs after May 1, 2021, then the fraction (subject to a maximum of one (1)) to be used to determine the number of shares of Restricted Stock to vest and the number of Performance Units to be earned hereunder shall have a </font></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-4-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap"></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:11pt;">denominator equal to sixty (60) and the numerator shall be equal to the number of fiscal months elapsed between May 2, 2020 and the date of the termination of employment (rounded up to the nearest whole month). Grantee&#8217;s right to this pro rata portion of Restricted Stock and Performance Units is conditioned upon Grantee signing and delivering to the Company, within the time period required by the Company, a written general release of claims against the Company in a form acceptable to the Company (the &#8220;Release&#8221;), and not revoking the Release within any applicable revocation period.&nbsp;&nbsp; </font></p></td></tr></table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Good Reason&#8221; shall exist under (e)(iii) or (iv) above if, without Grantee&#8217;s express written consent any of the following events or actions occurs, provided that no finding of Good Reason shall be effective unless and until the Grantee has provided the Company, within sixty (60) calendar days of becoming aware of the facts and circumstances underlying the finding of Good Reason, with written notice thereof stating with specificity the facts and circumstances underlying the finding of Good Reason and, if the basis for such finding of Good Reason is capable of being cured by the Company, providing the Company with an opportunity to cure the same within thirty (30) calendar days after receipt of such notice: (A) the Company shall materially reduce the nature, scope or level of Grantee&#8217;s responsibilities from the nature, scope or level of such responsibilities prior to the Change of Control, or shall fail to provide Grantee with adequate office facilities and support services to perform such responsibilities; (B) the Company shall require Grantee to move Grantee&#8217;s principal business office more than 25 miles from Grantee&#8217;s principal business office at the time of this Award Agreement, or assign to Grantee duties that would reasonably require such move; provided, however, that if Grantee&#8217;s principal business office is not located at the Company&#8217;s then current corporate headquarters, and the Company requires Grantee to move Grantee&#8217;s principal business office to such corporate headquarters, or assigns to Grantee duties that would reasonably require such move, such actions shall not constitute &#8220;Good Reason&#8221; under this subsection; (C) the Company shall require Grantee, or assign duties to Grantee which would reasonably require Grantee, to increase, by more than twenty-four, the number of normal working days (determined at the time of this Award Agreement) that Grantee spends away from Grantee&#8217;s principal business office during any consecutive twelve-month period; (D) the Company shall reduce Grantee&#8217;s annual salary below that in effect as of the date of this Award Agreement (or as of the Change of Control, if greater); (E) the Company shall materially reduce or fail to continue in effect any cash or stock-based incentive or bonus plan, retirement plan, welfare benefit plan, or other benefit plan, program or arrangement, unless the aggregate value (as computed by an independent employee benefits consultant selected by the Company) of all such incentive, bonus, retirement and benefit plans, programs and arrangements provided to Grantee is not materially less than their aggregate value as of the date of this Award Agreement (or as of the Change of Control, if greater); or (F) if the Board of Directors fails to act in good faith with respect to the Company&#8217;s obligations hereunder, or the Company breaches its obligations hereunder.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Grantee agrees, as a condition of this Award, to make acceptable arrangements to pay any withholding or other taxes or deductions that may be due or may arise as a result of the vesting of the Restricted Stock, the settlement of the Performance Units, or any other payment or issuance of shares of Common Stock under this Award Agreement.&nbsp;&nbsp;In the event that the Company determines that any federal, state, local or foreign tax or withholding payment or other deduction is required relating to the vesting or issuance of shares or the payment of cash under this Award Agreement, the Company shall have the right to require such amounts or deductions from Grantee, or withhold such amounts or deductions from other payments due Grantee from the Company or any Subsidiary or Affiliate.</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-5</a>-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU7"></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.</font><font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Discretion to Adjust and Modify the Fiscal 2025 EBITDA Performance Levels</font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;The Committee shall have the authority to specify adjustments or modifications to be made to &#8206;the Threshold, Target and Maximum levels of Fiscal 2025 EBITDA based on and in order to &#8206;appropriately reflect the effect of the following events: (i) asset write-downs; (ii) litigation or claim judgments or &#8206;settlements; (iii) the effect of changes in tax laws, accounting principles, or other laws or &#8206;regulatory rules affecting reported results; (iv) any reorganization and restructuring programs; (v) &#8206;any change in the Company&#8217;s fiscal year; (vi) circumstances that impact the Company&#8217;s financial &#8206;performance that are outside of the control of the Company, such as acts of God; earthquakes; &#8206;fires; floods; severe weather events; natural or manmade disasters; wars; civil or military &#8206;disturbances; acts of terrorism; sabotage; embargoes; martial law; acts of civil or military &#8206;authorities; political unrest; riots; global economic events; strikes; labor disputes; lockouts; &#8206;epidemics; or pandemics; or (vii) unforeseen impacts related to mergers, acquisitions and &#8206;divestitures&#8206;.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Settlement of Performance Units</font>.&nbsp;&nbsp;Except as otherwise provided herein, the &#8206;Performance Units shall &#8206;&#8206;be &#8206;settled and paid in cash in an amount equal to the number of earned Performance Units multiplied by the Fair Market Value of the Company&#8217;s Common Stock as of the Vesting Date.&nbsp;&nbsp;The payment will be made within 2&#189; months after the end of the Performance &#8206;Period (or &#8206;earlier &#8206;as provided &#8206;in the Plan).&nbsp;&nbsp;At any time prior to the end of the Performance Period, the Committee shall have the authority to provide that the Performance Units will be settled in shares of the Company&#8217;s Common Stock instead of cash (the date of such Committee action referred to herein as the &#8220;Conversion Date&#8221;).&nbsp;&nbsp;In such event, if requested by the Committee, Grantee and the Company shall enter into an appropriate amendment to this Award Agreement to document such change.&nbsp;&nbsp;Notwithstanding the foregoing, in the event that the Grantee is a &#8220;specified employee&#8221; &#8206;within the meaning of Section 409A(a)(2)(B)(i) of the Code and the Award is considered &#8206;to be Nonqualified Deferred Compensation upon the Grantee&#8217;s &#8220;Separation from &#8206;Service&#8221; as defined below, any payment under this Award Agreement which results &#8206;from a Separation from Service shall be delayed until the earlier of (i) first day of the &#8206;seventh (7th) month beginning after the Grantee&#8217;s Separation from Service, or (ii) the &#8206;Grantee&#8217;s death, if such a delay is necessary to avoid the imposition of additional tax &#8206;and interest on the Grantee under Section 409A(a)(1)(B) of the Code.<font style="font-size:12pt;">&#8206;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Forfeiture</font>.&nbsp;&nbsp;If at any time any of the following events occur: (i) Grantee&#8217;s conviction of a felony other than a traffic violation; &#8206;(ii)&#8206; Grantee&#8217;s commission of any act or acts of personal dishonesty intended to &#8206;result in &#8206;personal enrichment to Grantee to the material detriment of the Company;&#8206; &#8206;(iii) a failure to perform assigned duties,&#8206; provided that such failure has continued for more than ten (10) days after the Board of Directors or the &#8206;Chief Executive Officer of the Company has given written notice of such failure;&#8206; &#8206;(iv)&#8206; any willful misconduct by the Grantee which materially affects the business &#8206;reputation &#8206;of the Company; &#8206;(v) breach in any material respect by the Grantee of any provision of any &#8206;employment, &#8206;consulting, advisory, nondisclosure, non-competition, proprietary information, or &#8206;other similar agreement &#8206;between the Grantee and the Company; or &#8206;(vi)&#8206; Grantee&#8217;s material violation of the Company&#8217;s code of conduct&#8206;, &#8206;then the unvested Restricted Stock and unearned Performance Units shall be forfeited to the Company effective as of the date on which the Grantee entered into such &#8206;activity, unless terminated sooner by operation of another term or condition of this Award Agreement or &#8206;the Plan.&#8206;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU8"></a>7.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Additional Delivery</font>.&nbsp;&nbsp;Within 2&#189; months of the date Restricted Stock vests under Section 3, the Company shall pay to the Grantee <font style="color:#000000;">an amount equal to the aggregate per share cash dividends with respect to all cash dividend record dates that fall between the Award Date and the date the unrestricted shares are registered with the Company&#8217;s transfer agent in the name of the Grantee, multiplied by the </font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-6-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;">number of shares of Restricted Stock that vest pursuant to this Award Agreement (without interest).&nbsp;&nbsp;In addition, if the Committee provides that the Performance Units will be settled in shares of the Company&#8217;s Common Stock instead of cash, then within 2&#189; months of the date the Performance Units vest under Section 3, the Company shall pay to the Grantee an amount equal to the aggregate per share cash dividends with respect to all cash dividend record dates that fall between the Conversion Date and the date the unrestricted shares are registered with the Company&#8217;s transfer agent in the name of the Grantee, multiplied by the number of Performance Units that vest pursuant to this Award Agreement (without interest). The Company may withhold from any payment that it is required to make under this Award Agreement amounts sufficient to satisfy applicable withholding requirements under any foreign, federal, state or local law due in connection with this Award or the payment described in this Section 7.&nbsp;&nbsp;No dividends shall be paid to the Grantee with respect to the Performance Units or Restricted Stock that does not vest and is forfeited by the Grantee. </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Restrictions</font>.&nbsp;&nbsp;None of the Restricted Stock or Performance Units may be sold, transferred, pledged, hypothecated or otherwise encumbered or disposed of until it has vested in accordance with the terms of this Award Agreement.&nbsp;&nbsp;Any Restricted Stock that is not vested and any Performance Units that are not earned shall be forfeited to the Company immediately upon termination of the Grantee&#8217;s employment with the Company and all of its Subsidiaries and Affiliates or upon the expiration of this Award Agreement.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Stock Delivery</font>.&nbsp;&nbsp;Within ten (10) days of the date of this Award Agreement, t<font style="color:#000000;">he Company will cause the Restricted Stock to be issued in the Grantee&#8217;s name either by book-entry registration or issuance of a stock certificate.&nbsp;&nbsp;While the Restricted Stock remains forfeitable, the Company will cause an appropriate stop-transfer order to be issued and to remain in effect with respect to the Restricted Stock. </font>Any stock certificate evidencing any Restricted Stock shall contain such legends and stock transfer instructions or limitations as may be determined or authorized by the Committee in its sole discretion; and the Company may, in its sole discretion, retain custody of any such certificate throughout the period during which any restrictions are in effect and require that the Grantee tender to the Company a stock power duly executed in blank relating thereto as a condition to issuing any such certificate.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Rights as Stockholder</font>.&nbsp;&nbsp;The Grantee shall have no rights as a stockholder with respect to any Restricted Stock until the Restricted Stock is issued in Grantee&#8217;s name either by book-entry registration or issuance of a stock certificate.&nbsp;&nbsp;Once the Restricted Stock is issued in Grantee&#8217;s name, the Grantee shall be entitled to all rights associated with ownership of the Restricted Stock, except that the Grantee shall not be entitled to receive any dividends (cash or stock) with respect to the Restricted Stock until such time as the restrictions lapse in accordance with the terms of this Award Agreement.&nbsp;&nbsp;&nbsp;&nbsp;The Grantee shall have no rights as a stockholder with respect to the Performance Units.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Construction</font>.&nbsp;&nbsp;This Award Agreement is subject to the terms of the Plan and shall be construed in accordance therewith.&nbsp;&nbsp;All capitalized and undefined terms herein are subject to the definitions contained in the Plan.&nbsp;&nbsp;The construction and operation of this Award Agreement are governed by the laws of the State of Illinois without regard to any conflicts or choice of law rules or principles that might otherwise refer construction or interpretation of this Award Agreement to the substantive law of another jurisdiction, and any litigation arising out of this Award Agreement shall be brought in the Circuit Court of the State of Illinois or the United States District Court for the Eastern Division of the Northern District of Illinois and the Grantee consents to the jurisdiction and venue of those courts.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-7</a>-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU9"></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.</font><font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Severability</font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;In the event that any provision or portion of this Award Agreement shall be determined to be invalid or unenforceable for any reason, the remaining provisions of this Award Agreement shall be unaffected thereby and shall remain in full force and effect.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Dispute Resolution</font>.&nbsp;&nbsp;The parties initially shall attempt to resolve by direct negotiation any dispute, controversy or claim arising out of or relating to this Award Agreement or its breach or interpretation (each, a &#8220;Dispute&#8221;).&nbsp;&nbsp;For purposes of this negotiation, the Company shall be represented by one or more of its independent directors appointed by the Board of Directors. If the parties are unable to resolve the Dispute by direct negotiation within 30 days after written notice by one party to the other of the Dispute, the Dispute shall be settled by submission by either party of the Dispute to binding arbitration in Chicago, Illinois (unless the parties agree in writing to a different location), before a single arbitrator in accordance with the American Arbitration Association's National Rules for the Resolution of Employment Disputes then in effect.&nbsp;&nbsp;The arbitrator will be an attorney licensed to practice law in the State of Illinois.<font style="font-family:Courier New;">&nbsp;&nbsp;</font>The decision and award made by the arbitrator shall be final, binding and conclusive on all parties hereto for all purposes, and judgment may be entered thereon in any court having jurisdiction thereof.&nbsp;&nbsp;Except as set forth below, each party shall pay:&nbsp;&nbsp;the fees of their or its attorneys; the expenses of their or its witnesses; and all other expenses connected with presenting their or its case.&nbsp;&nbsp;Except as set forth below, the costs of the arbitration, including the cost of any record or transcripts of the arbitration hearing, administrative fees, the fees of the arbitrator, and all other fees and costs shall be borne equally by the parties.&nbsp;&nbsp;In the event of a Dispute following or in connection with a Change of Control, the Company shall pay the fees of the arbitrator as well as the cost of any record or transcripts of the arbitration hearing and other administrative fees and costs.&nbsp;&nbsp;In all Disputes, the arbitrator will have discretion to make an award of fees, costs and expenses to the prevailing party.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Section 409A Compliance</font>.&nbsp;&nbsp;It is the intention of the Company and the Grantee that the Restricted Stock and related benefits awarded under this Award Agreement shall be exempt from the requirements of Section 409A of the Code and its implementing regulations (&#8220;Section 409A&#8221;) and shall be interpreted in a manner consistent with this intention.&nbsp;&nbsp;In the event that the Company or the Grantee reasonably determines that the Restricted Stock and/or any related benefits under this Award Agreement may be subject to Section 409A, the Company and Grantee shall work together to adopt such amendments to this Award Agreement or adopt other policies or procedures (including amendments, policies and procedures with retroactive effective to the extent allowed under applicable laws), or take any other commercially reasonable actions necessary or appropriate to cause the Restricted Stock and related benefits awarded under this Award Agreement to (i) be exempt from Section 409A, or (ii) otherwise comply with the requirements of Section 409A.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><a name="_AEIOULastRenderedPageBreakAEIOU10"></a>It is the intention of the Company and the Grantee that the Performance Units and related benefits awarded under this Award Agreement shall comply with Section 409A and shall be interpreted in a manner consistent with this intent.&nbsp;&nbsp;Notwithstanding anything to the contrary contained herein, a termination of Grantee&#8217;s employment shall not be deemed to have occurred for purposes of making any payments under this Award Agreement related to the Performance Units unless such termination gives rise to a &#8220;Separation from Service&#8221; (within the meaning of Section 409A, a &#8220;Separation from Service&#8221;) and references to &#8220;termination of employment&#8221; shall mean Separation from Service.&nbsp;&nbsp;In the event that the Company or the Grantee reasonably determines that the Performance Units and/or any related benefits under this Award Agreement fails to comply with Section 409A, the Company and Grantee shall work together to adopt such amendments to this Award Agreement or adopt other policies or procedures </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-8-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(including amendments, policies and procedures with retroactive effective to the extent allowable by applicable laws), or take any other commercially reasonable actions necessary or appropriate to comply with the requirements of Section 409A.&nbsp;&nbsp;Nothing in this Agreement shall be construed as a guarantee of any particular tax treatment to Grantee.&nbsp;&nbsp;Grantee shall be solely responsible for the tax consequences with respect to all amounts payable under this Award Agreement, and in no event shall the Company have any responsibility or liability if this Award Agreement does not meet any applicable requirements of Section 409A.</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">No Retention Rights</font>.&nbsp;&nbsp;Nothing herein contained shall confer on the Grantee any right with respect to continuation of employment or services by the Company or its Subsidiaries or Affiliates, or interfere with the right of the Company or its Subsidiaries or Affiliates to terminate at any time the employment or service of the Grantee.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">No Guarantee of Future Awards</font>.&nbsp;&nbsp;The grant of Awards is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants, even if Awards have previously been granted.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Counterparts</font>.&nbsp;&nbsp;This Award Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Entire Agreement; Clawback Policy</font>.&nbsp;&nbsp;This Award Agreement supersedes and cancels all prior written or oral agreements and understandings relating to the terms of this Award Agreement.&nbsp;&nbsp;This Award Agreement and the Awards granted hereunder are subject to any Company Clawback Policy in effect as of the date of this Award Agreement or as subsequently amended, modified or replaced, and the terms of the Change in Control Agreement between the Grantee and the Company, as the same may be amended from time to time, if any.</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[Signature Page to Follow]</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU11"></a><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-9-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-indent:7.69%;">IN WITNESS WHEREOF, the Company by one of its duly authorized representatives has executed this Award Agreement as of the day and year first above written.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">METHODE ELECTRONICS, INC.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="ggizbojlzucw000001.jpg" title="" alt ="" style="position:absolute;margin-left:-2.35pt;margin-top:4.6pt;width:201.8pt;height:42.8pt;z-index:-251658240;mso-wrap-edited:f"><font style="font-family:Times New Roman;font-size:1pt;color:#FFFFFF;"></font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:<font style="margin-left:27pt;"></font><font style="text-decoration:underline;margin-left:36pt;"></font><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="margin-left:27pt;">Darren M. Dawson</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Its:<font style="margin-left:27pt;">Chair, Compensation Committee</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Please indicate your acceptance of the terms and conditions of this Award Agreement by signing in the space provided below and returning a signed copy of this Award Agreement to the Company.&nbsp;&nbsp;IF A FULLY EXECUTED COPY OF THIS AWARD AGREEMENT HAS NOT BEEN RECEIVED BY THE COMPANY BY OCTOBER 23, 2020, THE AWARD UNDER THIS AWARD AGREEMENT SHALL BE CANCELLED.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">BY SIGNING BELOW, YOU ACKNOWLEDGE AND AGREE THAT YOU HAVE RECEIVED A COPY OF THE PLAN AND ARE FAMILIAR WITH THE TERMS AND PROVISIONS THEREOF, INCLUDING THE TERMS AND PROVISIONS OF THIS AWARD AGREEMENT.&nbsp;&nbsp;YOU HAVE REVIEWED THE PLAN AND THIS AWARD AGREEMENT IN THEIR ENTIRETY, HAVE HAD AN OPPORTUNITY TO OBTAIN THE ADVICE OF COUNSEL PRIOR TO EXECUTING THIS AWARD AGREEMENT AND FULLY UNDERSTAND ALL PROVISIONS OF THIS AWARD AGREEMENT.&nbsp;&nbsp;FINALLY, YOU HEREBY AGREE TO ACCEPT AS BINDING, CONCLUSIVE AND FINAL ALL DECISIONS OR INTERPRETATIONS OF THE ADMINISTRATOR UPON ANY QUESTIONS ARISING UNDER THE PLAN OR THIS AWARD AGREEMENT.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The undersigned hereby accepts, and agrees to, all terms and provisions of this Award Agreement and the Plan as they pertain hereto.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<div style="width:100%;">
<div style="float:left;width:48%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU12"></a>GRANTEE<font style="margin-left:36pt;"></font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">____________________________________</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[___________________]</p></div>
<div style="float:right;width:48%;padding-left:4%">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:5.77%;text-indent:-5.77%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU2"></a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">&nbsp;</font></p></div></div>
<p style=" clear:both;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-10</a>-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU13"></a><font style="text-decoration:underline;">Exhibit A</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Threshold Fiscal 2025 EBITDA<font style="margin-left:36pt;">$270 million</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Target Fiscal 2025 EBITDA<font style="margin-left:36pt;">$300 million</font><font style="font-size:12pt;"> </font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Maximum Fiscal 2025 EBITDA<font style="margin-left:36pt;">&#8206;$330 million&#8206;</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU14"></a><br /></p>
<p style="margin-top:12pt;margin-bottom:0pt;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">-<font style="font-size:11pt;">11-</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;text-decoration:underline;">Exhibit B</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If Fiscal 2025 EBITDA achieved is less than Threshold Fiscal 2025 EBITDA, then no Restricted Stock will vest.&nbsp;&nbsp;If Fiscal 2025 EBITDA achieved equals or exceeds Threshold Fiscal 2025 EBITDA, then the following formula will be used to calculate the percentage of Restricted Stock that will vest (subject to a maximum of 100%):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i) 50%, plus (ii) 50% multiplied by a fraction equal to (Fiscal 2025 EBITDA achieved less Threshold Fiscal 2025 EBITDA) divided by (Target Fiscal 2025 EBITDA less Threshold Fiscal 2025 EBITDA)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-12</a>-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Exhibit C</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If Fiscal 2025 EBITDA achieved is less than Target Fiscal 2025 EBITDA, then no Performance Units shall be earned.&nbsp;&nbsp;If Fiscal 2025 EBITDA achieved equals or exceeds Target Fiscal 2025 EBITDA, then the following formula will be used to calculate the number of Performance Units earned:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The number of Performance Units multiplied by a fraction (subject to a maximum of one (1)), &#8206;the numerator of which shall equal (i) Fiscal 2025 EBITDA achieved minus (ii) Target Fiscal 2025 &#8206;EBITDA, and the denominator of which shall equal (a) Maximum Fiscal 2025 EBITDA minus (b) &#8206;Target Fiscal 2025 EBITDA.&nbsp;&nbsp;&nbsp;&nbsp; </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-13</a>-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Exhibit D</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Following is an example (not actual numbers) of the calculation of whether the net impact of an acquisition on Fiscal 2025 earnings per share (EPS) is positive.&nbsp;&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;  margin-left:1.15%;width:105.57%;">
<tr>
<td style="width:35.47%;"></td>
<td style="width:21.9%;"></td>
<td style="width:3.1%;"></td>
<td style="width:21.74%;"></td>
<td style="width:3.59%;"></td>
<td style="width:21.9%;"></td>
</tr>
<tr style="height:15.75pt;">
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td>
<td colspan="5" valign="bottom"  style=" border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"> Fiscal 2025 </p></td>
</tr>
<tr style="height:15.75pt;">
<td valign="bottom"  style=" border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"> Methode </p></td>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"> Acquired </p></td>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000; border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"> Methode </p></td>
</tr>
<tr style="height:15.75pt;">
<td valign="bottom"  style=" border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  style=" border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"> Actual </p></td>
<td valign="bottom"  style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"> - </p></td>
<td valign="bottom"  style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"> Unit </p></td>
<td valign="bottom"  style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"> = </p></td>
<td valign="bottom"  style=" border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"> Pro Forma </p></td>
</tr>
<tr style="height:15.75pt;">
<td valign="bottom"  style=" border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EBITDA</p></td>
<td valign="bottom"  BGCOLOR="#FFFF00" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;300,000,000 </p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFF00" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11,000,000 </p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  style=" border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;289,000,000 </p></td>
</tr>
<tr style="height:15.75pt;">
<td valign="bottom"  style=" border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depr. &amp; Amor.</p></td>
<td valign="bottom"  BGCOLOR="#FFFF00" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;50,000,000 </p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFF00" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,000,000 </p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  style=" border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;49,000,000 </p></td>
</tr>
<tr style="height:15.75pt;">
<td valign="bottom"  style=" border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense (income)</p></td>
<td valign="bottom"  BGCOLOR="#FFFF00" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5,000,000 </p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFF00" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 200,000 </p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  style=" border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4,800,000 </p></td>
</tr>
<tr style="height:15.75pt;">
<td valign="bottom"  style=" border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income before taxes</p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;245,000,000 </p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9,800,000 </p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  style=" border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;235,200,000 </p></td>
</tr>
<tr style="height:15.75pt;">
<td valign="bottom"  style=" border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax (20% eff. tax rate)</p></td>
<td valign="bottom"  BGCOLOR="#FFFF00" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;49,000,000 </p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFF00" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,960,000 </p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  style=" border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;47,040,000 </p></td>
</tr>
<tr style="height:15.75pt;">
<td valign="bottom"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net income</p></td>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;196,000,000 </p></td>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7,840,000 </p></td>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;188,160,000 </p></td>
</tr>
<tr style="height:15.75pt;">
<td valign="bottom"  style=" border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic common shares O/S</p></td>
<td valign="bottom"  BGCOLOR="#FFFF00" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 39,600,866 </p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  style=" border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 38,100,866 </p></td>
</tr>
<tr style="height:15.75pt;">
<td valign="bottom"  style=" border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares issued for acquisition</p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp; </p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFF00" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,500,000 </p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  style=" border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr style="height:15.75pt;">
<td valign="bottom"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">Basic EPS</p></td>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4.95 </p></td>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4.94 </p></td>
</tr>
<tr style="height:15.75pt;">
<td valign="bottom"  style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p></td>
<td colspan="5" valign="bottom"  BGCOLOR="#92D050" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"> Actual &gt; Pro Forma = Accretive </p></td>
</tr>
<tr style="height:15.75pt;">
<td valign="bottom"  style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p></td>
<td colspan="5" valign="bottom"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"> Actual &lt; Pro Forma = Not Accretive </p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></a>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">83697058v.1</p>&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-14</a>-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>mei-ex102_37.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
mei-ex102_37.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Exhibit 10.2</font></p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">METHODE ELECTRONICS, INC. </font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FORM OF 2020 LONG-TERM PERFORMANCE-BASED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> AWARD AGREEMENT (CFO &amp; COO)</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Long-Term Performance-Based Award Agreement (the &#8220;Award Agreement&#8221;), effective as of September 27, 2020 (the &#8220;Award Date&#8221;), is entered into by and between Methode Electronics, Inc., a Delaware corporation (the &#8220;Company&#8221;) and [_____________] (the &#8220;Grantee&#8221;).&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">WHEREAS, the Company desires to reward Grantee for services to the Company and to encourage Grantee to continue to work for the benefit of the Company in a manner that will benefit all Company stockholders.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NOW, THEREFORE, in consideration of the premises and the mutual covenants and obligations hereinafter set forth, the Company agrees to award to Grantee (i) shares of Restricted Stock of the Company (the &#8220;Restricted Stock&#8221;), and (ii) Performance Units (the &#8220;Performance Units&#8221;) under the Methode Electronics, Inc. 2014 Omnibus Incentive Plan (the &#8220;Plan&#8221;) on the terms and conditions set forth herein and in the Plan (collectively, the &#8220;Awards&#8221;).</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">General</font>.&nbsp;&nbsp;This Award Agreement and the Restricted Stock and Performance Units awarded herein are subject to all of the provisions of the Plan applicable to such Awards. Unless the context otherwise requires, capitalized terms used herein shall have the same meanings as in the Plan.&nbsp;&nbsp;Grantee hereby acknowledges receipt of a copy of the Plan and that Grantee has read the Plan and fully understands its content.&nbsp;&nbsp;In the event of any conflict between the terms of this Award Agreement and the terms of the Plan, the terms of the Plan shall control.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Awards</font>.&nbsp;&nbsp;The Company hereby grants to Grantee (i) a total of [_______] shares of Restricted Stock and (ii) a total of [_______] Performance Units payable in cash.<font style="font-size:12pt;"> </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Vesting</font>.&nbsp;&nbsp;Subject to the terms of this Award Agreement, the Restricted Stock shall vest and the Performance Units shall be earned on the date (the &#8220;Vesting Date&#8221;) that the Committee certifies performance under this Award Agreement, subject to the Grantee&#8217;s continued employment by the Company or a Subsidiary or Affiliate through the end of the Performance Period.&nbsp;&nbsp;Any Restricted Stock that does not vest and any Performance Units that are not earned pursuant to this Section 3 shall be immediately cancelled and forfeited to the Company as of the Vesting Date.&nbsp;&nbsp;Except as provided in Section 3(d), 3(e) or 3(f) below, all Restricted Stock and Performance Units shall be immediately cancelled and forfeited to the Company in the event Grantee ceases to be employed by the Company or a Subsidiary or Affiliate at any time prior the end of the Performance Period.&nbsp;&nbsp;To the extent Restricted Stock vests pursuant to Section 3(e) below or the Restricted Stock or Performance Units are forfeited pursuant to Section 6 below, such Restricted Stock shall not be eligible for vesting pursuant to Section 3(b), 3(d) or 3(f) and such Performance Units may not be earned pursuant to Section 3(c) or Section 3(d).&nbsp;&nbsp;Any fractional shares created by the vesting calculations described below will be rounded down to a whole share number; no fractional shares will vest pursuant to this Award Agreement.&nbsp;&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><a name="_AEIOULastRenderedPageBreakAEIOU3"></a><font style="text-decoration:underline;font-size:11pt;">Performance Period and Fiscal 2025 EBITDA</font><font style="font-size:11pt;">.&nbsp;&nbsp;The &#8220;Performance Period&#8221; is the fiscal year of the Company ending on or about May 3, 2025 (&#8220;Fiscal 2025&#8221;).&nbsp;&nbsp;Except to the </font></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">83459061</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap"></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:11pt;">extent provided in Section 3(d), 3(e) or 3(f), the number of shares of Restricted Stock that shall vest and the number of Performance Units that shall be earned will be based on the Company&#8217;s EBITDA for the Performance Period (&#8220;Fiscal 2025 EBITDA&#8221;), subject to the Grantee&#8217;s continued employment with the Company or a Subsidiary or Affiliate through the end of such Performance Period, and provided that a Change of Control has not occurred before the end of the Performance Period.</font></p></td></tr></table></div>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:15.38%;text-indent:-7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For this purpose and subject to Section 4 below, Fiscal 2025 EBITDA shall equal the Company&#8217;s earnings before net interest, taxes, fixed asset depreciation and intangible asset amortization (&#8220;EBITDA&#8221;) in Fiscal 2025 adjusted as follows: (A) all positive EBITDA from acquisitions that close during the period from the Award Date to the end of the Performance Period and that are not accretive (as defined below) in Fiscal 2025 shall be excluded; and (B)<font style="font-size:12pt;"> </font>&#8206;to the extent not otherwise included in 2025 EBITDA, all EBITDA from business unit &#8206;divestitures or spinoffs that were approved by the Company&#8217;s Board of Directors and close &#8206;during the period from the Award Date to the end of the Performance Period shall be included.&nbsp;&nbsp;&#8206;The amount of EBITDA to be included for a business unit divestiture or spinoff shall be the &#8206;actual EBITDA of the business unit for the four full quarters immediately preceding the &#8206;divestiture or spinoff, or if greater, the amount of EBITDA that the Committee reasonably &#8206;determines more appropriately reflects the amount of EBITDA the business unit would have &#8206;contributed to Fiscal 2025 EBITDA.&#8206;&nbsp;&nbsp;In order for an acquisition to qualify as accretive, (Y) the EBITDA in Fiscal 2025 from the acquisition must exceed Fiscal 2025 interest expense related to any debt assumed or issued in connection with the acquisition, and (Z) the net impact of the acquisition on Fiscal 2025 earnings per share (&#8220;EPS&#8221;) must be positive (i.e., Fiscal 2025 EPS with the acquisition is greater than Fiscal 2025 EPS without the acquisition).&nbsp;&nbsp;<font style="text-decoration:underline;">Exhibit D</font> hereto includes an illustrative calculation of the net impact on EPS.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:15.38%;text-indent:-7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Threshold, Target and Maximum levels of Fiscal 2025 EBITDA are set forth on <font style="text-decoration:underline;">Exhibit A</font> attached hereto.&nbsp;&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="text-decoration:underline;font-size:11pt;">Number of Shares of Restricted Stock that Vest</font><font style="font-size:11pt;">.&nbsp;&nbsp;</font><font style="text-decoration:underline;font-size:11pt;">Exhibit B</font><font style="font-size:11pt;"> attached hereto sets forth the formula for calculating the vesting percentage applicable to the Restricted Stock based on the Fiscal 2025 EBITDA achieved.&nbsp;&nbsp;Pursuant to </font><font style="text-decoration:underline;font-size:11pt;">Exhibit B</font><font style="font-size:11pt;">, if the level of performance achieved is greater than or equal to Threshold Fiscal 2025 EBITDA, then the number of shares of Restricted Stock that will vest under this Award Agreement shall be determined by multiplying the number of shares of Restricted Stock by a percentage (subject to a maximum of one hundred percent (100%)), equal to (i) fifty percent (50%) plus (ii) fifty percent (50%) multiplied by a fraction, the numerator of which shall equal (x) Fiscal 2025 EBITDA achieved minus Threshold Fiscal 2025 EBITDA, and the denominator of which shall equal (y) Target Fiscal 2025 EBITDA minus Threshold Fiscal 2025 EBITDA.&nbsp;&nbsp;If the level of performance achieved is less than Threshold Fiscal 2025 EBITDA, then no Restricted Stock shall vest pursuant to this Section 3.3(b).&nbsp;&nbsp;Except as provided in Section 3(d), 3(e) or 3(f) below, if the Grantee experiences a termination of employment or a Change of Control occurs, in either case, prior to the end of the Performance Period, no vesting shall occur under this Section 3(b).</font></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-2</a>-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><a name="_AEIOULastRenderedPageBreakAEIOU4"></a><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="text-decoration:underline;font-size:11pt;">Number of Performance Units Earned</font><font style="font-size:11pt;">.&nbsp;&nbsp;</font><font style="text-decoration:underline;font-size:11pt;">Exhibit C</font><font style="font-size:11pt;"> attached hereto sets forth the formula for calculating the number of Performance Units earned based on the Fiscal &#8206;&#8206;2025 EBITDA achieved.&nbsp;&nbsp;Pursuant to </font><font style="text-decoration:underline;font-size:11pt;">Exhibit C</font><font style="font-size:11pt;">, the number of Performance Units earned shall be determined by &#8206;multiplying the number of Performance Units by a fraction (subject to a maximum of one (1)), &#8206;the numerator of which shall equal (i) Fiscal 2025 EBITDA achieved minus (ii) Target Fiscal 2025 &#8206;EBITDA, and the denominator of which shall equal (a) Maximum Fiscal 2025 EBITDA minus (b) &#8206;Target Fiscal 2025 EBITDA.&nbsp;&nbsp;If the level of performance achieved is less than or equal to the Target &#8206;Fiscal 2025 EBITDA, then no Performance Units shall be earned pursuant to this Section 3.3(c).&nbsp;&nbsp;Except as provided in Section 3(d) below, if the Grantee experiences a termination of employment or a Change of Control occurs, in either case, prior to the end of the Performance Period, no Performance Units shall be earned under this Section 3(c).</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="text-decoration:underline;font-size:11pt;">Effect of Termination of Employment in Connection with Death, Disability or Retirement</font><font style="font-size:11pt;">.&nbsp;&nbsp;Notwithstanding Sections (b) and (c) above, the following provisions shall apply to the Awards in the event of Grantee&#8217;s termination of employment in connection with death, disability or retirement prior to the end of the Performance Period: </font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">if Grantee&#8217;s employment with the Company and its Subsidiaries and Affiliates is terminated due to total and permanent disability as determined by the Company or death, then all of the Restricted Stock will become immediately vested and no Performance Units shall be earned and payable; and </p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">if Grantee&#8217;s employment with the Company and its Subsidiaries and Affiliates is terminated due to retirement on or after Grantee&#8217;s sixty-fifth birthday or retirement on or after Grantee&#8217;s fifty-fifth birthday with consent of the Committee then, the shares of Restricted Stock and the Performance Units shall, as of the Vesting Date, vest and be earned based on actual performance on a pro rata basis based on the date of termination.&nbsp;&nbsp;The fraction to be used to determine the number of shares of Restricted Stock to vest and the number of Performance Units to be earned hereunder shall have a numerator equal to the number of fiscal months elapsed between May 2, 2020 and the date of termination (rounded up to the nearest whole month), and the denominator of which shall be sixty (60).&nbsp;&nbsp;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(e)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="text-decoration:underline;font-size:11pt;">Change of Control</font><font style="font-size:11pt;">.&nbsp;&nbsp;Notwithstanding (b) and (c) above, the following provisions shall apply to the Awards in the event of a Change of Control prior to the end of the Performance Period&#8206;: </font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i) </font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">in the event of a Change of Control, the surviving or successor entity (or its parent corporation) may continue, assume or replace the Awards on substantially the same terms and conditions (with such adjustments as may be required or permitted by Section 15 of the Plan), and such Awards or replacements therefor shall remain outstanding and be governed by their respective terms, subject to (iii) and (iv) below; </p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii) </font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;"><a name="_AEIOULastRenderedPageBreakAEIOU5"></a>if and to the extent that the Awards are not continued, assumed or replaced in &#8206;&#8206;connection with a Change of Control that occurs after May 1, 2021&#8206;, then a pro rata </p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-3-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap"></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">portion of the shares of Restricted Stock will &#8206;&#8206;become immediately vested and no Performance Units &#8206;shall be earned and payable.&nbsp;&nbsp;&#8206; If the Change of &#8206;Control occurs on or before May 1, 2021, then no shares of Restricted Stock &#8206;shall be earned and payable.&nbsp;&nbsp;If the Change of Control occurs after May 1, 2021&#8206;, then the fraction (subject to a maximum of one (1)) to be used to &#8206;determine the number of shares of Restricted Stock to vest hereunder shall have a denominator equal &#8206;to sixty (60), and the numerator shall be determined as follows: (A) if the &#8206;Change of Control occurs after May 1, 2021 and on or before April 29, 2023, the &#8206;numerator shall be equal to the number of fiscal months elapsed between May 2, 2020 &#8206;and the date of the Change of Control (rounded up to the nearest whole month); and (B) &#8206;if the Change of Control occurs after April 29, 2023, the numerator shall be sixty (60)&#8206;;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iii)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">&#8206; if and to the extent that the Awards are continued, assumed or replaced under the &#8206;circumstances described in Section 3(e)(i) in connection with a Change of Control that occurs after May 1, 2021&#8206;, and if within two years after the Change of &#8206;Control, Grantee experiences an involuntary termination of employment or other service &#8206;for reasons other than Cause or Grantee shall terminate employment with Good Reason, &#8206;then a pro rata portion of the shares of Restricted Stock will become immediately vested and no &#8206;Performance Units shall be earned and payable.&nbsp;&nbsp;&#8206; If the Change of &#8206;Control occurs on or before May 1, 2021, then no shares of Restricted Stock &#8206;shall be earned and payable.&nbsp;&nbsp;If the Change of Control occurs after May 1, 2021&#8206;, then the fraction &#8206;&#8206;(subject to a maximum of one (1)) to be used to determine the number of shares of Restricted Stock &#8206;to vest hereunder shall have a denominator equal to sixty (60), and the numerator shall &#8206;be determined as follows: (A) if the termination of employment occurs &#8206;after May 1, 2021 and on or before April 29, 2023, the numerator shall be equal to the &#8206;number of fiscal months elapsed between May 2, 2020 and the date of the termination of &#8206;employment (rounded up to the nearest whole month); and (B) if the termination of &#8206;employment occurs after April 29, 2023, the numerator shall be sixty (60)&#8206;; and </p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iv)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;"><a name="_AEIOULastRenderedPageBreakAEIOU6"></a>Notwithstanding whether the Awards are continued, assumed or replaced in connection with a Change of Control, if Grantee experiences an involuntary termination of employment or other service for reasons other than Cause or Grantee shall terminate employment with Good Reason during the period beginning on the date an agreement is entered into by the Company with respect to a merger, consolidation or similar transaction of the Company, which would constitute a Change of Control, and the effective time of such merger, consolidation or similar transaction of the Company, and such effective time<font style="font-size:12pt;"> </font>occurs after May 1, 2021&#8206;, then a pro rata portion of the shares of Restricted Stock will become immediately vested and no Performance Units shall be earned and payable.&nbsp;&nbsp;If the Change of &#8206;Control occurs on or before May 1, 2021, then no shares of Restricted Stock &#8206;shall be earned and payable.&nbsp;&nbsp;If the Change of Control occurs after May 1, 2021&#8206;, then the fraction (subject to a maximum of one (1)) to be used to determine the number of shares of Restricted Stock to vest hereunder shall have a denominator equal to sixty (60), and the numerator shall be determined as follows: (A) if the Change of Controls occurs after May 1, 2021 and on or before April 29, 2023, the numerator shall be equal to the number of fiscal months elapsed between May 2, 2020 and the date of the Change of Control (rounded up to the nearest whole month); and (B) </p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-4-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap"></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">if the Change of Control occurs after April 30, 2023, the numerator shall be sixty (60).&nbsp;&nbsp;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(f)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="text-decoration:underline;font-size:11pt;">Effect of Involuntary Termination of Employment Without Cause</font><font style="font-size:11pt;">.&nbsp;&nbsp;Notwithstanding Sections (b) and (c) above, if Grantee experiences an involuntary termination of employment for reasons other than Cause after May 1, 2021, then shares of Restricted Stock and the Performance Units shall, as of the Vesting Date, vest and be earned based on actual performance on a pro rata basis based on the date of Grantee&#8217;s termination of employment.&nbsp;&nbsp;If the involuntary termination of employment for reasons other than Cause occurs on or before May 1, 2021, then no shares of Restricted Stock and no Performance Units &#8206;shall be earned and payable. If the involuntary termination of employment for reasons other than Cause occurs after May 1, 2021, then the fraction (subject to a maximum of one (1)) to be used to determine the number of shares of Restricted Stock to vest and the number of Performance Units to be earned hereunder shall have a denominator equal to sixty (60) and the numerator shall be equal to the number of fiscal months elapsed between May 2, 2020 and the date of the termination of employment (rounded up to the nearest whole month). Grantee&#8217;s right to this pro rata portion of Restricted Stock and Performance Units is conditioned upon Grantee signing and delivering to the Company, within the time period required by the Company, a written general release of claims against the Company in a form acceptable to the Company (the &#8220;Release&#8221;), and not revoking the Release within any applicable revocation period.&nbsp;&nbsp; </font></p></td></tr></table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU7"></a>&#8220;Good Reason&#8221; shall exist under (e)(iii) or (iv) above if, without Grantee&#8217;s express written consent any of the following events or actions occurs, provided that no finding of Good Reason shall be effective unless and until the Grantee has provided the Company, within sixty (60) calendar days of becoming aware of the facts and circumstances underlying the finding of Good Reason, with written notice thereof stating with specificity the facts and circumstances underlying the finding of Good Reason and, if the basis for such finding of Good Reason is capable of being cured by the Company, providing the Company with an opportunity to cure the same within thirty (30) calendar days after receipt of such notice: (A) the Company shall materially reduce the nature, scope or level of Grantee&#8217;s responsibilities from the nature, scope or level of such responsibilities prior to the Change of Control, or shall fail to provide Grantee with adequate office facilities and support services to perform such responsibilities; (B) the Company shall require Grantee to move Grantee&#8217;s principal business office more than 25 miles from Grantee&#8217;s principal business office at the time of this Award Agreement, or assign to Grantee duties that would reasonably require such move; provided, however, that if Grantee&#8217;s principal business office is not located at the Company&#8217;s then current corporate headquarters, and the Company requires Grantee to move Grantee&#8217;s principal business office to such corporate headquarters, or assigns to Grantee duties that would reasonably require such move, such actions shall not constitute &#8220;Good Reason&#8221; under this subsection; (C) the Company shall require Grantee, or assign duties to Grantee which would reasonably require Grantee, to increase, by more than twenty-four, the number of normal working days (determined at the time of this Award Agreement) that Grantee spends away from Grantee&#8217;s principal business office during any consecutive twelve-month period; (D) the Company shall reduce Grantee&#8217;s annual salary below that in effect as of the date of this Award Agreement (or as of the Change of Control, if greater); (E) the Company shall materially reduce or fail to continue in effect any cash or stock-based incentive or bonus plan, retirement plan, welfare benefit plan, or other benefit plan, program or arrangement, unless the aggregate value (as computed by an independent employee benefits consultant selected by the Company) of all such incentive, bonus, retirement and benefit plans, programs and arrangements provided </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-5-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to Grantee is not materially less than their aggregate value as of the date of this Award Agreement (or as of the Change of Control, if greater); or (F) if the Board of Directors fails to act in good faith with respect to the Company&#8217;s obligations hereunder, or the Company breaches its obligations hereunder.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Grantee agrees, as a condition of this Award, to make acceptable arrangements to pay any withholding or other taxes or deductions that may be due or may arise as a result of the vesting of the Restricted Stock, the settlement of the Performance Units, or any other payment or issuance of shares of Common Stock under this Award Agreement.&nbsp;&nbsp;In the event that the Company determines that any federal, state, local or foreign tax or withholding payment or other deduction is required relating to the vesting or issuance of shares or the payment of cash under this Award Agreement, the Company shall have the right to require such amounts or deductions from Grantee, or withhold such amounts or deductions from other payments due Grantee from the Company or any Subsidiary or Affiliate.</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Discretion to Adjust and Modify the Fiscal 2025 EBITDA Performance Levels</font>.&nbsp;&nbsp;The Committee shall have the authority to specify adjustments or modifications to be made to &#8206;the Threshold, Target and Maximum levels of Fiscal 2025 EBITDA based on and in order to &#8206;appropriately reflect the effect of the following events: (i) asset write-downs; (ii) litigation or claim judgments or &#8206;settlements; (iii) the effect of changes in tax laws, accounting principles, or other laws or &#8206;regulatory rules affecting reported results; (iv) any reorganization and restructuring programs; (v) &#8206;any change in the Company&#8217;s fiscal year; (vi) circumstances that impact the Company&#8217;s financial &#8206;performance that are outside of the control of the Company, such as acts of God; earthquakes; &#8206;fires; floods; severe weather events; natural or manmade disasters; wars; civil or military &#8206;disturbances; acts of terrorism; sabotage; embargoes; martial law; acts of civil or military &#8206;authorities; political unrest; riots; global economic events; strikes; labor disputes; lockouts; &#8206;epidemics; or pandemics; or (vii) unforeseen impacts related to mergers, acquisitions and &#8206;divestitures&#8206;.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Settlement of Performance Units</font>.&nbsp;&nbsp;Except as otherwise provided herein, the &#8206;Performance Units shall &#8206;&#8206;be &#8206;settled and paid in cash in an amount equal to the number of earned Performance Units multiplied by the Fair Market Value of the Company&#8217;s Common Stock as of the Vesting Date.&nbsp;&nbsp;The payment will be made within 2&#189; months after the end of the Performance &#8206;Period (or &#8206;earlier &#8206;as provided &#8206;in the Plan).&nbsp;&nbsp;At any time prior to the end of the Performance Period, the Committee shall have the authority to provide that the Performance Units will be settled in shares of the Company&#8217;s Common Stock instead of cash (the date of such Committee action referred to herein as the &#8220;Conversion Date&#8221;).&nbsp;&nbsp;In such event, if requested by the Committee, Grantee and the Company shall enter into an appropriate amendment to this Award Agreement to document such change.&nbsp;&nbsp;Notwithstanding the foregoing, in the event that the Grantee is a &#8220;specified employee&#8221; &#8206;within the meaning of Section 409A(a)(2)(B)(i) of the Code and the Award is considered &#8206;to be Nonqualified Deferred Compensation upon the Grantee&#8217;s &#8220;Separation from &#8206;Service&#8221; as defined below, any payment under this Award Agreement which results &#8206;from a Separation from Service shall be delayed until the earlier of (i) first day of the &#8206;seventh (7th) month beginning after the Grantee&#8217;s Separation from Service, or (ii) the &#8206;Grantee&#8217;s death, if such a delay is necessary to avoid the imposition of additional tax &#8206;and interest on the Grantee under Section 409A(a)(1)(B) of the Code.<font style="font-size:12pt;">&#8206;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU8"></a>6.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Forfeiture</font>.&nbsp;&nbsp;If at any time any of the following events occur: (i) Grantee&#8217;s conviction of a felony other than a traffic violation; &#8206;(ii)&#8206; Grantee&#8217;s commission of any act or acts of personal dishonesty intended to &#8206;result in &#8206;personal enrichment to Grantee to the material detriment of the Company;&#8206; &#8206;(iii) a failure to perform assigned duties,&#8206; provided that such failure has continued for more than ten (10) days </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-6-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">after the Board of Directors or the &#8206;Chief Executive Officer of the Company has given written notice of such failure;&#8206; &#8206;(iv)&#8206; any willful misconduct by the Grantee which materially affects the business &#8206;reputation &#8206;of the Company; &#8206;(v) breach in any material respect by the Grantee of any provision of any &#8206;employment, &#8206;consulting, advisory, nondisclosure, non-competition, proprietary information, or &#8206;other similar agreement &#8206;between the Grantee and the Company; or &#8206;(vi)&#8206; Grantee&#8217;s material violation of the Company&#8217;s code of conduct&#8206;, &#8206;then the unvested Restricted Stock and unearned Performance Units shall be forfeited to the Company effective as of the date on which the Grantee entered into such &#8206;activity, unless terminated sooner by operation of another term or condition of this Award Agreement or &#8206;the Plan.&#8206;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Additional Delivery</font>.&nbsp;&nbsp;Within 2&#189; months of the date Restricted Stock vests under Section 3, the Company shall pay to the Grantee <font style="color:#000000;">an amount equal to the aggregate per share cash dividends with respect to all cash dividend record dates that fall between the Award Date and the date the unrestricted shares are registered with the Company&#8217;s transfer agent in the name of the Grantee, multiplied by the number of shares of Restricted Stock that vest pursuant to this Award Agreement (without interest).&nbsp;&nbsp;In addition, if the Committee provides that the Performance Units will be settled in shares of the Company&#8217;s Common Stock instead of cash, then within 2&#189; months of the date the Performance Units vest under Section 3, the Company shall pay to the Grantee an amount equal to the aggregate per share cash dividends with respect to all cash dividend record dates that fall between the Conversion Date and the date the unrestricted shares are registered with the Company&#8217;s transfer agent in the name of the Grantee, multiplied by the number of Performance Units that vest pursuant to this Award Agreement (without interest). The Company may withhold from any payment that it is required to make under this Award Agreement amounts sufficient to satisfy applicable withholding requirements under any foreign, federal, state or local law due in connection with this Award or the payment described in this Section 7.&nbsp;&nbsp;No dividends shall be paid to the Grantee with respect to the Performance Units or Restricted Stock that does not vest and is forfeited by the Grantee. </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Restrictions</font>.&nbsp;&nbsp;None of the Restricted Stock or Performance Units may be sold, transferred, pledged, hypothecated or otherwise encumbered or disposed of until it has vested in accordance with the terms of this Award Agreement.&nbsp;&nbsp;Any Restricted Stock that is not vested and any Performance Units that are not earned shall be forfeited to the Company immediately upon termination of the Grantee&#8217;s employment with the Company and all of its Subsidiaries and Affiliates or upon the expiration of this Award Agreement.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Stock Delivery</font>.&nbsp;&nbsp;Within ten (10) days of the date of this Award Agreement, t<font style="color:#000000;">he Company will cause the Restricted Stock to be issued in the Grantee&#8217;s name either by book-entry registration or issuance of a stock certificate.&nbsp;&nbsp;While the Restricted Stock remains forfeitable, the Company will cause an appropriate stop-transfer order to be issued and to remain in effect with respect to the Restricted Stock. </font>Any stock certificate evidencing any Restricted Stock shall contain such legends and stock transfer instructions or limitations as may be determined or authorized by the Committee in its sole discretion; and the Company may, in its sole discretion, retain custody of any such certificate throughout the period during which any restrictions are in effect and require that the Grantee tender to the Company a stock power duly executed in blank relating thereto as a condition to issuing any such certificate.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU9"></a>10.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Rights as Stockholder</font>.&nbsp;&nbsp;The Grantee shall have no rights as a stockholder with respect to any Restricted Stock until the Restricted Stock is issued in Grantee&#8217;s name either by book-entry registration or issuance of a stock certificate.&nbsp;&nbsp;Once the Restricted Stock is issued in Grantee&#8217;s name, the </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-7-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Grantee shall be entitled to all rights associated with ownership of the Restricted Stock, except that the Grantee shall not be entitled to receive any dividends (cash or stock) with respect to the Restricted Stock until such time as the restrictions lapse in accordance with the terms of this Award Agreement.&nbsp;&nbsp;&nbsp;&nbsp;The Grantee shall have no rights as a stockholder with respect to the Performance Units.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Construction</font>.&nbsp;&nbsp;This Award Agreement is subject to the terms of the Plan and shall be construed in accordance therewith.&nbsp;&nbsp;All capitalized and undefined terms herein are subject to the definitions contained in the Plan.&nbsp;&nbsp;The construction and operation of this Award Agreement are governed by the laws of the State of Illinois without regard to any conflicts or choice of law rules or principles that might otherwise refer construction or interpretation of this Award Agreement to the substantive law of another jurisdiction, and any litigation arising out of this Award Agreement shall be brought in the Circuit Court of the State of Illinois or the United States District Court for the Eastern Division of the Northern District of Illinois and the Grantee consents to the jurisdiction and venue of those courts.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Severability</font>.&nbsp;&nbsp;In the event that any provision or portion of this Award Agreement shall be determined to be invalid or unenforceable for any reason, the remaining provisions of this Award Agreement shall be unaffected thereby and shall remain in full force and effect.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Dispute Resolution</font>.&nbsp;&nbsp;The parties initially shall attempt to resolve by direct negotiation any dispute, controversy or claim arising out of or relating to this Award Agreement or its breach or interpretation (each, a &#8220;Dispute&#8221;).&nbsp;&nbsp;For purposes of this negotiation, the Company shall be represented by one or more of its independent directors appointed by the Board of Directors. If the parties are unable to resolve the Dispute by direct negotiation within 30 days after written notice by one party to the other of the Dispute, the Dispute shall be settled by submission by either party of the Dispute to binding arbitration in Chicago, Illinois (unless the parties agree in writing to a different location), before a single arbitrator in accordance with the American Arbitration Association's National Rules for the Resolution of Employment Disputes then in effect.&nbsp;&nbsp;The arbitrator will be an attorney licensed to practice law in the State of Illinois.<font style="font-family:Courier New;">&nbsp;&nbsp;</font>The decision and award made by the arbitrator shall be final, binding and conclusive on all parties hereto for all purposes, and judgment may be entered thereon in any court having jurisdiction thereof.&nbsp;&nbsp;Except as set forth below, each party shall pay:&nbsp;&nbsp;the fees of their or its attorneys; the expenses of their or its witnesses; and all other expenses connected with presenting their or its case.&nbsp;&nbsp;Except as set forth below, the costs of the arbitration, including the cost of any record or transcripts of the arbitration hearing, administrative fees, the fees of the arbitrator, and all other fees and costs shall be borne equally by the parties.&nbsp;&nbsp;In the event of a Dispute following or in connection with a Change of Control, the Company shall pay the fees of the arbitrator as well as the cost of any record or transcripts of the arbitration hearing and other administrative fees and costs.&nbsp;&nbsp;In all Disputes, the arbitrator will have discretion to make an award of fees, costs and expenses to the prevailing party.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU10"></a>14.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Section 409A Compliance</font>.&nbsp;&nbsp;It is the intention of the Company and the Grantee that the Restricted Stock and related benefits awarded under this Award Agreement shall be exempt from the requirements of Section 409A of the Code and its implementing regulations (&#8220;Section 409A&#8221;) and shall be interpreted in a manner consistent with this intention.&nbsp;&nbsp;In the event that the Company or the Grantee reasonably determines that the Restricted Stock and/or any related benefits under this Award Agreement may be subject to Section 409A, the Company and Grantee shall work together to adopt such amendments to this Award Agreement or adopt other policies or procedures (including amendments, policies and procedures with retroactive effective to the extent allowed under applicable laws), or take </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-8-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">any other commercially reasonable actions necessary or appropriate to cause the Restricted Stock and related benefits awarded under this Award Agreement to (i) be exempt from Section 409A, or (ii) otherwise comply with the requirements of Section 409A.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">It is the intention of the Company and the Grantee that the Performance Units and related benefits awarded under this Award Agreement shall comply with Section 409A and shall be interpreted in a manner consistent with this intent.&nbsp;&nbsp;Notwithstanding anything to the contrary contained herein, a termination of Grantee&#8217;s employment shall not be deemed to have occurred for purposes of making any payments under this Award Agreement related to the Performance Units unless such termination gives rise to a &#8220;Separation from Service&#8221; (within the meaning of Section 409A, a &#8220;Separation from Service&#8221;) and references to &#8220;termination of employment&#8221; shall mean Separation from Service.&nbsp;&nbsp;In the event that the Company or the Grantee reasonably determines that the Performance Units and/or any related benefits under this Award Agreement fails to comply with Section 409A, the Company and Grantee shall work together to adopt such amendments to this Award Agreement or adopt other policies or procedures (including amendments, policies and procedures with retroactive effective to the extent allowable by applicable laws), or take any other commercially reasonable actions necessary or appropriate to comply with the requirements of Section 409A.&nbsp;&nbsp;Nothing in this Agreement shall be construed as a guarantee of any particular tax treatment to Grantee.&nbsp;&nbsp;Grantee shall be solely responsible for the tax consequences with respect to all amounts payable under this Award Agreement, and in no event shall the Company have any responsibility or liability if this Award Agreement does not meet any applicable requirements of Section 409A.</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">No Retention Rights</font>.&nbsp;&nbsp;Nothing herein contained shall confer on the Grantee any right with respect to continuation of employment or services by the Company or its Subsidiaries or Affiliates, or interfere with the right of the Company or its Subsidiaries or Affiliates to terminate at any time the employment or service of the Grantee.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">No Guarantee of Future Awards</font>.&nbsp;&nbsp;The grant of Awards is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants, even if Awards have previously been granted.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Counterparts</font>.&nbsp;&nbsp;This Award Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Entire Agreement; Clawback Policy</font>.&nbsp;&nbsp;This Award Agreement supersedes and cancels all prior written or oral agreements and understandings relating to the terms of this Award Agreement.&nbsp;&nbsp;This Award Agreement and the Awards granted hereunder are subject to any Company Clawback Policy in effect as of the date of this Award Agreement or as subsequently amended, modified or replaced, and the terms of the Change in Control Agreement between the Grantee and the Company, as the same may be amended from time to time, if any.</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[Signature Page to Follow]</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU11"></a><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-9-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-indent:7.69%;">IN WITNESS WHEREOF, the Company by one of its duly authorized representatives has executed this Award Agreement as of the day and year first above written.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">METHODE ELECTRONICS, INC.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gj4uhcx1wumu000001.jpg" title="" alt ="" style="position:absolute;margin-left:-2.35pt;margin-top:4.6pt;width:201.8pt;height:42.8pt;z-index:-251658240;mso-wrap-edited:f"><font style="font-family:Times New Roman;font-size:1pt;color:#FFFFFF;"></font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:<font style="margin-left:27pt;"></font><font style="text-decoration:underline;margin-left:36pt;"></font><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="margin-left:27pt;">Darren M. Dawson</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Its:<font style="margin-left:27pt;">Chair, Compensation Committee</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Please indicate your acceptance of the terms and conditions of this Award Agreement by signing in the space provided below and returning a signed copy of this Award Agreement to the Company.&nbsp;&nbsp;IF A FULLY EXECUTED COPY OF THIS AWARD AGREEMENT HAS NOT BEEN RECEIVED BY THE COMPANY BY OCTOBER 23, 2020, THE AWARD UNDER THIS AWARD AGREEMENT SHALL BE CANCELLED.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">BY SIGNING BELOW, YOU ACKNOWLEDGE AND AGREE THAT YOU HAVE RECEIVED A COPY OF THE PLAN AND ARE FAMILIAR WITH THE TERMS AND PROVISIONS THEREOF, INCLUDING THE TERMS AND PROVISIONS OF THIS AWARD AGREEMENT.&nbsp;&nbsp;YOU HAVE REVIEWED THE PLAN AND THIS AWARD AGREEMENT IN THEIR ENTIRETY, HAVE HAD AN OPPORTUNITY TO OBTAIN THE ADVICE OF COUNSEL PRIOR TO EXECUTING THIS AWARD AGREEMENT AND FULLY UNDERSTAND ALL PROVISIONS OF THIS AWARD AGREEMENT.&nbsp;&nbsp;FINALLY, YOU HEREBY AGREE TO ACCEPT AS BINDING, CONCLUSIVE AND FINAL ALL DECISIONS OR INTERPRETATIONS OF THE ADMINISTRATOR UPON ANY QUESTIONS ARISING UNDER THE PLAN OR THIS AWARD AGREEMENT.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The undersigned hereby accepts, and agrees to, all terms and provisions of this Award Agreement and the Plan as they pertain hereto.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<div style="width:100%;">
<div style="float:left;width:48%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU12"></a>GRANTEE<font style="margin-left:36pt;"></font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">____________________________________</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[___________________]</p></div>
<div style="float:right;width:48%;padding-left:4%">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:5.77%;text-indent:-5.77%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU2"></a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">&nbsp;</font></p></div></div>
<p style=" clear:both;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-10</a>-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU13"></a><font style="text-decoration:underline;">Exhibit A</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Threshold Fiscal 2025 EBITDA<font style="margin-left:36pt;">$270 million</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Target Fiscal 2025 EBITDA<font style="margin-left:36pt;">$300 million</font><font style="font-size:12pt;"> </font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Maximum Fiscal 2025 EBITDA<font style="margin-left:36pt;">&#8206;$330 million&#8206;</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU14"></a><br /></p>
<p style="margin-top:12pt;margin-bottom:0pt;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">-<font style="font-size:11pt;">11-</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;text-decoration:underline;">Exhibit B</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If Fiscal 2025 EBITDA achieved is less than Threshold Fiscal 2025 EBITDA, then no Restricted Stock will vest.&nbsp;&nbsp;If Fiscal 2025 EBITDA achieved equals or exceeds Threshold Fiscal 2025 EBITDA, then the following formula will be used to calculate the percentage of Restricted Stock that will vest (subject to a maximum of 100%):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i) 50%, plus (ii) 50% multiplied by a fraction equal to (Fiscal 2025 EBITDA achieved less Threshold Fiscal 2025 EBITDA) divided by (Target Fiscal 2025 EBITDA less Threshold Fiscal 2025 EBITDA)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-12</a>-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Exhibit C</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If Fiscal 2025 EBITDA achieved is less than Target Fiscal 2025 EBITDA, then no Performance Units shall be earned.&nbsp;&nbsp;If Fiscal 2025 EBITDA achieved equals or exceeds Target Fiscal 2025 EBITDA, then the following formula will be used to calculate the number of Performance Units earned:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The number of Performance Units multiplied by a fraction (subject to a maximum of one (1)), &#8206;the numerator of which shall equal (i) Fiscal 2025 EBITDA achieved minus (ii) Target Fiscal 2025 &#8206;EBITDA, and the denominator of which shall equal (a) Maximum Fiscal 2025 EBITDA minus (b) &#8206;Target Fiscal 2025 EBITDA.&nbsp;&nbsp;&nbsp;&nbsp; </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-13</a>-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Exhibit D</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Following is an example (not actual numbers) of the calculation of whether the net impact of an acquisition on Fiscal 2025 earnings per share (EPS) is positive.&nbsp;&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;  margin-left:1.15%;width:105.57%;">
<tr>
<td style="width:35.47%;"></td>
<td style="width:21.9%;"></td>
<td style="width:3.1%;"></td>
<td style="width:21.74%;"></td>
<td style="width:3.59%;"></td>
<td style="width:21.9%;"></td>
</tr>
<tr style="height:15.75pt;">
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;"><a name="RANGE!B1:G17"></a>&nbsp;</p></td>
<td colspan="5" valign="bottom"  style=" border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"> Fiscal 2025 </p></td>
</tr>
<tr style="height:15.75pt;">
<td valign="bottom"  style=" border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"> Methode </p></td>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"> Acquired </p></td>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000; border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"> Methode </p></td>
</tr>
<tr style="height:15.75pt;">
<td valign="bottom"  style=" border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  style=" border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"> Actual </p></td>
<td valign="bottom"  style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"> - </p></td>
<td valign="bottom"  style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"> Unit </p></td>
<td valign="bottom"  style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"> = </p></td>
<td valign="bottom"  style=" border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"> Pro Forma </p></td>
</tr>
<tr style="height:15.75pt;">
<td valign="bottom"  style=" border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EBITDA</p></td>
<td valign="bottom"  BGCOLOR="#FFFF00" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;300,000,000 </p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFF00" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11,000,000 </p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  style=" border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;289,000,000 </p></td>
</tr>
<tr style="height:15.75pt;">
<td valign="bottom"  style=" border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depr. &amp; Amor.</p></td>
<td valign="bottom"  BGCOLOR="#FFFF00" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;50,000,000 </p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFF00" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,000,000 </p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  style=" border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;49,000,000 </p></td>
</tr>
<tr style="height:15.75pt;">
<td valign="bottom"  style=" border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense (income)</p></td>
<td valign="bottom"  BGCOLOR="#FFFF00" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5,000,000 </p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFF00" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 200,000 </p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  style=" border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4,800,000 </p></td>
</tr>
<tr style="height:15.75pt;">
<td valign="bottom"  style=" border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income before taxes</p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;245,000,000 </p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9,800,000 </p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  style=" border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;235,200,000 </p></td>
</tr>
<tr style="height:15.75pt;">
<td valign="bottom"  style=" border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax (20% eff. tax rate)</p></td>
<td valign="bottom"  BGCOLOR="#FFFF00" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;49,000,000 </p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFF00" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,960,000 </p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  style=" border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;47,040,000 </p></td>
</tr>
<tr style="height:15.75pt;">
<td valign="bottom"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net income</p></td>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;196,000,000 </p></td>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7,840,000 </p></td>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;188,160,000 </p></td>
</tr>
<tr style="height:15.75pt;">
<td valign="bottom"  style=" border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic common shares O/S</p></td>
<td valign="bottom"  BGCOLOR="#FFFF00" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 39,600,866 </p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  style=" border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 38,100,866 </p></td>
</tr>
<tr style="height:15.75pt;">
<td valign="bottom"  style=" border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares issued for acquisition</p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp; </p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFF00" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,500,000 </p></td>
<td valign="bottom"  style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom"  style=" border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr style="height:15.75pt;">
<td valign="bottom"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">Basic EPS</p></td>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4.95 </p></td>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4.94 </p></td>
</tr>
<tr style="height:15.75pt;">
<td valign="bottom"  style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p></td>
<td colspan="5" valign="bottom"  BGCOLOR="#92D050" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"> Actual &gt; Pro Forma = Accretive </p></td>
</tr>
<tr style="height:15.75pt;">
<td valign="bottom"  style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p></td>
<td colspan="5" valign="bottom"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"> Actual &lt; Pro Forma = Not Accretive </p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></a>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">83692453v.1</p>&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-14</a>-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>mei-ex103_36.htm
<DESCRIPTION>EX-10.3
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
mei-ex103_36.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Exhibit 10.3</font></p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">METHODE ELECTRONICS, INC. </font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FORM OF 2020 LONG-TERM PERFORMANCE-BASED</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">AWARD AGREEMENT (DABIR)</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Long-Term Performance-Based Award Agreement (the &#8220;Award Agreement&#8221;), effective as of September 27, 2020 (the &#8220;Award Date&#8221;), is entered into by and between Methode Electronics, Inc., a Delaware corporation (the &#8220;Company&#8221;) and [_____________] (the &#8220;Grantee&#8221;).&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">WHEREAS, Grantee serves as President of Dabir Surfaces, Inc. (&#8220;Dabir&#8221;); and </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">WHEREAS, the Company desires to reward Grantee for services to the Company and to encourage Grantee to continue to work for the benefit of the Company in a manner that will benefit all Company stockholders.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NOW, THEREFORE, in consideration of the premises and the mutual covenants and obligations hereinafter set forth, the Company agrees to award to Grantee (i) shares of Restricted Stock of the Company (the &#8220;Restricted Stock&#8221;), and (ii) Performance Units (the &#8220;Performance Units&#8221;) under the Methode Electronics, Inc. 2014 Omnibus Incentive Plan (the &#8220;Plan&#8221;) on the terms and conditions set forth herein and in the Plan (collectively, the &#8220;Awards&#8221;).</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">General</font>.&nbsp;&nbsp;This Award Agreement and the Restricted Stock and Performance Units awarded herein are subject to all of the provisions of the Plan applicable to such Awards. Unless the context otherwise requires, capitalized terms used herein shall have the same meanings as in the Plan.&nbsp;&nbsp;Grantee hereby acknowledges receipt of a copy of the Plan and that Grantee has read the Plan and fully understands its content.&nbsp;&nbsp;In the event of any conflict between the terms of this Award Agreement and the terms of the Plan, the terms of the Plan shall control.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Awards</font>.&nbsp;&nbsp;The Company hereby grants to Grantee (i) a total of [_______] shares of Restricted Stock and (ii) a total of [_______] Performance Units payable in cash.<font style="font-size:12pt;"> </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Vesting</font>.&nbsp;&nbsp;Subject to the terms of this Award Agreement, the Restricted Stock shall vest and the Performance Units shall be earned on the date (the &#8220;Vesting Date&#8221;) that the Committee certifies performance under this Award Agreement, subject to the Grantee&#8217;s continued employment as President of Dabir through the end of the Performance Period.&nbsp;&nbsp;Any Restricted Stock that does not vest and any Performance Units that are not earned pursuant to this Section 3 shall be immediately cancelled and forfeited to the Company as of the Vesting Date.&nbsp;&nbsp;Except as provided in Section 3(d) or 3(e) below, all Restricted Stock and Performance Units shall be immediately cancelled and forfeited to the Company in the event Grantee ceases to be employed as President of Dabir at any time prior the end of the Performance Period.&nbsp;&nbsp;To the extent Restricted Stock vests pursuant to Section 3(e) below or the Restricted Stock or Performance Units are forfeited pursuant to Section 6 below, such Restricted Stock shall not be eligible for vesting pursuant to Section 3(b) or Section 3(d) and such Performance Units may not be earned pursuant to Section 3(c) or Section 3(d).&nbsp;&nbsp;Any fractional shares created by the vesting calculations described below will be rounded down to a whole share number; no fractional shares will vest pursuant to this Award Agreement.&nbsp;&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">83459293</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><a name="_AEIOULastRenderedPageBreakAEIOU3"></a><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="text-decoration:underline;font-size:11pt;">Performance Period and Fiscal 2025 Dabir EBITDA</font><font style="font-size:11pt;">.&nbsp;&nbsp;The &#8220;Performance Period&#8221; is the fiscal year of the Company ending on or about May 3, 2025 (&#8220;Fiscal 2025&#8221;).&nbsp;&nbsp;Except to the extent provided in Section 3(d) or 3(e), the number of shares of Restricted Stock that shall vest and the number of Performance Units that shall be earned will be based on Dabir&#8217;s EBITDA for the Performance Period (&#8220;Fiscal 2025 Dabir EBITDA&#8221;), subject to the Grantee&#8217;s continued employment as President of Dabir through the end of such Performance Period, and provided that a Change of Control has not occurred before the end of the Performance Period.</font></p></td></tr></table></div>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:15.38%;text-indent:-7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For this purpose, Fiscal 2025 Dabir EBITDA shall equal Dabir&#8217;s earnings before net interest, taxes, fixed asset depreciation and intangible asset amortization (&#8220;EBITDA&#8221;) in Fiscal 2025, as adjusted to exclude all EBITDA from acquisitions that close during the period from the Award Date to the end of the Performance Period.&nbsp;&nbsp; Fiscal 2025 Dabir EBITDA will be determined by the Committee in its sole discretion in consultation with the Chief Financial Officer.&nbsp;&nbsp;The Committee&#8217;s determination of Fiscal 2025 Dabir EBITDA shall be final and binding upon all parties to this Award Agreement.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:15.38%;text-indent:-7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Threshold, Target and Maximum levels of Fiscal 2025 Dabir EBITDA are set forth on <font style="text-decoration:underline;">Exhibit A</font> attached hereto.&nbsp;&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="text-decoration:underline;font-size:11pt;">Number of Shares of Restricted Stock that Vest</font><font style="font-size:11pt;">.&nbsp;&nbsp;</font><font style="text-decoration:underline;font-size:11pt;">Exhibit B</font><font style="font-size:11pt;"> attached hereto sets forth the formula for calculating the vesting percentage applicable to the Restricted Stock based on the Fiscal 2025 Dabir EBITDA achieved.&nbsp;&nbsp;Pursuant to </font><font style="text-decoration:underline;font-size:11pt;">Exhibit B</font><font style="font-size:11pt;">, if the level of performance achieved is greater than or equal to Threshold Fiscal 2025 Dabir EBITDA, then the number of shares of Restricted Stock that will vest under this Award Agreement shall be determined by multiplying the number of shares of Restricted Stock by a percentage (subject to a maximum of one hundred percent (100%)), equal to (i) fifty percent (50%) plus (ii) fifty percent (50%) multiplied by a fraction, the numerator of which shall equal (x) Fiscal 2025 Dabir EBITDA achieved minus Threshold Fiscal 2025 Dabir EBITDA, and the denominator of which shall equal (y) Target Fiscal 2025 Dabir EBITDA minus Threshold Fiscal 2025 Dabir EBITDA.&nbsp;&nbsp;If the level of performance achieved is less than Threshold Fiscal 2025 Dabir EBITDA, then no Restricted Stock shall vest pursuant to this Section 3.3(b).&nbsp;&nbsp;For the avoidance of doubt, if the Grantee ceases to serve as President of Dabir or a Change of Control occurs, in either case, prior to the end of the Performance Period, no vesting shall occur under this Section 3(b).</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><a name="_AEIOULastRenderedPageBreakAEIOU4"></a><font style="text-decoration:underline;font-size:11pt;">Number of Performance Units Earned</font><font style="font-size:11pt;">.&nbsp;&nbsp;&#8206; </font><font style="text-decoration:underline;font-size:11pt;">Exhibit C</font><font style="font-size:11pt;"> attached hereto sets forth the formula for calculating the number of Performance Units earned based on the Fiscal &#8206;&#8206;2025 Dabir EBITDA achieved.&nbsp;&nbsp;Pursuant to </font><font style="text-decoration:underline;font-size:11pt;">Exhibit C</font><font style="font-size:11pt;">, the number of Performance Units earned shall be determined by &#8206;multiplying the number of Performance Units by a fraction (subject to a maximum of one (1)), &#8206;the numerator of which shall equal (i) Fiscal 2025 Dabir EBITDA achieved minus (ii) Target Fiscal 2025 Dabir &#8206;EBITDA, and the denominator of which shall equal (a) Maximum Fiscal 2025 Dabir EBITDA minus (b) &#8206;Target Fiscal 2025 Dabir EBITDA.&nbsp;&nbsp;If the level of performance achieved is less than or equal to the Target &#8206;Fiscal 2025 Dabir EBITDA, then no Performance Units amounts shall be earned pursuant to this Section 3.3(c).&nbsp;&nbsp;For the avoidance of doubt, if the Grantee ceases to serve as President of </font></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-2-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap"></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:11pt;">Dabir or a Change of Control occurs, in either case, prior to the end of the Performance Period, no Performance Units shall be earned under this Section 3(c).</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="text-decoration:underline;font-size:11pt;">Effect of Termination of Employment in Connection with Death, Disability or Retirement</font><font style="font-size:11pt;">.&nbsp;&nbsp;Notwithstanding Sections (b) and (c) above, the following provisions shall apply to the Awards in the event of Grantee&#8217;s termination of employment in connection with death, disability or retirement prior to the end of the Performance Period: </font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">if Grantee&#8217;s employment with the Company and its Subsidiaries and Affiliates is terminated due to total and permanent disability as determined by the Company or death, then all of the Restricted Stock will become immediately vested and no Performance Units shall be earned and payable; and </p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">if Grantee&#8217;s employment with the Company and its Subsidiaries and Affiliates is terminated due to retirement on or after Grantee&#8217;s sixty-fifth birthday or retirement on or after Grantee&#8217;s fifty-fifth birthday with consent of the Committee then, the shares of Restricted Stock and the Performance Units shall, as of the Vesting Date, vest and be earned based on actual performance on a pro rata basis based on the date of termination.&nbsp;&nbsp;The fraction to be used to determine the number of shares of Restricted Stock to vest and the number of Performance Units to be earned hereunder shall have a numerator equal to the number of fiscal months elapsed between May 2, 2020 and the date of termination (rounded up to the nearest whole month), and the denominator of which shall be sixty (60).&nbsp;&nbsp;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(e)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="text-decoration:underline;font-size:11pt;">Change of Control</font><font style="font-size:11pt;">.&nbsp;&nbsp;Notwithstanding (b) and (c) above, the following provisions shall apply to the Awards in the event of a Change of Control prior to the end of the Performance Period&#8206;: </font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i) </font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">in the event of a Change of Control, the surviving or successor entity (or its parent corporation) may continue, assume or replace the Awards on substantially the same terms and conditions (with such adjustments as may be required or permitted by Section 15 of the Plan), and such Awards or replacements therefor shall remain outstanding and be governed by their respective terms, subject to (iii) and (iv) below; </p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii) </font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">if and to the extent that the Awards are not continued, assumed or replaced in connection with a Change of Control, then a pro rata portion of the shares of Restricted Stock will become immediately vested based on the date of the Change of Control and no Performance Units shall be earned and payable.&nbsp;&nbsp;The fraction to be used to determine the number of shares of Restricted Stock to vest hereunder shall have a numerator equal to the number of fiscal months elapsed between May 2, 2020 and the date of the Change of Control (rounded up to the nearest whole month) and the denominator of which shall be sixty (60);</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iii)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;"><a name="_AEIOULastRenderedPageBreakAEIOU5"></a> if and to the extent that the Awards are continued, assumed or replaced under the circumstances described in Section 3(e)(i), and if within two years<font style="font-weight:bold;"> </font>after the Change of Control, Grantee experiences an involuntary termination of employment or other service </p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-3-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap"></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">for reasons other than Cause or Grantee shall terminate employment with Good Reason, then a pro rata portion of the shares of Restricted Stock will become immediately vested based on the date of termination</font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and no Performance Units shall be earned and payable.&nbsp;&nbsp;The fraction (subject to a maximum of one (1)) to be used to determine the number of shares of Restricted Stock to vest hereunder shall have a numerator equal to the number of fiscal months elapsed between May 2, 2020 and the date of the termination (rounded up to the nearest whole month), and the denominator of which shall be sixty (60); and</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iv)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">Notwithstanding whether the Awards are continued, assumed or replaced in connection with a Change of Control, if Grantee experiences an involuntary termination of employment or other service for reasons other than Cause or Grantee shall terminate employment with Good Reason during the period beginning on the date an agreement is entered into by the Company with respect to a merger, consolidation or similar transaction of the Company, which would constitute a Change of Control, and the effective time of such merger, consolidation or similar transaction of the Company, then a pro rata portion of the shares of Restricted Stock will become immediately vested based on the date of the Change of Control and no Performance Units shall be earned and payable.&nbsp;&nbsp;The fraction (subject to a maximum of one (1)) to be used to determine the number of shares of Restricted Stock to vest hereunder shall have a numerator equal to the number of fiscal months elapsed between May 2, 2020 and the date of the Change of Control (rounded up to the nearest whole month), and the denominator of which shall be sixty (60).&nbsp;&nbsp; </p></td></tr></table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU6"></a>&#8220;Good Reason&#8221; shall exist under (iii) or (iv) above if, without Grantee&#8217;s express written consent any of the following events or actions occurs, provided that no finding of Good Reason shall be effective unless and until the Grantee has provided the Company, within sixty (60) calendar days of becoming aware of the facts and circumstances underlying the finding of Good Reason, with written notice thereof stating with specificity the facts and circumstances underlying the finding of Good Reason and, if the basis for such finding of Good Reason is capable of being cured by the Company, providing the Company with an opportunity to cure the same within thirty (30) calendar days after receipt of such notice: (A) the Company shall materially reduce the nature, scope or level of Grantee&#8217;s responsibilities from the nature, scope or level of such responsibilities prior to the Change of Control, or shall fail to provide Grantee with adequate office facilities and support services to perform such responsibilities; (B) the Company shall require Grantee to move Grantee&#8217;s principal business office more than 25 miles from Grantee&#8217;s principal business office at the time of this Award Agreement, or assign to Grantee duties that would reasonably require such move; provided, however, that if Grantee&#8217;s principal business office is not located at the Company&#8217;s then current corporate headquarters, and the Company requires Grantee to move Grantee&#8217;s principal business office to such corporate headquarters, or assigns to Grantee duties that would reasonably require such move, such actions shall not constitute &#8220;Good Reason&#8221; under this subsection; (C) the Company shall require Grantee, or assign duties to Grantee which would reasonably require Grantee, to increase, by more than twenty-four, the number of normal working days (determined at the time of this Award Agreement) that Grantee spends away from Grantee&#8217;s principal business office during any consecutive twelve-month period; (D) the Company shall reduce Grantee&#8217;s annual salary below that in effect as of the date of this Award Agreement (or as of the Change of Control, if greater); (E) the Company shall materially reduce or fail to continue in effect any cash or stock-based incentive or bonus plan, retirement plan, welfare benefit plan, or other benefit plan, program or arrangement, unless the </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-4-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">aggregate value (as computed by an independent employee benefits consultant selected by the Company) of all such incentive, bonus, retirement and benefit plans, programs and arrangements provided to Grantee is not materially less than their aggregate value as of the date of this Award Agreement (or as of the Change of Control, if greater); or (F) if the Board of Directors fails to act in good faith with respect to the Company&#8217;s obligations hereunder, or the Company breaches its obligations hereunder.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Grantee agrees, as a condition of this Award, to make acceptable arrangements to pay any withholding or other taxes or deductions that may be due or may arise as a result of the vesting of the Restricted Stock, the settlement of the Performance Units, or any other payment or issuance of shares of Common Stock under this Award Agreement.&nbsp;&nbsp;In the event that the Company determines that any federal, state, local or foreign tax or withholding payment or other deduction is required relating to the vesting or issuance of shares or the payment of cash under this Award Agreement, the Company shall have the right to require such amounts or deductions from Grantee, or withhold such amounts or deductions from other payments due Grantee from the Company or any Subsidiary or Affiliate.</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Discretion to Adjust and Modify the Fiscal 2025 Dabir EBITDA Performance Levels or Provide for a Replacement Metric</font>.&nbsp;&nbsp;The Committee shall have the authority to specify adjustments or modifications to be made to &#8206;the Threshold, Target and Maximum levels of Fiscal 2025 Dabir EBITDA based on and in order to &#8206;appropriately reflect the effect of the following events: (i) asset write-downs; (ii) litigation or claim judgments or &#8206;settlements; (iii) the effect of changes in tax laws, accounting principles, or other laws or &#8206;regulatory rules affecting reported results; (iv) any reorganization and restructuring programs; (v) &#8206;any change in Dabir&#8217;s fiscal year; (vi) circumstances that impact Dabir&#8217;s financial &#8206;performance that are outside of the control of Dabir, such as acts of God; earthquakes; &#8206;fires; floods; severe weather events; natural or manmade disasters; wars; civil or military &#8206;disturbances; acts of terrorism; sabotage; embargoes; martial law; acts of civil or military &#8206;authorities; political unrest; riots; global economic events; strikes; labor disputes; lockouts; &#8206;epidemics; or pandemics; or (vii) unforeseen impacts related to mergers, acquisitions and &#8206;divestitures&#8206;.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="font-size:11pt;">In the event Dabir is sold or spun-off prior to the end of the Performance Period and Grantee remains employed by the Company or a Subsidiary or Affiliate, or the Company reassigns Grantee to another position with the Company or a Subsidiary or Affiliate other than Dabir, the Committee shall have the authority to specify an appropriate replacement performance metric.&nbsp;&nbsp; In such event, Grantee and the Company agree to enter into an appropriate amendment to this Award Agreement. </font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU7"></a>5.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Settlement of Performance Units</font>.&nbsp;&nbsp;Except as otherwise provided herein, the &#8206;Performance Units shall &#8206;&#8206;be &#8206;settled and paid in cash in an amount equal to the number of earned Performance Units multiplied by the Fair Market Value of the Company&#8217;s Common Stock as of the Vesting Date.&nbsp;&nbsp;The payment will be made within 2&#189; months after the end of the Performance &#8206;Period (or &#8206;earlier &#8206;as provided &#8206;in the Plan).&nbsp;&nbsp;&#8206; At any time prior to the end of the Performance Period, the Committee shall have the authority to provide that the Performance Units will be settled in shares of the Company&#8217;s Common Stock instead of cash (the date of such Committee action referred to herein as the &#8220;Conversion Date&#8221;).&nbsp;&nbsp; In such event, if requested by the Committee, Grantee and the Company shall enter into an appropriate amendment to this Award Agreement to document such change.&nbsp;&nbsp;Notwithstanding the foregoing, in the event that the Grantee is a &#8220;specified employee&#8221; &#8206;within the meaning of Section 409A(a)(2)(B)(i) of the Code and the Award is considered &#8206;to be Nonqualified Deferred Compensation upon the Grantee&#8217;s &#8220;Separation from &#8206;Service&#8221; as defined below, any payment under this Award Agreement which results &#8206;from a Separation </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-5-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">from Service shall be delayed until the earlier of (i) first day of the &#8206;seventh (7th) month beginning after the Grantee&#8217;s Separation from Service, or (ii) the &#8206;Grantee&#8217;s death, if such a delay is necessary to avoid the imposition of additional tax &#8206;and interest on the Grantee under Section 409A(a)(1)(B) of the Code.</font><font style="font-size:12pt;">&#8206;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Forfeiture</font>.&nbsp;&nbsp;If at any time any of the following events occur: (i) Grantee&#8217;s conviction of a felony other than a traffic violation; &#8206;(ii)&#8206; Grantee&#8217;s commission of any act or acts of personal dishonesty intended to &#8206;result in &#8206;personal enrichment to Grantee to the material detriment of the Company;&#8206; &#8206;(iii) a failure to perform assigned duties,&#8206; provided that such failure has continued for more than ten (10) days after the Board of Directors or the &#8206;Chief Executive Officer of the Company has given written notice of such failure;&#8206; &#8206;(iv)&#8206; any willful misconduct by the Grantee which materially affects the business &#8206;reputation &#8206;of the Company; &#8206;(v) breach in any material respect by the Grantee of any provision of any &#8206;employment, &#8206;consulting, advisory, nondisclosure, non-competition, proprietary information, or &#8206;other similar agreement &#8206;between the Grantee and the Company; or &#8206;(vi)&#8206; Grantee&#8217;s material violation of the Company&#8217;s code of conduct&#8206;, &#8206;then the unvested Restricted Stock and unearned Performance Units shall be forfeited to the Company effective as of the date on which the Grantee entered into such &#8206;activity, unless terminated sooner by operation of another term or condition of this Award Agreement or &#8206;the Plan.&#8206;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Additional Delivery</font>.&nbsp;&nbsp;Within 2&#189; months of the date Restricted Stock vests under Section 3, the Company shall pay to the Grantee an amount equal to the aggregate per share cash dividends with respect to all cash dividend record dates that fall between the Award Date and the date the unrestricted shares are registered with the Company&#8217;s transfer agent in the name of the Grantee, multiplied by the number of shares of Restricted Stock that vest pursuant to this Award Agreement (without interest).&nbsp;&nbsp;In addition, if the Committee provides that the Performance Units will be settled in shares of the Company&#8217;s Common Stock instead of cash, then within 2&#189; months of the date the Performance Units vest under Section 3, the Company shall pay to the Grantee an amount equal to the aggregate per share cash dividends with respect to all cash dividend record dates that fall between the Conversion Date and the date the unrestricted shares are registered with the Company&#8217;s transfer agent in the name of the Grantee, multiplied by the number of Performance Units that vest pursuant to this Award Agreement (without interest). The Company may withhold from any payment that it is required to make under this Award Agreement amounts sufficient to satisfy applicable withholding requirements under any foreign, federal, state or local law due in connection with this Award or the payment described in this Section 7.&nbsp;&nbsp;No dividends shall be paid to the Grantee with respect to the Performance Units or Restricted Stock that does not vest and is forfeited by the Grantee.<font style="color:#000000;"> </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Restrictions</font>.&nbsp;&nbsp;None of the Restricted Stock or Performance Units may be sold, transferred, pledged, hypothecated or otherwise encumbered or disposed of until it has vested in accordance with the terms of this Award Agreement.&nbsp;&nbsp;Any Restricted Stock that is not vested and any Performance Units that are not earned shall be forfeited to the Company immediately upon termination of the Grantee&#8217;s employment with the Company and all of its Subsidiaries and Affiliates or upon the expiration of this Award Agreement.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU8"></a>9.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Stock Delivery</font>.&nbsp;&nbsp;Within ten (10) days of the date of this Award Agreement, t<font style="color:#000000;">he Company will cause the Restricted Stock to be issued in the Grantee&#8217;s name either by book-entry registration or issuance of a stock certificate.&nbsp;&nbsp;While the Restricted Stock remains forfeitable, the Company will cause an appropriate stop-transfer order to be issued and to remain in effect with respect to the Restricted Stock. </font>Any stock certificate evidencing any Restricted Stock shall contain such legends and stock transfer </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-6-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">instructions or limitations as may be determined or authorized by the Committee in its sole discretion; and the Company may, in its sole discretion, retain custody of any such certificate throughout the period during which any restrictions are in effect and require that the Grantee tender to the Company a stock power duly executed in blank relating thereto as a condition to issuing any such certificate.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Rights as Stockholder</font>.&nbsp;&nbsp;The Grantee shall have no rights as a stockholder with respect to any Restricted Stock until the Restricted Stock is issued in Grantee&#8217;s name either by book-entry registration or issuance of a stock certificate.&nbsp;&nbsp;Once the Restricted Stock is issued in Grantee&#8217;s name, the Grantee shall be entitled to all rights associated with ownership of the Restricted Stock, except that the Grantee shall not be entitled to receive any dividends (cash or stock) with respect to the Restricted Stock until such time as the restrictions lapse in accordance with the terms of this Award Agreement.&nbsp;&nbsp; The Grantee shall have no rights as a stockholder with respect to the Performance Units.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Construction</font>.&nbsp;&nbsp;This Award Agreement is subject to the terms of the Plan and shall be construed in accordance therewith.&nbsp;&nbsp;All capitalized and undefined terms herein are subject to the definitions contained in the Plan.&nbsp;&nbsp;The construction and operation of this Award Agreement are governed by the laws of the State of Illinois without regard to any conflicts or choice of law rules or principles that might otherwise refer construction or interpretation of this Award Agreement to the substantive law of another jurisdiction, and any litigation arising out of this Award Agreement shall be brought in the Circuit Court of the State of Illinois or the United States District Court for the Eastern Division of the Northern District of Illinois and the Grantee consents to the jurisdiction and venue of those courts.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Severability</font>.&nbsp;&nbsp;In the event that any provision or portion of this Award Agreement shall be determined to be invalid or unenforceable for any reason, the remaining provisions of this Award Agreement shall be unaffected thereby and shall remain in full force and effect.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Dispute Resolution</font>.&nbsp;&nbsp;The parties initially shall attempt to resolve by direct negotiation any dispute, controversy or claim arising out of or relating to this Award Agreement or its breach or interpretation (each, a &#8220;Dispute&#8221;).&nbsp;&nbsp;For purposes of this negotiation, the Company shall be represented by one or more of its independent directors appointed by the Board of Directors. If the parties are unable to resolve the Dispute by direct negotiation within 30 days after written notice by one party to the other of the Dispute, the Dispute shall be settled by submission by either party of the Dispute to binding arbitration in Chicago, Illinois (unless the parties agree in writing to a different location), before a single arbitrator in accordance with the American Arbitration Association's National Rules for the Resolution of Employment Disputes then in effect.&nbsp;&nbsp;The arbitrator will be an attorney licensed to practice law in the State of Illinois.<font style="font-family:Courier New;">&nbsp;&nbsp;</font>The decision and award made by the arbitrator shall be final, binding and conclusive on all parties hereto for all purposes, and judgment may be entered thereon in any court having jurisdiction thereof.&nbsp;&nbsp;Except as set forth below, each party shall pay:&nbsp;&nbsp;the fees of their or its attorneys; the expenses of their or its witnesses; and all other expenses connected with presenting their or its case.&nbsp;&nbsp;Except as set forth below, the costs of the arbitration, including the cost of any record or transcripts of the arbitration hearing, administrative fees, the fees of the arbitrator, and all other fees and costs shall be borne equally by the parties.&nbsp;&nbsp;In the event of a Dispute following or in connection with a Change of Control, the Company shall pay the fees of the arbitrator as well as the cost of any record or transcripts of the arbitration hearing and other administrative fees and costs.&nbsp;&nbsp;In all Disputes, the arbitrator will have discretion to make an award of fees, costs and expenses to the prevailing party.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-7</a>-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU9"></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14.</font><font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Section 409A Compliance</font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;It is the intention of the Company and the Grantee that the Restricted Stock and related benefits awarded under this Award Agreement shall be exempt from the requirements of Section 409A of the Code and its implementing regulations (&#8220;Section 409A&#8221;) and shall be interpreted in a manner consistent with this intention.&nbsp;&nbsp;In the event that the Company or the Grantee reasonably determines that the Restricted Stock and/or any related benefits under this Award Agreement may be subject to Section 409A, the Company and Grantee shall work together to adopt such amendments to this Award Agreement or adopt other policies or procedures (including amendments, policies and procedures with retroactive effective to the extent allowed under applicable laws), or take any other commercially reasonable actions necessary or appropriate to cause the Restricted Stock and related benefits awarded under this Award Agreement to (i) be exempt from Section 409A, or (ii) otherwise comply with the requirements of Section 409A.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">It is the intention of the Company and the Grantee that the Performance Units and related benefits awarded under this Award Agreement shall comply with Section 409A and shall be interpreted in a manner consistent with this intent.&nbsp;&nbsp;Notwithstanding anything to the contrary contained herein, a termination of Grantee&#8217;s employment shall not be deemed to have occurred for purposes of making any payments under this Award Agreement related to the Performance Units unless such termination gives rise to a &#8220;Separation from Service&#8221; (within the meaning of Section 409A, a &#8220;Separation from Service&#8221;) and references to &#8220;termination of employment&#8221; shall mean Separation from Service.&nbsp;&nbsp;In the event that the Company or the Grantee reasonably determines that the Performance Units and/or any related benefits under this Award Agreement fails to comply with Section 409A, the Company and Grantee shall work together to adopt such amendments to this Award Agreement or adopt other policies or procedures (including amendments, policies and procedures with retroactive effective to the extent allowable by applicable laws), or take any other commercially reasonable actions necessary or appropriate to comply with the requirements of Section 409A. Nothing in this Agreement shall be construed as a guarantee of any particular tax treatment to Grantee.&nbsp;&nbsp;Grantee shall be solely responsible for the tax consequences with respect to all amounts payable under this Award Agreement, and in no event shall the Company have any responsibility or liability if this Award Agreement does not meet any applicable requirements of Section 409A. </p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">No Retention Rights</font>.&nbsp;&nbsp;Nothing herein contained shall confer on the Grantee any right with respect to continuation of employment or services by the Company or its Subsidiaries or Affiliates, or interfere with the right of the Company or its Subsidiaries or Affiliates to terminate at any time the employment or service of the Grantee.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">No Guarantee of Future Awards</font>.&nbsp;&nbsp;The grant of Awards is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants, even if Awards have previously been granted.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Counterparts</font>.&nbsp;&nbsp;This Award Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU10"></a>18.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Entire Agreement; Clawback Policy</font>.&nbsp;&nbsp;This Award Agreement supersedes and cancels all prior written or oral agreements and understandings relating to the terms of this Award Agreement.&nbsp;&nbsp;This Award Agreement and the Awards granted hereunder are subject to any Company Clawback Policy in </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-8-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">effect as of the date of this Award Agreement or as subsequently amended, modified or replaced, and the terms of the Change in Control Agreement between the Grantee and the Company, as the same may be amended from time to time, if any.</font></p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[Signature Page to Follow]</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU11"></a><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-9-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-indent:7.69%;">IN WITNESS WHEREOF, the Company by one of its duly authorized representatives has executed this Award Agreement as of the day and year first above written.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">METHODE ELECTRONICS, INC.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gmzchffphou0000001.jpg" title="" alt ="" style="position:absolute;margin-left:-2.35pt;margin-top:4.6pt;width:201.8pt;height:42.8pt;z-index:-251658240;mso-wrap-edited:f"><font style="font-family:Times New Roman;font-size:1pt;color:#FFFFFF;"></font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:<font style="margin-left:27pt;"></font><font style="text-decoration:underline;margin-left:36pt;"></font><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="margin-left:27pt;">Darren M. Dawson</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Its:<font style="margin-left:27pt;">Chair, Compensation Committee</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Please indicate your acceptance of the terms and conditions of this Award Agreement by signing in the space provided below and returning a signed copy of this Award Agreement to the Company.&nbsp;&nbsp;IF A FULLY EXECUTED COPY OF THIS AWARD AGREEMENT HAS NOT BEEN RECEIVED BY THE COMPANY BY OCTOBER 23, 2020, THE AWARD UNDER THIS AWARD AGREEMENT SHALL BE CANCELLED.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">BY SIGNING BELOW, YOU ACKNOWLEDGE AND AGREE THAT YOU HAVE RECEIVED A COPY OF THE PLAN AND ARE FAMILIAR WITH THE TERMS AND PROVISIONS THEREOF, INCLUDING THE TERMS AND PROVISIONS OF THIS AWARD AGREEMENT.&nbsp;&nbsp;YOU HAVE REVIEWED THE PLAN AND THIS AWARD AGREEMENT IN THEIR ENTIRETY, HAVE HAD AN OPPORTUNITY TO OBTAIN THE ADVICE OF COUNSEL PRIOR TO EXECUTING THIS AWARD AGREEMENT AND FULLY UNDERSTAND ALL PROVISIONS OF THIS AWARD AGREEMENT.&nbsp;&nbsp;FINALLY, YOU HEREBY AGREE TO ACCEPT AS BINDING, CONCLUSIVE AND FINAL ALL DECISIONS OR INTERPRETATIONS OF THE ADMINISTRATOR UPON ANY QUESTIONS ARISING UNDER THE PLAN OR THIS AWARD AGREEMENT.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The undersigned hereby accepts, and agrees to, all terms and provisions of this Award Agreement and the Plan as they pertain hereto.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<div style="width:100%;">
<div style="float:left;width:48%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU12"></a>GRANTEE<font style="margin-left:36pt;"></font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">____________________________________</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[___________________]</p></div>
<div style="float:right;width:48%;padding-left:4%">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:5.77%;text-indent:-5.77%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU2"></a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">&nbsp;</font></p></div></div>
<p style=" clear:both;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-10</a>-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU13"></a><font style="text-decoration:underline;">Exhibit A</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Threshold Fiscal 2025 Dabir EBITDA<font style="margin-left:36pt;">$*</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Target Fiscal 2025 Dabir EBITDA <font style="margin-left:36pt;">$*</font><font style="font-size:12pt;"> </font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Maximum Fiscal 2025 Dabir EBITDA<font style="margin-left:36pt;">&#8206;$*&#8206;</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*&nbsp;&nbsp;The Company believes that the disclosure of the fiscal 2025 Dabir EBITDA goals would cause competitive harm and has intentionally omitted this information.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU14"></a><br /></p>
<p style="margin-top:12pt;margin-bottom:0pt;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">-<font style="font-size:11pt;">11-</font></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;text-decoration:underline;">Exhibit B</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If Fiscal 2025 Dabir EBITDA achieved is less than Threshold Fiscal 2025 Dabir EBITDA, then no Restricted Stock will vest.&nbsp;&nbsp;If Fiscal 2025 Dabir EBITDA achieved equals or exceeds Threshold Fiscal 2025 Dabir EBITDA, then the following formula will be used to calculate the percentage of Restricted Stock that will vest (subject to a maximum of 100%):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i) 50%, plus (ii) 50% multiplied by a fraction equal to (Fiscal 2025 Dabir EBITDA achieved less Threshold Fiscal 2025 Dabir EBITDA) divided by (Target Fiscal 2025 Dabir EBITDA less Threshold Fiscal 2025 Dabir EBITDA)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-12</a>-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Exhibit C</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If Fiscal 2025 Dabir EBITDA achieved is less than Target Fiscal 2025 Dabir EBITDA, then no Performance Units shall be earned.&nbsp;&nbsp;If Fiscal 2025 Dabir EBITDA achieved equals or exceeds Target Fiscal 2025 Dabir EBITDA, then the following formula will be used to calculate the number of Performance Units earned: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The number of Performance Units multiplied by a fraction (subject to a maximum of one (1)), &#8206;the numerator of which shall equal (i) Fiscal 2025 Dabir EBITDA achieved minus (ii) Target Fiscal 2025 Dabir &#8206;EBITDA, and the denominator of which shall equal (a) Maximum Fiscal 2025 Dabir EBITDA minus (b) &#8206;Target Fiscal 2025 Dabir EBITDA.&nbsp;&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="RANGE!B1:G17"></a>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">83692495v.1</p><font style="font-size:11pt;"><a name="RANGE!B1:G17"></a>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-13</a>-</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>mei-ex104_35.htm
<DESCRIPTION>EX-10.4
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
mei-ex104_35.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Exhibit 10.4</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">METHODE ELECTRONICS, INC. </font><font style="font-weight:normal;"> </font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">FORM OF 2020 LONG-TERM TIME-BASED</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">AWARD AGREEMENT (CEO)</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Long-Term Time-Based Award Agreement (the &#8220;Award Agreement&#8221;), effective as of September 27, 2020 (the &#8220;Award Date&#8221;), is entered into by and between Methode Electronics, Inc., a Delaware corporation (the &#8220;Company&#8221;) and [_____________] (the &#8220;Grantee&#8221;). </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">WHEREAS, the Company desires to reward Grantee for services to the Company and to encourage Grantee to continue to work for the benefit of the Company in a manner that will benefit all Company stockholders.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">NOW, THEREFORE, in consideration of the premises and the mutual covenants and obligations set forth herein, the Company agrees to award to Grantee Restricted Stock Units under the Methode Electronics, Inc. 2014 Omnibus Incentive Plan (the &#8220;Plan&#8221;) on the terms and conditions set forth herein and in the Plan.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.<font style="margin-left:0pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">General</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;This Award Agreement and the Restricted Stock Units awarded herein are subject to all of the provisions of the Plan applicable to Restricted Stock Units.&nbsp;&nbsp;Unless the context otherwise requires, capitalized terms used herein shall have the same meanings as in the Plan.&nbsp;&nbsp;Grantee hereby acknowledges receipt of a copy of the Plan and that Grantee has read the Plan and fully understands its content.&nbsp;&nbsp;In the event of any conflict between the terms of this Award Agreement and the terms of the Plan, the terms of the Plan shall control.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Grant</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;The Company hereby grants to Grantee a total of [______] Restricted Stock Units (the &#8220;Restricted Stock Units&#8221;), subject to the restrictions set forth in Section 3 hereof and the Plan.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Restrictions</font><font style="font-size:11pt;font-family:Times New Roman;">.</font></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:11pt;">None of the Restricted Stock Units may be sold, transferred, pledged, hypothecated or otherwise encumbered or disposed of.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:11pt;">Except as provided below, any Restricted Stock Units that are not vested shall be forfeited to the Company immediately upon termination of the Grantee&#8217;s employment with the Company and all of its Subsidiaries and Affiliates.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:11pt;">Any Restricted Stock Units that are not vested may be forfeited to the Company in accordance with Section 9 of this Award Agreement.</font></p></td></tr></table></div>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Payment for Restricted Stock Units</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;</font></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:11pt;">The Company will pay one share of Common Stock to the Grantee for each vested Restricted Stock Unit as soon as reasonably possible following vesting under this Award Agreement.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><a name="_AEIOULastRenderedPageBreakAEIOU2"></a><font style="font-size:11pt;">Notwithstanding the foregoing, in the event that the Grantee is a &#8220;specified employee&#8221; within the meaning of Section 409A(a)(2)(B)(i) of the Code and the Award is considered to be Nonqualified Deferred Compensation upon the Grantee&#8217;s &#8220;Separation from </font></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">83634489</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:7pt;">&nbsp;</p>
<p style="line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap"></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:11pt;">Service&#8221; as defined below, any payment under this Award Agreement which results from a Separation from Service shall be delayed until the earlier of (i) first day of the seventh (7th) month beginning after the Grantee&#8217;s Separation from Service, or (ii) the Grantee&#8217;s death, if such a delay is necessary to avoid the imposition of additional tax and interest on the Grantee under Section 409A(a)(1)(B) of the Code.</font></p></td></tr></table></div>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Rights as Stockholder</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;The Grantee shall have no rights as a stockholder with respect to any Restricted Stock Units.&nbsp;&nbsp;The Grantee will only have stockholder rights after a stock certificate is issued.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Vesting</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;The Restricted Stock Units granted hereunder will vest as follows: (i) thirty percent (30%) on April 29, 2023; (ii) thirty percent (30%) on May 4, 2024; and (iii) forty percent (40%) on May 3, 2025, (each a &#8220;Vesting Date&#8221;), provided the Grantee continues to be employed by the Company (or a Subsidiary or Affiliate thereof) until such dates.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Effect of Termination of Employment in Connection with Death, Disability or Retirement or Involuntary Termination Without Cause.</font><font style="font-size:11pt;font-family:Times New Roman;">&nbsp;&nbsp;Notwithstanding Section 6 above, the following provisions shall apply to the Restricted Stock Units in the event of Grantee&#8217;s termination of employment in connection with death, disability or retirement or involuntary termination without cause prior to May 3, 2025: </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:36pt;">if Grantee&#8217;s employment with the Company and its Subsidiaries and Affiliates is terminated due to total and permanent disability as determined by the Committee or death, the unvested Restricted Stock Units shall become vested and payable as of the date of termination; and</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:36pt;">if Grantee experiences an involuntary termination of employment for reasons other than Cause after May 1, 2021, then a pro rata portion of the Restricted Stock Units will become immediately vested. If the involuntary termination of employment for reasons other than Cause occurs on or before May 1, 2021, then no Restricted Stock Units &#8206;shall vest. If the involuntary termination of employment for reasons other than Cause occurs after May 1, 2021, then the number of Restricted Stock Units to vest under 7(b) shall be calculated as follows:</font></p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:433.6pt;;">
<tr>
<td style="width:13.5pt;"></td>
<td style="width:64.5pt;"></td>
<td style="width:13.5pt;"></td>
<td style="width:157.75pt;"></td>
<td style="width:18pt;"></td>
<td style="width:22.5pt;"></td>
<td style="width:13.5pt;"></td>
<td style="width:13.5pt;"></td>
<td style="width:116.85pt;"></td>
</tr>
<tr style="height:40.25pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Number of Restricted Stock Units</p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">x</p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Number of fiscal months elapsed between May 2, 2020 and termination date (rounded up to the nearest whole month)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">x</p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">1</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8722;</p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Number of Restricted Stock Units previously vested under Section 6</p></td>
</tr>
</table></div>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-size:11pt;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Grantee&#8217;s right to this pro rata portion of Restricted Stock Units is conditioned upon Grantee signing and delivering to the Company, within the time period required by the Company, a written general release of all claims against the Company in a form acceptable to the Company (the &#8220;Release&#8221;), and not revoking the Release within any applicable revocation period.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU3"></a>(c)<font style="margin-left:36pt;"><a name="_AEIOULastRenderedPageBreakAEIOU3"></a>if Grantee&#8217;s employment with the Company and its Subsidiaries and Affiliates is &#8206;terminated due to retirement on or after Grantee&#8217;s sixty-fifth birthday or retirement on or &#8206;after Grantee&#8217;s fifty-fifth birthday with consent of the Committee (in either case, &#8206;&#8206;&#8220;Retirement&#8221;), then </font>the unvested Restricted Stock Units shall &#8206;vest as provided herein.&nbsp;&nbsp;If Grantee&#8217;s Retirement occurs </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">after April 29, 2023, all unvested Restricted Stock Units shall &#8206;vest immediately on the date of termination and be paid on such termination date.&nbsp;&nbsp;If Grantee&#8217;s &#8206;Retirement occurs on or before April 29, &#8206;&#8206;2023, the Restricted Stock units shall vest pro rata based on the date of termination and be paid on such termination date and the number of Restricted Stock Units to vest under 7(c) shall be &#8206;calculated as follows:&#8206;</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:433.6pt;;">
<tr>
<td style="width:13.5pt;"></td>
<td style="width:64.5pt;"></td>
<td style="width:13.5pt;"></td>
<td style="width:157.75pt;"></td>
<td style="width:18pt;"></td>
<td style="width:22.5pt;"></td>
<td style="width:13.5pt;"></td>
<td style="width:13.5pt;"></td>
<td style="width:116.85pt;"></td>
</tr>
<tr style="height:40.25pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU4"></a>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Number of Restricted Stock Units</p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">x</p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Number of fiscal months elapsed between May 2, 2020 and termination date (rounded up to the nearest whole month)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">x</p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">1</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8722;</p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Number of Restricted Stock Units previously vested under Section 6</p></td>
</tr>
</table></div>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU5"></a>8.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Change of Control.</font><font style="font-size:11pt;font-family:Times New Roman;">&nbsp;&nbsp;Notwithstanding Section 6 above, the following provisions shall apply to the Award in the event of a Change of Control prior to May 3, 2025&#8206;:</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:36pt;">In the event of a Change of Control, the surviving or successor entity (or its parent corporation) may continue, assume or replace the Restricted Stock Units outstanding as of the date of the Change of Control on substantially the same terms and conditions (with such adjustments as may be required or permitted by Section 15 of the Plan), and such Restricted Stock Units or replacements therefor shall remain outstanding and be governed by their respective terms, subject to (c) and (d) below. </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:36pt;">If and to the extent that the outstanding Restricted Stock Units are not continued, assumed or replaced in connection with a Change of Control, then all unvested Restricted Stock Units will become immediately vested and non-forfeitable and payable as of the date of the Change of Control.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:36pt;">If and to the extent that the Restricted Stock Units are continued, assumed or replaced under the circumstances described in (a), and if within two years after the Change of Control the Grantee experiences an involuntary termination of employment or other service for reasons other than Cause</font> or Grantee shall terminate employment with Good Reason, then all unvested Restricted Stock Units will become immediately vested and non-forfeitable and payable as of the date of termination of employment.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)<font style="margin-left:36pt;">Notwithstanding whether an Award is continued, assumed or replaced in connection with a Change of Control, if Grantee experiences an involuntary termination of employment or other service for reasons other than Cause or Grantee shall terminate employment with Good Reason during the period beginning on the date an agreement is entered into by the Company with respect to a merger, consolidation or similar transaction of the Company, which would constitute a Change of Control, and the effective time of such merger, consolidation or similar transaction of the Company, then all unvested Restricted Stock Units will become immediately vested and non-forfeitable and payable as of the date of the Change of Control.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU6"></a><a name="_AEIOULastRenderedPageBreakAEIOU6"></a>&#8220;Good Reason&#8221; shall exist hereunder if, without Grantee&#8217;s express written consent any of the following events or actions occurs, provided that no finding of Good Reason shall be effective unless and until the Grantee has provided the Company, within sixty (60) calendar days of becoming aware of the facts and circumstances underlying the finding of Good Reason, with written notice thereof stating with specificity the facts and circumstances underlying the finding of Good Reason and, if the basis for such finding of Good Reason is capable of being cured by the Company, providing the Company with an opportunity to cure the same within thirty (30) </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Exhibit 10.4</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">calendar days after receipt of such notice: (A) the Company shall materially reduce the nature, scope or level of Grantee&#8217;s responsibilities from the nature, scope or level of such responsibilities prior to the Change of Control, or shall fail to provide Grantee with adequate office facilities and support services to perform such responsibilities; (B) the Company shall require Grantee to move Grantee&#8217;s principal business office more than 25 miles from Grantee&#8217;s principal business office at the time of this Award Agreement, or assign to Grantee duties that would reasonably require such move; provided, however, that if Grantee&#8217;s principal business office is not located at the Company&#8217;s then current corporate headquarters, and the Company requires Grantee to move Grantee&#8217;s principal business office to such corporate headquarters, or assigns to Grantee duties that would reasonably require such move, such actions shall not constitute &#8220;Good Reason&#8221; under this subsection; (C) the Company shall require Grantee, or assign duties to Grantee which would reasonably require Grantee, to increase, by more than twenty-four, the number of normal working days (determined at the time of this Award Agreement) that Grantee spends away from Grantee&#8217;s principal business office during any consecutive twelve-month period; (D) the Company shall reduce Grantee&#8217;s annual salary below that in effect as of the date of this Award Agreement (or as of the Change of Control, if greater); (E) the Company shall materially reduce or fail to continue in effect any cash or stock-based incentive or bonus plan, retirement plan, welfare benefit plan, or other benefit plan, program or arrangement, unless the aggregate value (as computed by an independent employee benefits consultant selected by the Company) of all such incentive, bonus, retirement and benefit plans, programs and arrangements provided to Grantee is not materially less than their aggregate value as of the date of this Award Agreement (or as of the Change of Control, if greater); or (F) if the Board of Directors fails to act in good faith with respect to the Company&#8217;s obligations hereunder, or the Company breaches its obligations hereunder.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Forfeiture</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;If at any time any of the following events occur: (i) Grantee&#8217;s conviction of a felony other than a traffic violation; &#8206;(ii)&#8206; Grantee&#8217;s commission of any act or acts of personal dishonesty intended to &#8206;result in &#8206;personal enrichment to Grantee to the material detriment of the Company;&#8206; &#8206;(iii) a failure to perform assigned duties,&#8206; provided that such failure has continued for more than ten (10) days after the Board of Directors or the &#8206;Chief Executive Officer of the Company has given written notice of such failure;&#8206; &#8206;(iv)&#8206; any willful misconduct by the Grantee which materially affects the business &#8206;reputation &#8206;of the Company; &#8206;(v) breach in any material respect by the Grantee of any provision of any &#8206;employment, &#8206;consulting, advisory, nondisclosure, non-competition, proprietary information, or &#8206;other similar agreement &#8206;between the Grantee and the Company; or &#8206;(vi)&#8206; Grantee&#8217;s material violation of the Company&#8217;s code of conduct&#8206;,&#8206; then the unvested Restricted Stock Units shall be forfeited to the Company effective as of the date on which the Grantee entered into such activity, unless terminated sooner by operation of another term or condition of this Award Agreement or the Plan.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Additional Delivery</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;Within 2&#189; months of the date Restricted Stock Units have vested &#8206;pursuant to this &#8206;Award Agreement, the Company shall pay to the Grantee a dividend equivalent &#8206;equal to the aggregate per &#8206;share cash dividends with respect to all cash dividend record dates that &#8206;fall between the Award &#8206;Date and the relevant Vesting Date multiplied by the number of Restricted Stock Units &#8206;that vest &#8206;as of such Vesting Date (without interest).&nbsp;&nbsp;The Company may withhold from &#8206;any payment that &#8206;it is required to make under this Award Agreement amounts sufficient to satisfy &#8206;applicable &#8206;withholding requirements under any federal, state or local law due in connection with &#8206;this Award &#8206;or the payment described in this section.&nbsp;&nbsp;No dividends shall be paid to the Grantee &#8206;with respect &#8206;to any Restricted Stock Unit that does not vest and is forfeited by the Grantee&#8206;.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU7"></a>11.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Applicable Law</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;The validity, construction, interpretation and enforceability of this Award Agreement shall be determined and governed by the laws of the State of Illinois without regard to any conflicts or choice of law rules or principles that might otherwise refer construction or interpretation </font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">83634489</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:7pt;">&nbsp;</p>
<p style="line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;">of this Award Agreement to the substantive law of another jurisdiction, and any litigation arising out of this Award Agreement shall be brought in the Circuit Court of the State of Illinois or the United States District Court of the Eastern Division of the Northern District of Illinois and the Grantee consents to the jurisdiction and venue of those courts.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Severability</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;The provisions of this Award Agreement are severable and if any one or more provisions may be determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions, and any partially unenforceable provision to the extent enforceable in any jurisdiction, shall nevertheless be binding and enforceable.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Waiver</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;The waiver by the Company of a breach of any provision of this Award Agreement by Grantee shall not operate or be construed as a waiver of any subsequent breach by Grantee.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Binding Effect</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;The provisions of this Award Agreement shall be binding upon the parties hereto, their successors and assigns, including, without limitation, the Company, its successors or assigns, the estate of the Grantee and the executors, administrators or trustees of such estate and any receiver, trustee in bankruptcy or representative of the creditors of the Grantee.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Withholding</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;Grantee agrees, as a condition of this grant, to make acceptable arrangements to pay any withholding or other taxes or deductions that may be due or may arise as a result of the vesting of the Restricted Stock Units or other payments under this Award Agreement.&nbsp;&nbsp;In the event that the Company determines that any federal, state, local or foreign tax or withholding payment or other deduction is required relating to the vesting of shares or other payments arising from this grant, the Company shall have the right to require such amounts or deductions from Grantee, or withhold such amounts or deductions from other payments due Grantee from the Company or any Subsidiary or Affiliate.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Dispute Resolution</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;The parties initially shall attempt to resolve by direct negotiation any dispute, controversy or claim arising out of or relating to this Award Agreement or its breach or interpretation (each, a &#8220;Dispute&#8221;). For purposes of this negotiation, the Company shall be represented by one or more of its independent directors appointed by the Board of Directors. If the parties are unable to resolve the Dispute by direct negotiation within 30 days after written notice by one party to the other of the Dispute, the Dispute shall be settled by submission by either party of the Dispute to binding arbitration in Chicago, Illinois (unless the parties agree in writing to a different location), before a single arbitrator in accordance with the American Arbitration Association's National Rules for the Resolution of Employment Disputes then in effect.&nbsp;&nbsp;The arbitrator will be an attorney licensed to practice law in the State of Illinois.</font><font style="font-family:Courier New;font-size:11pt;">&nbsp;&nbsp;</font><font style="font-size:11pt;font-family:Times New Roman;">The decision and award made by the arbitrator shall be final, binding and conclusive on all parties hereto for all purposes, and judgment may be entered thereon in any court having jurisdiction thereof.&nbsp;&nbsp;Except as set forth below, each party shall pay:&nbsp;&nbsp;the fees of their or its attorneys; the expenses of their or its witnesses; and all other expenses connected with presenting their or its case.&nbsp;&nbsp;Except as set forth below, the costs of the arbitration, including the cost of any record or transcripts of the arbitration hearing, administrative fees, the fees of the arbitrator, and all other fees and costs shall be borne equally by the parties.&nbsp;&nbsp;In the event of a Dispute following or in connection with a Change of Control, the Company shall pay the fees of the arbitrator as well as the cost of any record or transcripts of the arbitration hearing and other administrative fees and costs.&nbsp;&nbsp;In all Disputes, the arbitrator will have discretion to make an award of fees, costs and expenses to the prevailing party.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU8"></a>17.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Section 409A Compliance</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;It is the intention of the Company and the Grantee that the Restricted Stock Units and other benefits awarded under this Award Agreement shall comply with </font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;">Section 409A of the Code and its implementing regulations (&#8220;Section 409A&#8221;) and shall be interpreted in a manner consistent with this intent.&nbsp;&nbsp;Notwithstanding anything to the contrary contained herein, a termination of Grantee&#8217;s employment shall not be deemed to have occurred for purposes of making any payments under this Award Agreement unless such termination gives rise to a &#8220;Separation from Service&#8221; (within the meaning of Section 409A, a &#8220;Separation from Service&#8221;) and references to &#8220;termination of employment&#8221; shall mean Separation from Service.&nbsp;&nbsp;In the event that the Company or the Grantee reasonably determines that any award under this Award Agreement fails to comply with Section 409A, the Company and Grantee shall work together to adopt such amendments to this Award Agreement or adopt other policies or procedures (including amendments, policies and procedures with retroactive effective to the extent allowable by applicable laws), or take any other commercially reasonable actions necessary or appropriate to comply with the requirements of Section 409A.</font><font style="font-size:11pt;font-family:Times New Roman;"> </font><font style="font-size:11pt;font-family:Times New Roman;">Nothing in this Agreement shall be construed as a guarantee of any particular tax treatment to Grantee.&nbsp;&nbsp;Grantee shall be solely responsible for the tax consequences with respect to all amounts payable under this Award Agreement, and in no event shall the Company have any responsibility or liability if this Award Agreement does not meet any applicable requirements of Section 409A. </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">No Retention Rights</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;Nothing herein contained shall confer on the Grantee any right with respect to continuation of employment or services by the Company or its Subsidiaries or Affiliates, or interfere with the right of the Company or its Subsidiaries or Affiliates to terminate at any time the employment or service of the Grantee.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">No Guarantee of Future Awards</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;The grant of the Restricted Stock Units is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants, even if Restricted Stock Units have previously been granted.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;font-size:11pt;font-family:Times New Roman;">Entire Agreement and Clawback Policy</font><font style="color:#000000;font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;This Award Agreement supersedes and cancels all prior written or oral agreements and understandings relating to the terms of this Award Agreement.&nbsp;&nbsp;</font><font style="font-size:11pt;font-family:Times New Roman;">This Award Agreement and the Restricted Stock Units granted hereunder are subject to any Company Clawback Policy in effect as of the date of this Award Agreement or as subsequently amended, modified or replaced, and the terms of the Change in Control Agreement between the Company and Grantee, as the same may be amended from time to time, if any.</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[Signature Page to Follow]</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU9"></a><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-indent:7.69%;">IN WITNESS WHEREOF, the Company by one of its duly authorized representatives has executed this Award Agreement as of the day and year first above written.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">METHODE ELECTRONICS, INC.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font><font style="margin-left:36pt;"></font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">Darren M. Dawson</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Its:<font style="margin-left:36pt;">Chair, Compensation Committee</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Please indicate your acceptance of the terms and conditions of this Award Agreement by signing in the space provided below and returning a signed copy of this Award Agreement to the Company.&nbsp;&nbsp;IF A FULLY EXECUTED COPY OF THIS AWARD AGREEMENT HAS NOT BEEN RECEIVED BY THE COMPANY BY OCTOBER 23, 2020, THE RESTRICTED STOCK UNITS GRANTED UNDER THIS AWARD AGREEMENT SHALL BE CANCELLED.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">BY SIGNING BELOW, YOU ACKNOWLEDGE AND AGREE THAT YOU HAVE RECEIVED A COPY OF THE PLAN AND ARE FAMILIAR WITH THE TERMS AND PROVISIONS THEREOF, INCLUDING THE TERMS AND PROVISIONS OF THIS AWARD AGREEMENT.&nbsp;&nbsp;YOU HAVE REVIEWED THE PLAN AND THIS AWARD AGREEMENT IN THEIR ENTIRETY, HAVE HAD AN OPPORTUNITY TO OBTAIN THE ADVICE OF COUNSEL PRIOR TO EXECUTING THIS AWARD AGREEMENT AND FULLY UNDERSTAND ALL PROVISIONS OF THIS AWARD AGREEMENT.&nbsp;&nbsp;FINALLY, YOU HEREBY AGREE TO ACCEPT AS BINDING, CONCLUSIVE AND FINAL ALL DECISIONS OR INTERPRETATIONS OF THE ADMINISTRATOR UPON ANY QUESTIONS ARISING UNDER THE PLAN OR THIS AWARD AGREEMENT.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The undersigned hereby accepts, and agrees to, all terms and provisions of this Award Agreement and the Plan as they pertain hereto.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">GRANTEE<font style="margin-left:36pt;"></font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">____________________________________</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[___________________]</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:53.85%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>6
<FILENAME>mei-ex105_34.htm
<DESCRIPTION>EX-10.5
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
mei-ex105_34.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Exhibit 10.5</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">METHODE ELECTRONICS, INC. </font><font style="font-weight:normal;"> </font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">FORM OF 2020 LONG-TERM TIME-BASED</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">AWARD AGREEMENT (CFO &amp; COO)</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Long-Term Time-Based Award Agreement (the &#8220;Award Agreement&#8221;), effective as of September 27, 2020 (the &#8220;Award Date&#8221;), is entered into by and between Methode Electronics, Inc., a Delaware corporation (the &#8220;Company&#8221;) and [_____________] (the &#8220;Grantee&#8221;). </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">WHEREAS, the Company desires to reward Grantee for services to the Company and to encourage Grantee to continue to work for the benefit of the Company in a manner that will benefit all Company stockholders.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">NOW, THEREFORE, in consideration of the premises and the mutual covenants and obligations set forth herein, the Company agrees to award to Grantee Restricted Stock Units under the Methode Electronics, Inc. 2014 Omnibus Incentive Plan (the &#8220;Plan&#8221;) on the terms and conditions set forth herein and in the Plan.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.<font style="margin-left:0pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">General</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;This Award Agreement and the Restricted Stock Units awarded herein are subject to all of the provisions of the Plan applicable to Restricted Stock Units.&nbsp;&nbsp;Unless the context otherwise requires, capitalized terms used herein shall have the same meanings as in the Plan.&nbsp;&nbsp;Grantee hereby acknowledges receipt of a copy of the Plan and that Grantee has read the Plan and fully understands its content.&nbsp;&nbsp;In the event of any conflict between the terms of this Award Agreement and the terms of the Plan, the terms of the Plan shall control.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Grant</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;The Company hereby grants to Grantee a total of [______] Restricted Stock Units (the &#8220;Restricted Stock Units&#8221;), subject to the restrictions set forth in Section 3 hereof and the Plan.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Restrictions</font><font style="font-size:11pt;font-family:Times New Roman;">.</font></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:11pt;">None of the Restricted Stock Units may be sold, transferred, pledged, hypothecated or otherwise encumbered or disposed of.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:11pt;">Except as provided below, any Restricted Stock Units that are not vested shall be forfeited to the Company immediately upon termination of the Grantee&#8217;s employment with the Company and all of its Subsidiaries and Affiliates.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:11pt;">Any Restricted Stock Units that are not vested may be forfeited to the Company in accordance with Section 9 of this Award Agreement.</font></p></td></tr></table></div>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Payment for Restricted Stock Units</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;</font></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:11pt;">The Company will pay one share of Common Stock to the Grantee for each vested Restricted Stock Unit as soon as reasonably possible following vesting under this Award Agreement.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><a name="_AEIOULastRenderedPageBreakAEIOU2"></a><font style="font-size:11pt;">Notwithstanding the foregoing, in the event that the Grantee is a &#8220;specified employee&#8221; within the meaning of Section 409A(a)(2)(B)(i) of the Code and the Award is considered to be Nonqualified Deferred Compensation upon the Grantee&#8217;s &#8220;Separation from </font></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">83435388</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:7pt;">&nbsp;</p>
<p style="line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap"></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:11pt;">Service&#8221; as defined below, any payment under this Award Agreement which results from a Separation from Service shall be delayed until the earlier of (i) first day of the seventh (7th) month beginning after the Grantee&#8217;s Separation from Service, or (ii) the Grantee&#8217;s death, if such a delay is necessary to avoid the imposition of additional tax and interest on the Grantee under Section 409A(a)(1)(B) of the Code.</font></p></td></tr></table></div>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Rights as Stockholder</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;The Grantee shall have no rights as a stockholder with respect to any Restricted Stock Units.&nbsp;&nbsp;The Grantee will only have stockholder rights after a stock certificate is issued.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Vesting</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;The Restricted Stock Units granted hereunder will vest as follows: (i) thirty percent (30%) on April 29, 2023; (ii) thirty percent (30%) on May 4, 2024; and (iii) forty percent (40%) on May 3, 2025, (each a &#8220;Vesting Date&#8221;), provided the Grantee continues to be employed by the Company (or a Subsidiary or Affiliate thereof) until such dates.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Effect of Termination of Employment in Connection with Death, Disability or Retirement or Involuntary Termination Without Cause.</font><font style="font-size:11pt;font-family:Times New Roman;">&nbsp;&nbsp;Notwithstanding Section 6 above, the following provisions shall apply to the Restricted Stock Units in the event of Grantee&#8217;s termination of employment in connection with death, disability or retirement or involuntary termination without cause prior to May 3, 2025: </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:36pt;">if Grantee&#8217;s employment with the Company and its Subsidiaries and Affiliates is terminated due to total and permanent disability as determined by the Company or death, the unvested Restricted Stock Units shall become vested and payable as of the date of termination; and</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:36pt;">if Grantee experiences an involuntary termination of employment for reasons other than Cause after May 1, 2021, then a pro rata portion of the Restricted Stock Units will become immediately vested. If the involuntary termination of employment for reasons other than Cause occurs on or before May 1, 2021, then no Restricted Stock Units &#8206;shall vest. If the involuntary termination of employment for reasons other than Cause occurs after May 1, 2021, then the number of Restricted Stock Units to vest under 7(b) shall be calculated as follows:</font></p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:433.6pt;;">
<tr>
<td style="width:13.5pt;"></td>
<td style="width:64.5pt;"></td>
<td style="width:13.5pt;"></td>
<td style="width:157.75pt;"></td>
<td style="width:18pt;"></td>
<td style="width:22.5pt;"></td>
<td style="width:13.5pt;"></td>
<td style="width:13.5pt;"></td>
<td style="width:116.85pt;"></td>
</tr>
<tr style="height:40.25pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Number of Restricted Stock Units</p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">x</p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Number of fiscal months elapsed between May 2, 2020 and termination date (rounded up to the nearest whole month)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">x</p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">1</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8722;</p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Number of Restricted Stock Units previously vested under Section 6</p></td>
</tr>
</table></div>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-size:11pt;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Grantee&#8217;s right to this pro rata portion of Restricted Stock Units is conditioned upon Grantee signing and delivering to the Company, within the time period required by the Company, a written general release of all claims against the Company in a form acceptable to the Company (the &#8220;Release&#8221;), and not revoking the Release within any applicable revocation period.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU3"></a>(c)<font style="margin-left:36pt;"><a name="_AEIOULastRenderedPageBreakAEIOU3"></a>if Grantee&#8217;s employment with the Company and its Subsidiaries and Affiliates is terminated due to retirement on or after Grantee&#8217;s sixty-fifth birthday or retirement on or after Grantee&#8217;s fifty-fifth birthday with consent of the Committee,&nbsp;&nbsp;then the unvested Restricted Stock </font>Units shall vest pro rata based on the date of termination and be paid on such termination date.&nbsp;&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For purposes of this calculation, the number of Restricted Stock Units to vest under 7(c) shall be calculated as follows:</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:433.6pt;;">
<tr>
<td style="width:13.5pt;"></td>
<td style="width:64.5pt;"></td>
<td style="width:13.5pt;"></td>
<td style="width:157.75pt;"></td>
<td style="width:18pt;"></td>
<td style="width:22.5pt;"></td>
<td style="width:13.5pt;"></td>
<td style="width:13.5pt;"></td>
<td style="width:116.85pt;"></td>
</tr>
<tr style="height:40.25pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU4"></a>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Number of Restricted Stock Units</p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">x</p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Number of fiscal months elapsed between May 2, 2020 and termination date (rounded up to the nearest whole month)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">x</p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">1</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8722;</p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Number of Restricted Stock Units previously vested under Section 6</p></td>
</tr>
</table></div>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU5"></a>8.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Change of Control.</font><font style="font-size:11pt;font-family:Times New Roman;">&nbsp;&nbsp;Notwithstanding Section 6 above, the following provisions shall apply to the Award in the event of a Change of Control prior to May 3, 2025&#8206;:</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:36pt;">In the event of a Change of Control, the surviving or successor entity (or its parent corporation) may continue, assume or replace the Restricted Stock Units outstanding as of the date of the Change of Control on substantially the same terms and conditions (with such adjustments as may be required or permitted by Section 15 of the Plan), and such Restricted Stock Units or replacements therefor shall remain outstanding and be governed by their respective terms, subject to (c) and (d) below. </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:36pt;">If and to the extent that the outstanding Restricted Stock Units are not continued, assumed or replaced in connection with a Change of Control, then all unvested Restricted Stock Units will become immediately vested and non-forfeitable and payable as of the date of the Change of Control.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:36pt;">If and to the extent that the Restricted Stock Units are continued, assumed or replaced under the circumstances described in (a), and if within two years after the Change of Control the Grantee experiences an involuntary termination of employment or other service for reasons other than Cause</font> or Grantee shall terminate employment with Good Reason, then all unvested Restricted Stock Units will become immediately vested and non-forfeitable and payable as of the date of termination of employment.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)<font style="margin-left:36pt;">Notwithstanding whether an Award is continued, assumed or replaced in connection with a Change of Control, if Grantee experiences an involuntary termination of employment or other service for reasons other than Cause or Grantee shall terminate employment with Good Reason during the period beginning on the date an agreement is entered into by the Company with respect to a merger, consolidation or similar transaction of the Company, which would constitute a Change of Control, and the effective time of such merger, consolidation or similar transaction of the Company, then all unvested Restricted Stock Units will become immediately vested and non-forfeitable and payable as of the date of the Change of Control.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU6"></a><a name="_AEIOULastRenderedPageBreakAEIOU6"></a>&#8220;Good Reason&#8221; shall exist hereunder if, without Grantee&#8217;s express written consent any of the following events or actions occurs, provided that no finding of Good Reason shall be effective unless and until the Grantee has provided the Company, within sixty (60) calendar days of becoming aware of the facts and circumstances underlying the finding of Good Reason, with written notice thereof stating with specificity the facts and circumstances underlying the finding of Good Reason and, if the basis for such finding of Good Reason is capable of being cured by the Company, providing the Company with an opportunity to cure the same within thirty (30) calendar days after receipt of such notice: (A) the Company shall materially reduce the nature, scope or level of Grantee&#8217;s responsibilities from the nature, scope or level of such responsibilities prior to the Change of Control, or shall fail to provide Grantee with adequate office facilities and </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Exhibit 10.5</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">support services to perform such responsibilities; (B) the Company shall require Grantee to move Grantee&#8217;s principal business office more than 25 miles from Grantee&#8217;s principal business office at the time of this Award Agreement, or assign to Grantee duties that would reasonably require such move; provided, however, that if Grantee&#8217;s principal business office is not located at the Company&#8217;s then current corporate headquarters, and the Company requires Grantee to move Grantee&#8217;s principal business office to such corporate headquarters, or assigns to Grantee duties that would reasonably require such move, such actions shall not constitute &#8220;Good Reason&#8221; under this subsection; (C) the Company shall require Grantee, or assign duties to Grantee which would reasonably require Grantee, to increase, by more than twenty-four, the number of normal working days (determined at the time of this Award Agreement) that Grantee spends away from Grantee&#8217;s principal business office during any consecutive twelve-month period; (D) the Company shall reduce Grantee&#8217;s annual salary below that in effect as of the date of this Award Agreement (or as of the Change of Control, if greater); (E) the Company shall materially reduce or fail to continue in effect any cash or stock-based incentive or bonus plan, retirement plan, welfare benefit plan, or other benefit plan, program or arrangement, unless the aggregate value (as computed by an independent employee benefits consultant selected by the Company) of all such incentive, bonus, retirement and benefit plans, programs and arrangements provided to Grantee is not materially less than their aggregate value as of the date of this Award Agreement (or as of the Change of Control, if greater); or (F) if the Board of Directors fails to act in good faith with respect to the Company&#8217;s obligations hereunder, or the Company breaches its obligations hereunder.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Forfeiture</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;If at any time any of the following events occur: (i) Grantee&#8217;s conviction of a felony other than a traffic violation; &#8206;(ii)&#8206; Grantee&#8217;s commission of any act or acts of personal dishonesty intended to &#8206;result in &#8206;personal enrichment to Grantee to the material detriment of the Company;&#8206; &#8206;(iii) a failure to perform assigned duties,&#8206; provided that such failure has continued for more than ten (10) days after the Board of Directors or the &#8206;Chief Executive Officer of the Company has given written notice of such failure;&#8206; &#8206;(iv)&#8206; any willful misconduct by the Grantee which materially affects the business &#8206;reputation &#8206;of the Company; &#8206;(v) breach in any material respect by the Grantee of any provision of any &#8206;employment, &#8206;consulting, advisory, nondisclosure, non-competition, proprietary information, or &#8206;other similar agreement &#8206;between the Grantee and the Company; or &#8206;(vi)&#8206; Grantee&#8217;s material violation of the Company&#8217;s code of conduct&#8206;,&#8206; then the unvested Restricted Stock Units shall be forfeited to the Company effective as of the date on which the Grantee entered into such activity, unless terminated sooner by operation of another term or condition of this Award Agreement or the Plan.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Additional Delivery</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;Within 2&#189; months of the date Restricted Stock Units have vested &#8206;pursuant to this &#8206;Award Agreement, the Company shall pay to the Grantee a dividend equivalent &#8206;equal to the aggregate per &#8206;share cash dividends with respect to all cash dividend record dates that &#8206;fall between the Award &#8206;Date and the relevant Vesting Date multiplied by the number of Restricted Stock Units &#8206;that vest &#8206;as of such Vesting Date (without interest).&nbsp;&nbsp;The Company may withhold from &#8206;any payment that &#8206;it is required to make under this Award Agreement amounts sufficient to satisfy &#8206;applicable &#8206;withholding requirements under any federal, state or local law due in connection with &#8206;this Award &#8206;or the payment described in this section.&nbsp;&nbsp;No dividends shall be paid to the Grantee &#8206;with respect &#8206;to any Restricted Stock Unit that does not vest and is forfeited by the Grantee&#8206;.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU7"></a>11.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Applicable Law</font><font style="font-size:11pt;font-family:Times New Roman;"><a name="_AEIOULastRenderedPageBreakAEIOU7"></a>.&nbsp;&nbsp;The validity, construction, interpretation and enforceability of this Award Agreement shall be determined and governed by the laws of the State of Illinois without regard to any conflicts or choice of law rules or principles that might otherwise refer construction or interpretation of this Award Agreement to the substantive law of another jurisdiction, and any litigation arising out of this Award Agreement shall be brought in the Circuit Court of the State of Illinois or the United States </font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">83435388</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:7pt;">&nbsp;</p>
<p style="line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;">District Court of the Eastern Division of the Northern District of Illinois and the Grantee consents to the jurisdiction and venue of those courts.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Severability</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;The provisions of this Award Agreement are severable and if any one or more provisions may be determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions, and any partially unenforceable provision to the extent enforceable in any jurisdiction, shall nevertheless be binding and enforceable.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Waiver</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;The waiver by the Company of a breach of any provision of this Award Agreement by Grantee shall not operate or be construed as a waiver of any subsequent breach by Grantee.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Binding Effect</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;The provisions of this Award Agreement shall be binding upon the parties hereto, their successors and assigns, including, without limitation, the Company, its successors or assigns, the estate of the Grantee and the executors, administrators or trustees of such estate and any receiver, trustee in bankruptcy or representative of the creditors of the Grantee.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Withholding</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;Grantee agrees, as a condition of this grant, to make acceptable arrangements to pay any withholding or other taxes or deductions that may be due or may arise as a result of the vesting of the Restricted Stock Units or other payments under this Award Agreement.&nbsp;&nbsp;In the event that the Company determines that any federal, state, local or foreign tax or withholding payment or other deduction is required relating to the vesting of shares or other payments arising from this grant, the Company shall have the right to require such amounts or deductions from Grantee, or withhold such amounts or deductions from other payments due Grantee from the Company or any Subsidiary or Affiliate.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Dispute Resolution</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;The parties initially shall attempt to resolve by direct negotiation any dispute, controversy or claim arising out of or relating to this Award Agreement or its breach or interpretation (each, a &#8220;Dispute&#8221;). For purposes of this negotiation, the Company shall be represented by one or more of its independent directors appointed by the Board of Directors. If the parties are unable to resolve the Dispute by direct negotiation within 30 days after written notice by one party to the other of the Dispute, the Dispute shall be settled by submission by either party of the Dispute to binding arbitration in Chicago, Illinois (unless the parties agree in writing to a different location), before a single arbitrator in accordance with the American Arbitration Association's National Rules for the Resolution of Employment Disputes then in effect.&nbsp;&nbsp;The arbitrator will be an attorney licensed to practice law in the State of Illinois.</font><font style="font-family:Courier New;font-size:11pt;">&nbsp;&nbsp;</font><font style="font-size:11pt;font-family:Times New Roman;">The decision and award made by the arbitrator shall be final, binding and conclusive on all parties hereto for all purposes, and judgment may be entered thereon in any court having jurisdiction thereof.&nbsp;&nbsp;Except as set forth below, each party shall pay:&nbsp;&nbsp;the fees of their or its attorneys; the expenses of their or its witnesses; and all other expenses connected with presenting their or its case.&nbsp;&nbsp;Except as set forth below, the costs of the arbitration, including the cost of any record or transcripts of the arbitration hearing, administrative fees, the fees of the arbitrator, and all other fees and costs shall be borne equally by the parties.&nbsp;&nbsp;In the event of a Dispute following or in connection with a Change of Control, the Company shall pay the fees of the arbitrator as well as the cost of any record or transcripts of the arbitration hearing and other administrative fees and costs.&nbsp;&nbsp;In all Disputes, the arbitrator will have discretion to make an award of fees, costs and expenses to the prevailing party.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU8"></a>17.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Section 409A Compliance</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;It is the intention of the Company and the Grantee that the Restricted Stock Units and other benefits awarded under this Award Agreement shall comply with Section 409A of the Code and its implementing regulations (&#8220;Section 409A&#8221;) and shall be interpreted in a manner consistent with this intent.&nbsp;&nbsp;Notwithstanding anything to the contrary contained herein, a </font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;">termination of Grantee&#8217;s employment shall not be deemed to have occurred for purposes of making any payments under this Award Agreement unless such termination gives rise to a &#8220;Separation from Service&#8221; (within the meaning of Section 409A, a &#8220;Separation from Service&#8221;) and references to &#8220;termination of employment&#8221; shall mean Separation from Service.&nbsp;&nbsp;In the event that the Company or the Grantee reasonably determines that any award under this Award Agreement fails to comply with Section 409A, the Company and Grantee shall work together to adopt such amendments to this Award Agreement or adopt other policies or procedures (including amendments, policies and procedures with retroactive effective to the extent allowable by applicable laws), or take any other commercially reasonable actions necessary or appropriate to comply with the requirements of Section 409A.</font><font style="font-size:11pt;font-family:Times New Roman;"> </font><font style="font-size:11pt;font-family:Times New Roman;">Nothing in this Agreement shall be construed as a guarantee of any particular tax treatment to Grantee.&nbsp;&nbsp;Grantee shall be solely responsible for the tax consequences with respect to all amounts payable under this Award Agreement, and in no event shall the Company have any responsibility or liability if this Award Agreement does not meet any applicable requirements of Section 409A. </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">No Retention Rights</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;Nothing herein contained shall confer on the Grantee any right with respect to continuation of employment or services by the Company or its Subsidiaries or Affiliates, or interfere with the right of the Company or its Subsidiaries or Affiliates to terminate at any time the employment or service of the Grantee.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">No Guarantee of Future Awards</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;The grant of the Restricted Stock Units is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants, even if Restricted Stock Units have previously been granted.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;font-size:11pt;font-family:Times New Roman;">Entire Agreement and Clawback Policy</font><font style="color:#000000;font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;This Award Agreement supersedes and cancels all prior written or oral agreements and understandings relating to the terms of this Award Agreement.&nbsp;&nbsp;</font><font style="font-size:11pt;font-family:Times New Roman;">This Award Agreement and the Restricted Stock Units granted hereunder are subject to any Company Clawback Policy in effect as of the date of this Award Agreement or as subsequently amended, modified or replaced, and the terms of the Change in Control Agreement between the Company and Grantee, as the same may be amended from time to time, if any.</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[Signature Page to Follow]</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU9"></a><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-indent:7.69%;">IN WITNESS WHEREOF, the Company by one of its duly authorized representatives has executed this Award Agreement as of the day and year first above written.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">METHODE ELECTRONICS, INC.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font><font style="margin-left:36pt;"></font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">Darren M. Dawson</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Its:<font style="margin-left:36pt;">Chair, Compensation Committee</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Please indicate your acceptance of the terms and conditions of this Award Agreement by signing in the space provided below and returning a signed copy of this Award Agreement to the Company.&nbsp;&nbsp;IF A FULLY EXECUTED COPY OF THIS AWARD AGREEMENT HAS NOT BEEN RECEIVED BY THE COMPANY BY OCTOBER 23, 2020, THE RESTRICTED STOCK UNITS GRANTED UNDER THIS AWARD AGREEMENT SHALL BE CANCELLED.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">BY SIGNING BELOW, YOU ACKNOWLEDGE AND AGREE THAT YOU HAVE RECEIVED A COPY OF THE PLAN AND ARE FAMILIAR WITH THE TERMS AND PROVISIONS THEREOF, INCLUDING THE TERMS AND PROVISIONS OF THIS AWARD AGREEMENT.&nbsp;&nbsp;YOU HAVE REVIEWED THE PLAN AND THIS AWARD AGREEMENT IN THEIR ENTIRETY, HAVE HAD AN OPPORTUNITY TO OBTAIN THE ADVICE OF COUNSEL PRIOR TO EXECUTING THIS AWARD AGREEMENT AND FULLY UNDERSTAND ALL PROVISIONS OF THIS AWARD AGREEMENT.&nbsp;&nbsp;FINALLY, YOU HEREBY AGREE TO ACCEPT AS BINDING, CONCLUSIVE AND FINAL ALL DECISIONS OR INTERPRETATIONS OF THE ADMINISTRATOR UPON ANY QUESTIONS ARISING UNDER THE PLAN OR THIS AWARD AGREEMENT.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The undersigned hereby accepts, and agrees to, all terms and provisions of this Award Agreement and the Plan as they pertain hereto.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">GRANTEE<font style="margin-left:36pt;"></font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">____________________________________</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[___________________]</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:53.85%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>7
<FILENAME>mei-ex106_33.htm
<DESCRIPTION>EX-10.6
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
mei-ex106_33.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Exhibit 10.6</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">METHODE ELECTRONICS, INC. </font><font style="font-weight:normal;"> </font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">FORM OF 2020 LONG-TERM TIME-BASED</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">AWARD AGREEMENT (DABIR)</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Long-Term Time-Based Award Agreement (the &#8220;Award Agreement&#8221;), effective as of September 27, 2020 (the &#8220;Award Date&#8221;), is entered into by and between Methode Electronics, Inc., a Delaware corporation (the &#8220;Company&#8221;) and [_____________] (the &#8220;Grantee&#8221;). </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">WHEREAS, the Company desires to reward Grantee for services to the Company and to encourage Grantee to continue to work for the benefit of the Company in a manner that will benefit all Company stockholders.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">NOW, THEREFORE, in consideration of the premises and the mutual covenants and obligations set forth herein, the Company agrees to award to Grantee Restricted Stock Units under the Methode Electronics, Inc. 2014 Omnibus Incentive Plan (the &#8220;Plan&#8221;) on the terms and conditions set forth herein and in the Plan.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.<font style="margin-left:0pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">General</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;This Award Agreement and the Restricted Stock Units awarded herein are subject to all of the provisions of the Plan applicable to Restricted Stock Units.&nbsp;&nbsp;Unless the context otherwise requires, capitalized terms used herein shall have the same meanings as in the Plan.&nbsp;&nbsp;Grantee hereby acknowledges receipt of a copy of the Plan and that Grantee has read the Plan and fully understands its content.&nbsp;&nbsp;In the event of any conflict between the terms of this Award Agreement and the terms of the Plan, the terms of the Plan shall control.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Grant</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;The Company hereby grants to Grantee a total of [______] Restricted Stock Units (the &#8220;Restricted Stock Units&#8221;), subject to the restrictions set forth in Section 3 hereof and the Plan.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Restrictions</font><font style="font-size:11pt;font-family:Times New Roman;">.</font></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:11pt;">None of the Restricted Stock Units may be sold, transferred, pledged, hypothecated or otherwise encumbered or disposed of.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:11pt;">Except as provided below, any Restricted Stock Units that are not vested shall be forfeited to the Company immediately upon termination of the Grantee&#8217;s employment with the Company and all of its Subsidiaries and Affiliates.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:11pt;">Any Restricted Stock Units that are not vested may be forfeited to the Company in accordance with Section 9 of this Award Agreement.</font></p></td></tr></table></div>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Payment for Restricted Stock Units</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;</font></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:11pt;">The Company will pay one share of Common Stock to the Grantee for each vested Restricted Stock Unit as soon as reasonably possible following vesting under this Award Agreement.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><a name="_AEIOULastRenderedPageBreakAEIOU2"></a><font style="font-size:11pt;">Notwithstanding the foregoing, in the event that the Grantee is a &#8220;specified employee&#8221; within the meaning of Section 409A(a)(2)(B)(i) of the Code and the Award is considered to be Nonqualified Deferred Compensation upon the Grantee&#8217;s &#8220;Separation from </font></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">83634865</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:7pt;">&nbsp;</p>
<p style="line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap"></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:11pt;">Service&#8221; as defined below, any payment under this Award Agreement which results from a Separation from Service shall be delayed until the earlier of (i) first day of the seventh (7th) month beginning after the Grantee&#8217;s Separation from Service, or (ii) the Grantee&#8217;s death, if such a delay is necessary to avoid the imposition of additional tax and interest on the Grantee under Section 409A(a)(1)(B) of the Code.</font></p></td></tr></table></div>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Rights as Stockholder</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;The Grantee shall have no rights as a stockholder with respect to any Restricted Stock Units.&nbsp;&nbsp;The Grantee will only have stockholder rights after a stock certificate is issued.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Vesting</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;The Restricted Stock Units granted hereunder will vest as follows: (i) thirty percent (30%) on April 29, 2023; (ii) thirty percent (30%) on May 4, 2024; and (iii) forty percent (40%) on May 3, 2025, (each a &#8220;Vesting Date&#8221;), provided the Grantee continues to be employed by the Company (or a Subsidiary or Affiliate thereof) until such dates.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Effect of Termination of Employment in Connection with Death, Disability or Retirement.</font><font style="font-size:11pt;font-family:Times New Roman;">&nbsp;&nbsp;Notwithstanding Section 6 above, the following provisions shall apply to the Restricted Stock Units in the event of Grantee&#8217;s termination of employment in connection with death, disability or retirement prior to May 3, 2025: </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:36pt;">if Grantee&#8217;s employment with the Company and its Subsidiaries and Affiliates is terminated due to total and permanent disability as determined by the Company or death, the unvested Restricted Stock Units shall become vested and payable as of the date of termination; and</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:36pt;">if Grantee&#8217;s employment with the Company and its Subsidiaries and Affiliates is terminated due to retirement on or after Grantee&#8217;s sixty-fifth birthday or retirement on or after Grantee&#8217;s fifty-fifth birthday with consent of the Committee,&nbsp;&nbsp;then the unvested Restricted Stock Units shall vest pro rata based on the date of termination and be paid on such termination date.&nbsp;&nbsp;For purposes of this calculation, the number of Restricted Stock Units to vest under 7(b) shall be calculated as follows:</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:433.6pt;;">
<tr>
<td style="width:13.5pt;"></td>
<td style="width:64.5pt;"></td>
<td style="width:13.5pt;"></td>
<td style="width:157.75pt;"></td>
<td style="width:18pt;"></td>
<td style="width:22.5pt;"></td>
<td style="width:13.5pt;"></td>
<td style="width:13.5pt;"></td>
<td style="width:116.85pt;"></td>
</tr>
<tr style="height:40.25pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU3"></a>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Number of Restricted Stock Units</p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">x</p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Number of fiscal months elapsed between May 2, 2020 and termination date (rounded up to the nearest whole month)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">x</p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">1</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8722;</p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Number of Restricted Stock Units previously vested under Section 6</p></td>
</tr>
</table></div>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU4"></a>8.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Change of Control.</font><font style="font-size:11pt;font-family:Times New Roman;">&nbsp;&nbsp;Notwithstanding Section 6 above, the following provisions shall apply to the Award in the event of a Change of Control prior to May 3, 2025&#8206;:</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:36pt;">In the event of a Change of Control, the surviving or successor entity (or its parent corporation) may continue, assume or replace the Restricted Stock Units outstanding as of the date of the Change of Control on substantially the same terms and conditions (with such adjustments as may be required or permitted by Section 15 of the Plan), and such Restricted Stock Units or replacements therefor shall remain outstanding and be governed by their respective terms, subject to (c) and (d) below. </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU5"></a>(b)<font style="margin-left:36pt;">If and to the extent that the outstanding Restricted Stock Units are not continued, </font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Exhibit 10.6</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">assumed or replaced in connection with a Change of Control, then all unvested Restricted Stock Units will become immediately vested and non-forfeitable and payable as of the date of the Change of Control.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)<font style="margin-left:36pt;">If and to the extent that the Restricted Stock Units are continued, assumed or replaced under the circumstances described in (a), and if within two years after the Change of Control the Grantee experiences an involuntary termination of employment or other service for reasons other than Cause</font> or Grantee shall terminate employment with Good Reason, then all unvested Restricted Stock Units will become immediately vested and non-forfeitable and payable as of the date of termination of employment.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)<font style="margin-left:36pt;">Notwithstanding whether an Award is continued, assumed or replaced in connection with a Change of Control, if Grantee experiences an involuntary termination of employment or other service for reasons other than Cause or Grantee shall terminate employment with Good Reason during the period beginning on the date an agreement is entered into by the Company with respect to a merger, consolidation or similar transaction of the Company, which would constitute a Change of Control, and the effective time of such merger, consolidation or similar transaction of the Company, then all unvested Restricted Stock Units will become immediately vested and non-forfeitable and payable as of the date of the Change of Control.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Good Reason&#8221; shall exist hereunder if, without Grantee&#8217;s express written consent any of the following events or actions occurs, provided that no finding of Good Reason shall be effective unless and until the Grantee has provided the Company, within sixty (60) calendar days of becoming aware of the facts and circumstances underlying the finding of Good Reason, with written notice thereof stating with specificity the facts and circumstances underlying the finding of Good Reason and, if the basis for such finding of Good Reason is capable of being cured by the Company, providing the Company with an opportunity to cure the same within thirty (30) calendar days after receipt of such notice: (A) the Company shall materially reduce the nature, scope or level of Grantee&#8217;s responsibilities from the nature, scope or level of such responsibilities prior to the Change of Control, or shall fail to provide Grantee with adequate office facilities and support services to perform such responsibilities; (B) the Company shall require Grantee to move Grantee&#8217;s principal business office more than 25 miles from Grantee&#8217;s principal business office at the time of this Award Agreement, or assign to Grantee duties that would reasonably require such move; provided, however, that if Grantee&#8217;s principal business office is not located at the Company&#8217;s then current corporate headquarters, and the Company requires Grantee to move Grantee&#8217;s principal business office to such corporate headquarters, or assigns to Grantee duties that would reasonably require such move, such actions shall not constitute &#8220;Good Reason&#8221; under this subsection; (C) the Company shall require Grantee, or assign duties to Grantee which would reasonably require Grantee, to increase, by more than twenty-four, the number of normal working days (determined at the time of this Award Agreement) that Grantee spends away from Grantee&#8217;s principal business office during any consecutive twelve-month period; (D) the Company shall reduce Grantee&#8217;s annual salary below that in effect as of the date of this Award Agreement (or as of the Change of Control, if greater); (E) the Company shall materially reduce or fail to continue in effect any cash or stock-based incentive or bonus plan, retirement plan, welfare benefit plan, or other benefit plan, program or arrangement, unless the aggregate value (as computed by an independent employee benefits consultant selected by the Company) of all such incentive, bonus, retirement and benefit plans, programs and arrangements provided to Grantee is not materially less than their aggregate value as of the date of this Award Agreement (or as of the Change of Control, if greater); or (F) if the Board of Directors fails to act in good faith with respect to the Company&#8217;s obligations hereunder, or the Company breaches its obligations hereunder.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">83634865</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:7pt;">&nbsp;</p>
<p style="line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU6"></a><font style="font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.</font><font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Forfeiture</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;If at any time any of the following events occur: (i) Grantee&#8217;s conviction of a felony other than a traffic violation; &#8206;(ii)&#8206; Grantee&#8217;s commission of any act or acts of personal dishonesty intended to &#8206;result in &#8206;personal enrichment to Grantee to the material detriment of the Company;&#8206; &#8206;(iii) a failure to perform assigned duties,&#8206; provided that such failure has continued for more than ten (10) days after the Board of Directors or the &#8206;Chief Executive Officer of the Company has given written notice of such failure;&#8206; &#8206;(iv)&#8206; any willful misconduct by the Grantee which materially affects the business &#8206;reputation &#8206;of the Company; &#8206;(v) breach in any material respect by the Grantee of any provision of any &#8206;employment, &#8206;consulting, advisory, nondisclosure, non-competition, proprietary information, or &#8206;other similar agreement &#8206;between the Grantee and the Company; or &#8206;(vi)&#8206; Grantee&#8217;s material violation of the Company&#8217;s code of conduct&#8206;,&#8206; then the unvested Restricted Stock Units shall be forfeited to the Company effective as of the date on which the Grantee entered into such activity, unless terminated sooner by operation of another term or condition of this Award Agreement or the Plan.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Additional Delivery</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;Within 2&#189; months of the date Restricted Stock Units have vested &#8206;pursuant to this &#8206;Award Agreement, the Company shall pay to the Grantee a dividend equivalent &#8206;equal to the aggregate per &#8206;share cash dividends with respect to all cash dividend record dates that &#8206;fall between the Award &#8206;Date and the relevant Vesting Date multiplied by the number of Restricted Stock Units &#8206;that vest &#8206;as of such Vesting Date (without interest).&nbsp;&nbsp;The Company may withhold from &#8206;any payment that &#8206;it is required to make under this Award Agreement amounts sufficient to satisfy &#8206;applicable &#8206;withholding requirements under any federal, state or local law due in connection with &#8206;this Award &#8206;or the payment described in this section.&nbsp;&nbsp;No dividends shall be paid to the Grantee &#8206;with respect &#8206;to any Restricted Stock Unit that does not vest and is forfeited by the Grantee&#8206;.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Applicable Law</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;The validity, construction, interpretation and enforceability of this Award Agreement shall be determined and governed by the laws of the State of Illinois without regard to any conflicts or choice of law rules or principles that might otherwise refer construction or interpretation of this Award Agreement to the substantive law of another jurisdiction, and any litigation arising out of this Award Agreement shall be brought in the Circuit Court of the State of Illinois or the United States District Court of the Eastern Division of the Northern District of Illinois and the Grantee consents to the jurisdiction and venue of those courts.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Severability</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;The provisions of this Award Agreement are severable and if any one or more provisions may be determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions, and any partially unenforceable provision to the extent enforceable in any jurisdiction, shall nevertheless be binding and enforceable.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Waiver</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;The waiver by the Company of a breach of any provision of this Award Agreement by Grantee shall not operate or be construed as a waiver of any subsequent breach by Grantee.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Binding Effect</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;The provisions of this Award Agreement shall be binding upon the parties hereto, their successors and assigns, including, without limitation, the Company, its successors or assigns, the estate of the Grantee and the executors, administrators or trustees of such estate and any receiver, trustee in bankruptcy or representative of the creditors of the Grantee.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU7"></a>15.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Withholding</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;Grantee agrees, as a condition of this grant, to make acceptable arrangements to pay any withholding or other taxes or deductions that may be due or may arise as a result of the vesting of the Restricted Stock Units or other payments under this Award Agreement.&nbsp;&nbsp;In the event that the Company determines that any federal, state, local or foreign tax or withholding payment or other deduction is required relating to the vesting of shares or other payments arising from this grant, the </font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;">Company shall have the right to require such amounts or deductions from Grantee, or withhold such amounts or deductions from other payments due Grantee from the Company or any Subsidiary or Affiliate.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Dispute Resolution</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;The parties initially shall attempt to resolve by direct negotiation any dispute, controversy or claim arising out of or relating to this Award Agreement or its breach or interpretation (each, a &#8220;Dispute&#8221;). For purposes of this negotiation, the Company shall be represented by one or more of its independent directors appointed by the Board of Directors. If the parties are unable to resolve the Dispute by direct negotiation within 30 days after written notice by one party to the other of the Dispute, the Dispute shall be settled by submission by either party of the Dispute to binding arbitration in Chicago, Illinois (unless the parties agree in writing to a different location), before a single arbitrator in accordance with the American Arbitration Association's National Rules for the Resolution of Employment Disputes then in effect.&nbsp;&nbsp;The arbitrator will be an attorney licensed to practice law in the State of Illinois.</font><font style="font-family:Courier New;font-size:11pt;">&nbsp;&nbsp;</font><font style="font-size:11pt;font-family:Times New Roman;">The decision and award made by the arbitrator shall be final, binding and conclusive on all parties hereto for all purposes, and judgment may be entered thereon in any court having jurisdiction thereof.&nbsp;&nbsp;Except as set forth below, each party shall pay:&nbsp;&nbsp;the fees of their or its attorneys; the expenses of their or its witnesses; and all other expenses connected with presenting their or its case.&nbsp;&nbsp;Except as set forth below, the costs of the arbitration, including the cost of any record or transcripts of the arbitration hearing, administrative fees, the fees of the arbitrator, and all other fees and costs shall be borne equally by the parties.&nbsp;&nbsp;In the event of a Dispute following or in connection with a Change of Control, the Company shall pay the fees of the arbitrator as well as the cost of any record or transcripts of the arbitration hearing and other administrative fees and costs.&nbsp;&nbsp;In all Disputes, the arbitrator will have discretion to make an award of fees, costs and expenses to the prevailing party.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">Section 409A Compliance</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;It is the intention of the Company and the Grantee that the Restricted Stock Units and other benefits awarded under this Award Agreement shall comply with Section 409A of the Code and its implementing regulations (&#8220;Section 409A&#8221;) and shall be interpreted in a manner consistent with this intent.&nbsp;&nbsp;Notwithstanding anything to the contrary contained herein, a termination of Grantee&#8217;s employment shall not be deemed to have occurred for purposes of making any payments under this Award Agreement unless such termination gives rise to a &#8220;Separation from Service&#8221; (within the meaning of Section 409A, a &#8220;Separation from Service&#8221;) and references to &#8220;termination of employment&#8221; shall mean Separation from Service.&nbsp;&nbsp;In the event that the Company or the Grantee reasonably determines that any award under this Award Agreement fails to comply with Section 409A, the Company and Grantee shall work together to adopt such amendments to this Award Agreement or adopt other policies or procedures (including amendments, policies and procedures with retroactive effective to the extent allowable by applicable laws), or take any other commercially reasonable actions necessary or appropriate to comply with the requirements of Section 409A. Nothing in this Agreement shall be construed as a guarantee of any particular tax treatment to Grantee.&nbsp;&nbsp;Grantee shall be solely responsible for the tax consequences with respect to all amounts payable under this Award Agreement, and in no event shall the Company have any responsibility or liability if this Award Agreement does not meet any applicable requirements of Section 409A. </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">No Retention Rights</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;Nothing herein contained shall confer on the Grantee any right with respect to continuation of employment or services by the Company or its Subsidiaries or Affiliates, or interfere with the right of the Company or its Subsidiaries or Affiliates to terminate at any time the employment or service of the Grantee.</font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU8"></a><font style="font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19.</font><font style="margin-left:36pt;"></font><font style="text-decoration:underline;font-size:11pt;font-family:Times New Roman;">No Guarantee of Future Awards</font><font style="font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;The grant of the Restricted Stock Units is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants, even if Restricted Stock Units have previously been granted.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:(normal text);font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;color:#000000;font-size:11pt;font-family:Times New Roman;">Entire Agreement and Clawback Policy</font><font style="color:#000000;font-size:11pt;font-family:Times New Roman;">.&nbsp;&nbsp;This Award Agreement supersedes and cancels all prior written or oral agreements and understandings relating to the terms of this Award Agreement.&nbsp;&nbsp;</font><font style="font-size:11pt;font-family:Times New Roman;">This Award Agreement and the Restricted Stock Units granted hereunder are subject to any Company Clawback Policy in effect as of the date of this Award Agreement or as subsequently amended, modified or replaced, and the terms of the Change in Control Agreement between the Company and Grantee, as the same may be amended from time to time, if any.</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[Signature Page to Follow]</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU9"></a><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-indent:7.69%;">IN WITNESS WHEREOF, the Company by one of its duly authorized representatives has executed this Award Agreement as of the day and year first above written.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">METHODE ELECTRONICS, INC.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font><font style="margin-left:36pt;"></font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">Darren M. Dawson</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Its:<font style="margin-left:36pt;">Chair, Compensation Committee</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Please indicate your acceptance of the terms and conditions of this Award Agreement by signing in the space provided below and returning a signed copy of this Award Agreement to the Company.&nbsp;&nbsp;IF A FULLY EXECUTED COPY OF THIS AWARD AGREEMENT HAS NOT BEEN RECEIVED BY THE COMPANY BY OCTOBER 23, 2020, THE RESTRICTED STOCK UNITS GRANTED UNDER THIS AWARD AGREEMENT SHALL BE CANCELLED.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">BY SIGNING BELOW, YOU ACKNOWLEDGE AND AGREE THAT YOU HAVE RECEIVED A COPY OF THE PLAN AND ARE FAMILIAR WITH THE TERMS AND PROVISIONS THEREOF, INCLUDING THE TERMS AND PROVISIONS OF THIS AWARD AGREEMENT.&nbsp;&nbsp;YOU HAVE REVIEWED THE PLAN AND THIS AWARD AGREEMENT IN THEIR ENTIRETY, HAVE HAD AN OPPORTUNITY TO OBTAIN THE ADVICE OF COUNSEL PRIOR TO EXECUTING THIS AWARD AGREEMENT AND FULLY UNDERSTAND ALL PROVISIONS OF THIS AWARD AGREEMENT.&nbsp;&nbsp;FINALLY, YOU HEREBY AGREE TO ACCEPT AS BINDING, CONCLUSIVE AND FINAL ALL DECISIONS OR INTERPRETATIONS OF THE ADMINISTRATOR UPON ANY QUESTIONS ARISING UNDER THE PLAN OR THIS AWARD AGREEMENT.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The undersigned hereby accepts, and agrees to, all terms and provisions of this Award Agreement and the Plan as they pertain hereto.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">GRANTEE<font style="margin-left:36pt;"></font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">____________________________________</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[___________________]</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:53.85%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ggizbojlzucw000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ggizbojlzucw000001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %E!I$# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
=HH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>gj4uhcx1wumu000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gj4uhcx1wumu000001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %E!I$# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
=HH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>gmzchffphou0000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gmzchffphou0000001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %E!I$# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
=HH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>mei-20200927.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2020-09-28T19:18:34.9545213+00:00 -->
<!-- Version            : 5.0.1.513 -->
<!-- Package ID         : ed84c0b5956d4413a5407535331b86cf -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:mei="http://www.methode.com/20200927" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.methode.com/20200927" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" namespace="http://xbrl.sec.gov/country/2020-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd" namespace="http://xbrl.sec.gov/currency/2020-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2019-01-31" />
  <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
  <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd" namespace="http://xbrl.sec.gov/exch/2020-01-31" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/negated" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/net" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" namespace="http://fasb.org/srt/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd" namespace="http://fasb.org/srt-roles/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" namespace="http://fasb.org/srt-types/2020-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" namespace="http://xbrl.sec.gov/stpr/2018-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" namespace="http://fasb.org/us-gaap/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd" namespace="http://fasb.org/us-roles/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" namespace="http://fasb.org/us-types/2020-01-31" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType id="TemplateLink" roleURI="http://www.methode.com/20200927/role/TemplateLink" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>00000 - Document - Template Link</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mei-20200927_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mei-20200927_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.methode.com/20200927/taxonomy/role/DocumentCoverPage" id="Role_DocumentCoverPage">
        <link:definition>100000 - Document - Cover Page</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>mei-20200927_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2020-09-28T19:18:34.9545213+00:00 -->
<!-- Version            : 5.0.1.513 -->
<!-- Package ID         : ed84c0b5956d4413a5407535331b86cf -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/axisDefault" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd#axisDefault" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>mei-20200927_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2020-09-28T19:18:34.9545213+00:00 -->
<!-- Version            : 5.0.1.513 -->
<!-- Package ID         : ed84c0b5956d4413a5407535331b86cf -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.methode.com/20200927/role/TemplateLink" xlink:href="mei-20200927.xsd#TemplateLink" xlink:type="simple" />
  <link:roleRef roleURI="http://www.methode.com/20200927/taxonomy/role/DocumentCoverPage" xlink:href="mei-20200927.xsd#Role_DocumentCoverPage" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.methode.com/20200927/taxonomy/role/DocumentCoverPage">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>mei-8k_20200927_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mei-20200927.xsd" xlink:type="simple"/>
    <context id="C_0000065270_20200927_20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000065270</identifier>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="C_0000065270_20200927_20200927" id="F_000005">0000065270</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="C_0000065270_20200927_20200927" id="F_000006">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="C_0000065270_20200927_20200927" id="F_000000">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="C_0000065270_20200927_20200927" id="F_000001">2020-09-27</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="C_0000065270_20200927_20200927" id="F_000002">METHODE ELECTRONICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="C_0000065270_20200927_20200927" id="F_000003">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="C_0000065270_20200927_20200927" id="F_000004">001-33731</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="C_0000065270_20200927_20200927" id="F_000007">36-2090085</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="C_0000065270_20200927_20200927" id="F_000008">8750 West Bryn Mawr Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="C_0000065270_20200927_20200927" id="F_000009">Chicago</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="C_0000065270_20200927_20200927" id="F_000010">IL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="C_0000065270_20200927_20200927" id="F_000011">60631</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="C_0000065270_20200927_20200927" id="F_000012">708</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="C_0000065270_20200927_20200927" id="F_000013">867-6777</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="C_0000065270_20200927_20200927" id="F_000014">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="C_0000065270_20200927_20200927" id="F_000015">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="C_0000065270_20200927_20200927" id="F_000016">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="C_0000065270_20200927_20200927" id="F_000017">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="C_0000065270_20200927_20200927" id="F_000018">Common Stock, $0.50 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="C_0000065270_20200927_20200927" id="F_000019">MEI</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="C_0000065270_20200927_20200927" id="F_000020">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="C_0000065270_20200927_20200927" id="F_000021">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139704449137432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Sep. 27, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 27,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">METHODE ELECTRONICS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33731<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000065270<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">36-2090085<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">8750 West Bryn Mawr Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Chicago<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">60631<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">708<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">867-6777<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.50 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MEI<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>16
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M"  4FSQ1;7H)ES8$   R$   &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;*6877/B-A2&K[>_0L/THIT)\0<?)CN$&4+(+K/Y8 )MINWT0M@"-+$E5Y(#
M_/L>&;#IUAS3:2YBR]9Y_>A(>B71WTCUKM>,&;)-8J%O&VMCTL^.H\,U2ZB^
MEBD3\&8I54(-%-7*T:EB-,J#DMCQ7;?K))2+QJ"?/YNJ05]F)N:"317169)0
MM;MCL=S<-KS&\<$K7ZV-?> ,^BE=L1DSOZ13!26G4(EXPH3F4A#%EK>-H??Y
MSF_;@+S&KYQM],D]L4U92/EN"Y/HMN%:(A:ST%@)"I</-F)Q;)6 XZ^#:*/X
MI@T\O3^J/^2-A\8LJ&8C&;_QR*QO&[T&B=B29K%YE9NO[-"@CM4+9:SS_V2S
MK]MN-TB8:2.30S 0)%SLKW1[2,1)0,L]$^ ? OR<>_^AG/*>&CKH*[DARM8&
M-7N3-S6/!C@N;*_,C(*W'.+,8"0_F")3Z("^8T#//G7"0^S=/M8_$SMCZ37Q
M@ROBN[[[SW ', H6OV#Q<[T6RO+'<*&-@M[Z$Y%L%9*M7+)]1O)>AAF,(4/F
MN[2RA7AXK_D-@6@7$.W+(*9,<1F1L8@(=%8E#ZYTS/@/GS[5Y+Q3L'50Q;$P
MW.S(*UMQFW6 ?*9))1FN\S2>?WVY'Y/QXW@T?WUYGHQF5V3R/+I&&+L%8_<2
MQHD(I4JEHG8Z7Y&9@102J<A(9L*H'5RC2G!<_'Z,$ 8%87 )X0./&7G.D@53
M52"XANMZS58K:'D(3Z_@Z5W",X)!IV@,F8O8EGQCNRHJ7,FU?]V.'V"#[:;
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MI6J//X7W*+F?&^[_$L4/4$L#!!0    ( !2;/%&7BKL<P    !,"   +
M7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_
MK]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?2
M0$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-
MTG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z
M6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ %)L\41E%%?4W 0
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M)H]:1NO<2KGW\$JV''..?[3\ 5!+ P04    "  4FSQ1)!Z;HJT   #X 0
M&@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4 -5"I
M0P5,75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K!LID
MR^SO *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1UW6E\
M./VR./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6
M?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ %)L\4660>9(9 0
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M<',O87!P+GAM;%!+ 0(4 Q0    ( !2;/%%%N2!C[P   "L"   1
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M96QS+RYR96QS4$L! A0#%     @ %)L\41E%%?4W 0  )P(   \
M     ( !8@\  'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( !2;/%$D'INB
MK0   /@!   :              "  <80  !X;"]?<F5L<R]W;W)K8F]O:RYX
M;6PN<F5L<U!+ 0(4 Q0    ( !2;/%%ED'F2&0$  ,\#   3
M  "  :L1  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  /42
$

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="mei-8k_20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.methode.com/20200927/taxonomy/role/DocumentCoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="mei-8k_20200927.htm">mei-8k_20200927.htm</File>
    <File>mei-20200927.xsd</File>
    <File>mei-20200927_lab.xml</File>
    <File>mei-20200927_pre.xml</File>
    <File>mei-ex101_38.htm</File>
    <File>mei-ex102_37.htm</File>
    <File>mei-ex103_36.htm</File>
    <File>mei-ex104_35.htm</File>
    <File>mei-ex105_34.htm</File>
    <File>mei-ex106_33.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "mei-8k_20200927.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "mei-8k_20200927.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mei-20200927_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mei-20200927_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "mei-20200927.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "mei",
   "nsuri": "http://www.methode.com/20200927",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "mei-8k_20200927.htm",
      "contextRef": "C_0000065270_20200927_20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Cover Page",
     "role": "http://www.methode.com/20200927/taxonomy/role/DocumentCoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "mei-8k_20200927.htm",
      "contextRef": "C_0000065270_20200927_20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.methode.com/20200927/taxonomy/role/DocumentCoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.methode.com/20200927/taxonomy/role/DocumentCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.methode.com/20200927/taxonomy/role/DocumentCoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "verboseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.methode.com/20200927/taxonomy/role/DocumentCoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address Address Line1",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.methode.com/20200927/taxonomy/role/DocumentCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.methode.com/20200927/taxonomy/role/DocumentCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.methode.com/20200927/taxonomy/role/DocumentCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.methode.com/20200927/taxonomy/role/DocumentCoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.methode.com/20200927/taxonomy/role/DocumentCoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.methode.com/20200927/taxonomy/role/DocumentCoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.methode.com/20200927/taxonomy/role/DocumentCoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.methode.com/20200927/taxonomy/role/DocumentCoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.methode.com/20200927/taxonomy/role/DocumentCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.methode.com/20200927/taxonomy/role/DocumentCoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.methode.com/20200927/taxonomy/role/DocumentCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.methode.com/20200927/taxonomy/role/DocumentCoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.methode.com/20200927/taxonomy/role/DocumentCoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security12b Title",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.methode.com/20200927/taxonomy/role/DocumentCoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.methode.com/20200927/taxonomy/role/DocumentCoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.methode.com/20200927/taxonomy/role/DocumentCoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.methode.com/20200927/taxonomy/role/DocumentCoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.methode.com/20200927/taxonomy/role/DocumentCoverPage"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0001564590-20-044842-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001564590-20-044842-xbrl.zip
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MA\Q4)(>=I'9X<YH$U#*-P2::X0Z'W?/*!"4'(%'B4&U88K4M8>!HI8.@(-;
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M:79EY.=-71\Y.IJ<H[Q:*94>+0L>Y"[$.FOEM,>/.""%]T&V^U6<@S=P])=
M" OH!#CMM^-W("$\ONMSI:>[I#%)YF2A\PH.0O1Z+?O(H/S%A(?5;$P++\\W
M.E53,0-2@U,C>!#A']^@:J%IKA;&B$K*Z:GS.GJU=)_$<%&9KV"H^QY6Z&FL
M&FX?8Q:0T!CR%8R=6:#[%#)-<5)-;'T?#U[-$)N*"OJ#T9?@22Q4YM O^37N
M'(A#/I-20M;V"6'"!B(Z$/,=W^M%4D0+ZF9H.DBE3*1/C,21_(F?^!2.?O;F
M_']02P,$%     @ %)L\47\QHW;_!   H"L  !0   !M96DM,C R,# Y,C=?
M<')E+GAM;.5:76_B.!1]7VG_@S?S,J/=?!&8%E1FQ-)VA9:V"-C=T;Z,@F/
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M/"!!&D8C>WU'DM;3]IG .QW3P15$3W) $6Q-Q),=$ KAW;H^,/6!Z;CK#/@
MI[[?\)C&RYN0R DHTQ]2S.-I6X21SY>[##"=D$*F)YD_(JQI' UAOSWD <$S
MJ5M<X*G/)^3>#\FI6/-]"P YE+Z6^L$R' EV*KIG3@5RYU9&0QJSLWG+_ H
MUY,$\@8R'A.=]AVE9D0.]6TD'\9C(D\%>SQ.\>!?#[MHP#!I4DQCR+<[4&8)
M\^C)R9#C60# ?R#A0$0U)S-.5].A.A7C ><"8.J9FO6F4,'=S\+1Z<.][U<
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MN(#VD%D_5(@/'8^%-X;G/AY*/I ><[Q[)!-\B-1#CO._DCYW4 1R23CF1MA
M/KY')!\%CD]=Y@72F1!)?2[[$]73=/!Z0#S:NV1"BL3LB#R <02A[B1\UO<<
M>#GVPS,RCHY*V5H@RNV.?Q</9<-Q-9TC]9FCTPT/:K<XG(45S%D=M>?R$QFZ
MZ[*!Q\AO'=*=C$!2/3?=I6NPV%G>[X+[0&;HKPY<XYZ4VQV]]CS/Z5&@+Q^H
M'(G@I%FK?5AQ4[Z(EY/&,R-FQP+!0!Q ' 4Y&4?B!&\"8(=:I6[X=BX^$,,"
M#\M-TKZX(95JJ0 -M3YY;.NW.LTC(!N/:HY71/.Q%"U4EA; TAU\ UD,@SBO
M@^"?"BL[)O@9N,G(P'N1VLLUFB]7(@0?BX*=DGNM5- M,XI_A.)CN8#7@J&$
MQVPU%:R/=H6XZO?7W+%DE+]F[+=@>2L"]T=E?KEFYRN'O:/5^$"WS3CA$4YH
M+N&$CI0!$QD_["L_5%F^AI4_5N$'TS:1'U*=:J]H)QDQ ?76C@G8'(Z3\DN4
M##%;/8!3ZQUM[)(]RL<_?R!QCXE4'I-2H5D?^^0O.K'MA;W.SYK4=XLE$W2:
MC34DED.E7,<G7UX.0#6',>;(^"\"Q"<(%"G7,QH1%#GQI6.QGC>S6UDCAZL>
M];T7ZJ]EU']I4HN4@&2AF0'J]'[(X9>9SMW,WH[J( 3&"N!]W8ZN=(L\%O5E
MS)I)N=)3.FK-N".P( %%7=^S?N3(3R4L^ .<B'A8C/=:D^5W1>OK5P_91*>M
M2',OO<S=46$L",ZH/JT=ULW'[+Q[0JMEA)9*:)52DK@+][%KY_\N.!U05859
M;KC:__7$#RT0IYOE%0+%WL(.N>/:Z$N '>>$6.K<%6;[ _0W4^DY<X>B7!+J
M$@80&:!O>B"\>W^(+HDQ'I1226S6YZ[.*=8G,J5Z0KF&696&*CE$SFE^P""7
M4OF#.IP)^\#; !=CE93L">/>J/3RE54K0,R-C1Z/6??(Z(57?%A^GHP,(X_
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M&8X%L,./?2YQI5B\7B%F^KU2BM%V&]<FL0J]WD&@+)F;RO2M2\6OO@S!=R:
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MG'+42I,^ LC 98/@ LA1[JC8(. @S?8L9"=#;>CZLI-,I;TJG!<].^U1Z\<
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M9WTRRX&XZO>YQ<0ZQ<AV&*RQ!R$C'XL]SYXH@ S]D0,?_A]02P,$%     @
M%)L\42,2-./T,P  BYX! !    !M96DM97@Q,#%?,S@N:'1M[7UI4QO)ENCW
MB7C_(8=[NT=$"(%8O(#=$;*0;6(P\ "WG]^-B1NE4@I5=ZE*754"T[]^SI*9
ME;5) @0(61W1&*2J7$Z>//OR[C\/3]N7W\\ZXO/EEV-Q]O7#\5%;K&UL;G[;
M:6]N'EX>\A>[C:VFN(R<(/82+PP<?W.S<[(FU@9),MK?W+RYN6G<[#3"Z&KS
M\GQSD S]W4T_#&/9Z"6]M=_^SW^\P\_H7^GT\-_$2WP)OPREMR%_-+>:_]YY
MTX"'X*M-_=V[3?WT?VYLB)-/HAT&US)*9"2N]QI;C>W&WI;8V, 'NF'O%O[]
MCW<C$2>WOGR_EL@?R8;C>U?!?N1=#9*#H1-=><%&-TR2<+B_-3*?).&(_J0W
MO* G@V1_ZY>#?A@D&S<2W]WOAGZ//XB]O^5^LPF/TY]]9^CYM_N7WE#&XD3>
MB/-PZ 3J45S(?A!&0\?GP1,$8!\^@$\#R4]=.Y'GP(Q"/;CVVSO\/+.-GG3#
MR$' [X]A?9'OP=MKOW5^#+RNEXCF5J/Y;A/?^NW=YNBWN0-AXB8)'OCFVF^_
M!MUX=%"]!!<&E=$2'L27SN7GT\..Z!QWVI?GIR='[8NZ.#II-\348WD(3%(0
M+!_L/YZ>?Q&G'\7VUO:6.#X]^;1QV8%/SCKG^$WKI-W9^-"ZZ!R*Y=ERZUOK
M_%"T/IUW.E\Z)Y>BUNZ<KE=O[X]QG'C]V\='G?*)FMN39WK=>/6V,-E4V"FX
M*Y@\")R7 R\6QV%PM7$IHZ$XDQ&^X@2NW/C@Q+(G6C=.!#^O(BF'L&)12P92
M_/J/-]O;6P>Y[^C3YL%Z7<A^7[J)=RV%$XNP+R[D*)'#+K"D[==UQM;B.(=.
M(M,A8%F$F; $+TA"T;T53M 379G<2!F(+S(9A#TI.CY,%(6!Y\9 3 *W41>.
M.)2^ T-* 71HI$A19L)V.!PYP:V>C4;^U[_M__XG\_PG@&4BS>H:C Q+BA+?
M/G?..RV@S0@ !2G1D[$7P;1P$I&DXU(P$3">B&5T[;G\M?T6PA4^DH$;CB/G
M2IJ7X$,79O>",?U^$T9_TD#X<E<&L@\,&_#&'LL+X&1AOX'$QYQ$W'B^;QYV
MX'?]9)R$[I\#($HRBAM+=SPGI]_JXA+/"&A\IXYP 5#&'NR6$5W!;13)H1?#
M4N@0X(/A.!D[/CQ\+0,8DK\(NP +>B\6 [AM7N#T472,98('D@RR:.#@7:=C
M=@@)X!=]I#5O7<0#!Y$$5G NXR3RW 2N[P4>1_XT[=N5?S8E KC"F@<#6W1)
M? T\6+P]0.%;<[%)_J")*PD&D*/FKC@=!EYW'.,G<,I(N<Y\)TLT\ ,S,, 9
MOP)0#1F0< 8]C^%H8*<@2M][_ */ZH:^SP32OV4 VY30+'_YD+?9R(B+:JF^
M["?[.Z^(SVI9<%:I\A,0@,CQU6L9RDR\+<^_]&TH("A^440S0G-X1I\D,)5X
MW/T##H\N 5 =<]W":R^F\U>?T%$[HY'ON4[7)SH7C]T!KRANP 2^C&-Z%&DA
M[%&$\$=T [<6B.Q?8R2X=>$Z(R^!0_\;5L'H-H[3!<&-@S4,'$!8'"AVAG#1
MI1-XP56,S-="NPQL]*W%89"UNG\&X8TO>U=P_)%TI3<B NS TD:WV1T1 ('^
MFB$<?,7I91_ICWW_EN]?G, 'L!0 )VTT2#)+.>(ERFL\'IP3R ,\UP>X)8;?
MIY>-UC+A8*VG>#GU\H\5Z'!%4>@OWU7;GOM58\0MOVDI95<8=141C\DQ" <^
M &3&<_B7D;0F< W# $I?+%[7D7-+=PV9HA,/LB"P#F.; #!=\7RA9[\S][/_
M'4X&:$K9X5^D]'#J+:V7TUZ^BM?PL;G&Q;/EA[I *9PH@%<5"^Z!VI#ATVJI
M&7V"*9820(9>@OCHR@C.UH.#&%ES:8FA;.UQ=J>65M!\?1 ;B;8GY'#DA[=$
MEN JV'(/R+B. (B!O.8Y$?W=ZO<]W\-=)(,H'%\-F!RB<-8O@ )^]\)>!OXM
M&+8 4=IO+X3-!6&20A:74(0L/8RL#9]5T!V-HW@,^^/- C0N4& !F.^D!^$-
MA[*'*P=*[^)X(-7TF/J'45]ZN)R\1F!HL'U,F?UT?KB@+N*3Q%-[I &FT]=Z
M(!CNU.0ZPFZGUE^'E?CA39V8\8Q<_2$[\&QVI6F;*YV8Y6+$3SI]>/,N9X\G
M ,\D0!E@WY[2A6;'@DM>)5QA7%<!#H@!<>904X!*!4*A)BW*[E&99!1)"TAE
M([_2)T-B3\6E1Y1#F &Y]9!RHQ9XK5"C?+E=.O]>>OYX7#1%<9%#Y];,4,3K
M=$R71K-QK'#%^I'CLE5?,RP7I)XD/6:]:M?QW;&O="K0F]W(Z^)3!&*EM JX
MZ %B=B^\"4B2%#>@L4H>6@1C-)8<P-)+IJ4AZ$87[FB.8I78*7K>M2#6]GX-
MV<$:?)00Q^R&(.=&[]>VU@3>@GCDN+ 9\_?(Z?7TWYI?\"L;J,PXHUCNZU\.
M8(F]9+#?W-KZY8!FB/!'3URKF8%GKNE!^%'FF#<#P*4-G!J9WDWDC-8>S)?G
MRUIGM/1OYTR&[S:3WC.#(%W84PHBD^2OIUQ'S5FW9+WRXWC)J/;.$0&H?N_7
M_MWJ')U^/7;BY%RB)"-[9\Z5_ "4ZD_Z9@=%/V=6N:]@!2\R(:*^'[T8J!X:
M=O=$Y\/1Y6&K3+XLC%;0(4KL.3R+DN/0*HRDML_SW0)-SQN68-=(A-$.!NRV
M&XX3\068P$Z=5U=34U@K+K7J*B%$\?X\[L"/"'\@Y81_@:C:R&.AA8TFEN^A
MTMGP]HGOQ9N=5SL[>\T=W!GZG2.]AQ%@S487T6:##(+[CG_CW,8'.<J>W_,3
MNDR?;,85RWQY+',)*?Q$2JK$_MD4)E;"6<9$\CG!_D*:88EVGKY<H4WFE74M
M]W;)J:A4=\L-1PHTLP[C""IA-B7D6[V5.@WNHZ7?>,G@07IZ0?_@!;,+PQP+
M*]JB/7""*XFOM=GZ2#94U%-"UQU'$6D+,)*<00>\&VNZ%];;YJ/F7F/GS2\9
MVKKQ[.:NCZ&RV(!"- ICJ31"@P;Z*NQJA;2(/@IAY5_H(BO#3<1C,JJKDPED
M@HYID+!BM&HY/]!6W_=^H/D@1@]03XXBZ7KLDV,/4 +'3DHN/^$,PRCQ_E;N
M:87966S&BVPOUNGAL=$<<$U\V$R\+VJM=3)^P-8]<EWI>Q2%0^&X?XV]6'FF
M"/]<'T'4&T<H)Y'K@N\6/8Y_I^YX?8<FHF#J$= F),<%U9A64G-0!>Y[@5:
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M(J[E^#BQ;1WZ7Z)7I:$7%$5S-79R2<YHXG#'U%'6^2$2+#V<RX'/3%D(?<*
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M#"[:K9-VY_BX<YA9[@I=[T7%OXN+HT\G1R>? ++'I]_JXOOI5]%J__?)Z3>
M\"<XEQ-U"' JK4OZ^G/K]TYZP"T+*SKB[+AUPN^<=\3'UI>CXZ/6.4JYG^GK
MR\[YEPOZ_NS\]/>CBZ/3DPO\@F5?$&:.OQ[B8BJ?K4"^#"I8:_S]J/,-UIA9
M62EV@2@.#QV="_CCZ+QS^;W.0WQNP5,GXO3L[/3\\NO)T26@\ZDX_7#9XC=$
MZ_#WHW8'U]4^_7IRT3F&U1Z=GN-3?&UX.R53XEKX?A'67UP2V(Z/[[K=CT<G
M\-9W/CH$)1RJ.K%3.,IVYPSFNA ?CDX0M$#U3Q',%W!XO 1\G>8][+3UM.<
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M7=[#YVXDL4[TXJ'[XYW#8UZ %;HO$KK[.70_"9-)*+])5<GALYYW?2?*FP'
MDK9^*)N11GVKC^O)&D$X+W/A;W9>O7V]M??FNM%$X)<>0^5U?"$-979_JH8R
M[S:[8>\6^\IL#I*A#[_\+U!+ P04    "  4FSQ1TC\VFLDT  #\I@$ $
M &UE:2UE>#$P,E\S-RYH=&WM??E3V\C6Z.]?U?L?^G+OS#-59C%+%DBFR@$G
MH;X$>$ F+^_65[=DN8TU(TL>26:9O_Z=I;O5VHP-!HRCJ1H"MM3+Z=-G7][]
MX_#DX.+':4=\OOCZ19Q^^_#EZ$"LK&UL?-\^V-@XO#CD+W;6-UOB(G*"V$N\
M,'#\C8W.\8I8&23):&]CX_KZ>OUZ>SV,+C<NSC8&R=#?V?##,);KO:2W\MO_
M^J]W^!G]*YT>_IMXB2_AEZ'TUN1-:W/K/]NOU^$A^&I#?_=N0S_]C[4U<?Q)
M'(3!E8P2&8FKW?7-]:WUW4VQMH8/=,/>+?S[7^]&(DYN??E^)9$WR9KC>Y?!
M7N1=#I+]H1-=>L%:-TR2<+BW.3*?).&(_J0WO* G@V1O\Y?]?A@D:]<2W]WK
MAGZ//XB]O^5>JP6/TY]]9^CYMWL7WE#&XEA>B[-PZ 3J45S(7A!&0\?GP1,$
M8!\^@$\#R4]=.9'GP(Q"/;CRVSO\/+.-GG3#R$' [XUA?9'OP=LKOW5N!E[7
M2T0+0/%N ]_Z[=W&Z+>Y V'B)@D>^.;*;[\&W7BT7[T$%P:5T1(>Q-?.Q>>3
MPX[H?.D<7)R='!\=G#?%T?'!NKCS6!X"DQ0$RP?[CR=G7\7)1[&UN;4IOIP<
M?UJ[Z, GIYTS_*9]?-!9^] ^[QPNSXY%^WO[[%"T/YUU.E\[QQ>B<?#Q1/SJ
M#$?[XN#D9+5ZIW^,X\3KWSX^$I5/U-J:/-/K]5=O"Y/="49U! H\#X+LQ<"+
MQ9<PN%R[D-%0G,H(7W$"5ZY]<&+9$^UK)X*?EY&40UBQ:"0#*7[]YYNMK<W]
MW'?T:6M_M2EDOR_=Q+N2PHE%V!?G<I3(81>8T];K)N-M<9Q#)Y'I$+ L0E)8
M@A<DH>C>"B?HB:Y,KJ4,Q%>9#,*>%!T?)HK"P'-C("N!N]X4CCB4O@-#2@$4
M::2(4F;"@W X<H);/1N-_.__V/_]3^;Y3P#+1)K5K3,R+"E*?/_<.>NT@4HC
M !2D1$_&7@33PDE$DHY+P43 >"*6T97G\M?V6PA7^$@&;CB.G$MI7H(/79C=
M"\;T^W48_4D#X<M=&<@^L&[ &WLL+X"3A?T&$A]S$G'M^;YYV('?]9-Q$KI_
M#H ^R2A>7[KC.3[YWA07>$9 [3M-A N ,O9@MXSH"FZC2 Z]&)9"AP ?#,?)
MV/'AX2L9P)#\1=@%6-![L1C ;?,"IX]"9"P3/)!DD$4#!^\Z';-#2 "_Z"-M
M>*LB'CB()+"",QDGD><F<'W/\3CRIVG?KORS*1' %38\&-BB2^);X,'B[0$*
MWYJ+39((35Q),( <M7;$R3#PNN,8/X%31LIUZCM9HH$?F($!SO@5@&K(@(0S
MZ'D,1P,[!5'ZWN,7>%0W]'TFD/XM ]BFA&;YRX>\K?6,X*B6ZLM^LK?]BOBL
ME@JGE2\_ 0&('%^]EJ',Q-OR_$O?A@*"XA=%-",TAV?T20)3B<?=/^#PZ!(
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M?G*;/K,+CX@12$H<1U3VK5JYQ_MPC,O5V,DPLC:DK0!#< <96T'C9G42K@F
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MQ61V%YV99**/\L13(]PHO,8PSS'04$FF,,;L+NCI?UIQGN@S1ODW&].+J5*
M*/H,\SM;/KHWM9?I+7N96IOSES5P,X34=$]0LI51541BMA IA2L$(8?0QGR8
M<3I(4=LINY>IC[;PE1=;M/%IZ.))X%:0Q3L7PT1RN?PYKVM_3NW/629_3I:
M=24W^?59&:!,54W+XM#U2!4B*A9>!S**!]ZH.KE#<C1?@5^F"<NYZ:CFP!7[
M[E.%O9%)*5V=2C121)3X)8<#L),GP^*IGLW#M;/YLH12BT-%JM3+9_>MUMS9
M]T&82JKE7+O$UL7)\']89V"=/SM56"C6M\3E60K:/<EQ>*99!9[T@Q$(S#Y)
MP^R?TG%@/)4.&J2$F\Q2Z#D5EJS$]50[8G]/#@5="P9<Z=AV,95;^Z)"&VL5
MV\\@.$^4!GCD Z!#+S;U:=#$&_6T. -3]WW/92N9.PB5(Q?M>YP0@#':)I&
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M\;JYN?-(#/'.$.2'Q7#69TYG?HRIH\19YQP@_I"@NV4 ['27J?7VU8R<MCZ
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MPF-)[]T2=9_9^:FZS[S;Z(:]6VQ"LS%(AC[\\O\!4$L#!!0    ( !2;/%%
MV!BI*2X  $PO 0 0    ;65I+65X,3 S7S,V+FAT;>U]:5,;2;;H]XEX_R&'
MN3T/)L3N%=P=(8-L$Q<##^3V<TS<F$A5I5!UEZK4M0#J7W_/DIF5M4EB,08:
M?[ MJ2J7DR?/OKS[^_[Q7O_;24]\ZG\^%"=?WA\>[(FEU?7UK]M[Z^O[_7W^
MX<7:QJ;H)S)*@RR((QFNK_>.EL32*,LF.^OKEY>7:Y?;:W%ROMX_71]EX_#%
M>AC'J5KS,W_IE__SMW?X'?VKI(__9D$6*OC/6 6KZFIS8_L_VZ_6X"'X:=W\
M]F[=//WWU55Q]%'LQ=&%2C*5B(N7:QMK6VLO-\3J*CXPB/TI_/NW=Q.19M-0
M_;R4J:ML58;!>;23!.>C;'<LD_,@6AW$61:/=S8F]ILLGM!'>B.(?!5E.QL_
M[0[C*%N]5/CNSB .??XB#?Y4.YN;\#A]',IQ$$YW^L%8I>)(78K3>"PC_2@N
M9">*D[$,>? , 3B$+^#;2/%3%S()),PH](-+O[S#[TO;\)47)Q(!OY/#^I(P
M@+>7?NE=C8)!D(G-C;7M=^OXUB_OUB>_W#D09FZ2X(%O+OWRSVB03G;;E^#!
MH"IY@@?QN=?_=+S?$[W#WE[_]/CH8.^L(PZ.]M;$W&.Y#4P*$#P]V'\X/OTL
MCC^(K8VM#7%X?/1QM=^#;TYZI_A+]VBOM_J^>];;?SH[[G[MGNZ+[L?37N]S
M[Z@OEO>[[P].5]HW^%N>9L%P^OUQIWFBS:W9,[U>>_6V-ME<Z&G(:ZC<"J#]
M49"*PS@Z7^VK9"Q.5(*OR,A3J^]EJGS1O90)_'V>*#6&%8OE;*3$/__Q9FMK
M8[?R&WV[N;O2$6HX5%X67"@A4Q$/Q9F:9&H\ )ZT];K#Z%H?9U]FJA@"ED6X
M"4L(HBP6@ZF0D2\&*KM4*A*?53:*?25Z(4R4Q%'@I4!-(F^M(Z385Z&$(94
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MR3_$ X %O9>*$9"E())#%+)3E>&!9*,R&D@DBG3,DI  _F..=#E8$>E((I+
M"DY5FB6!EP&=.\/CJ)ZF2X:JSQ;4$E>X',# #@$77Z( %N\.4/O54D"2U&CB
M5LH*='OSA3@>1\$@3_$;.&4D\2>A+%-7_,(.#'#&GP!48P8DG($?,!PM[#1$
MZ?> 7^!1O3@,F9.$4P:PRS+L\I\>\FZNE01KO=10#;.=[5<DD!BI>5'Y^R,0
M@$2&^K42"R,AH,KHS6VH(2C^4$<S0G-XQIPD<-\T'_P&AT>7 *B.O6[Q19#2
M^>MOZ*CE9!(&GAR$1.?2W!OQBM(UF"!4:4J/(BV$/8H8/B27<&N!R/Z1(\'M
M"$].@@P._4]8!:-;GA8+@AL':QA)0%@<*)5CN.A*1D%T3JS-0;L2;,RMQ6%0
M!O%^C^++4/GG</R)\E0P(0(L86F3:7E'!$"@OW8(B:](O_S(, _#*=^_-(,O
M8"D 3MIHE)66<L!+5!>: 2-Y@.>& +?,"D;%9:.US#A8YRE>3J?Y:PTZ7%$2
MAT_OJFW=^55CQ&V^:05EUQAUGA"/J3 ("5\ ,N,Y_-N*I#.XAF4 C2_6K^M$
M3NFN(5.4Z:@, N<PM@@ \U7T1WKVVW=^]K_"R0!-:3K\LX(>SKVEG6;:RU<1
MI/'B&M?/EA\: *60202O:A;L@WY5XM-ZJ27%BRF6%D#&08;XZ*D$SC: @Y@X
M<QF)H6GM:7FGCOJT^7HWM1*M+]1X$L93)DN-ZD4V2N+\?,2$#\6P86W3\/\@
M]DN0[L+UJL&.=N;'L(THS@H8XE6LPY >1B:&SVHX3O(DS6$GO"W8]QF*)@#=
M[0+DP7BL_   "C3=P_% ?O&9SL?)4 6XG*KL;ZFM>R"E_?2N/-"@\4GBGCXI
MQ<7TRS[(60G\JU9@#6%\V2&&NR#GOLW: Y<E&?KE*9FR[(LX2">,XS2>+T(9
MQLG@GL/> JW9+'[2?5X/7$@<MK9C/.6T=' %T RPA)ZT+HDG37).HAQP-(W\
MRIP!"3$M5QC1"J$#Q#- .HPZW84^_N;E#NB,2V>.1T.3U)<YEE,[1QU[BU&\
MVJBUBS1,I,?^#,. /)!B<$/ O1!P9MV>#+T\U#H2Z,%>$@SP*0*R5D(%7.<(
M\=>/+R.2#,4E:*"*AQ91CE:B75AZP[0T!-W;VDVL4*!9!AJ'';GLR;$,MIH"
MW]XS=WJS_>+EVZVWV[@#= LE9@\3>:Y6!W *OZ^2%KHCPTLY37<O S\;[6QN
MP*J7&O9\CQZ->YO1#RX$B2 _+R';QFUG)-D,8M!'DI^7-I8$4K)T(CU 4OMY
M(GW??#:+YE=64>F4DU3MF/_LB@I@LP3_\L6%GADVM60&X4=9LKD< 958Q:GQ
M^"\3.5FZM?QTMTBV(-RW*G!_MY[Y/Q@$Q<+N\TK.DI/O<QW+<L61R9N/XS&C
MVCLI(E#1?U[Z3[=W</SE4*;9J4*)4_DG0/S>(^VC7[911)</YER:U(4'MIQV
M[:7F]*H+7R1S? A2X/7HQWFIQ;C>^X/^?G?.YGG,FC[<8)ODN;1.@JX@%#.&
M/.L4Y)FJD10P P40M.F"2#F(\TQ\!@%HN\-K-$X)9]V-KAPM9F<EF7*>Q,V:
M&@LNN*X92CHI%0TJ7/%RBR)2U>B,,#4@%QTLR+I;2+_BT[!^@H93;(!(Z20+
MR_)W5>5JPBLOC^W9%O"LBXF]D8S.%;ZVQZ8H,JBAD!M[7IXD)&K"2&H!%:)*
M.^&O!/]"R0'^!:'BUL33M25LOES;?O-32>99_>&VCP^Q5M]!FI[$J>JTWFN-
M?^H/=(N440T1DDRH&O21RM!?"W0Z11N&O$++[#"X(@40[?V^FB3*"]@#P_;^
M#,Z5E"!^0H[C) O^U%Y;C:AEM,2[Z"RV@Q@G?3P;5E'5E1?FOB(MV%R&)!X+
MZ?V1!ZGV/A!:>2'L7/AY@O2#S--\0>AQ_%SXIBU=6%@Y;0>HN<"^0BM0$!7*
M5&%V@3V2>H[:D0\#)8H@HMU8>9@QA"Z#C._4WBA00Y@R@N4$,.OQ<!AX*FFR
M/_(,]A#-*JQ;; XB#) 8HV)&'OF B6\^P0.%7R<2CL^X.!MTL[LP(C[XRX6
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M+'(A4LK-(90US K' &6T" 4K2FVG,1"1!%$CGJC$ L38 /%)<HLTN]4=>;\
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MNF?L;V0G3XDT4&VCVRMIXO:(UFB*>'JZS>;FG5.#O;C@9\U$H,'ZQ14G?G.
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M:EJ>X51UC%:9-_JH,>7F4(#EF+($.V[ C/RV*T_&7C9"A,,$*E\D7BS["G>
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M;U5%72"A](+,)TNY494".9*I-GT7PE7)2ISWDP=OJ'8B29T@]++]6Y!C(Z)
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M'$9EC7J[T3P_;YZ5K H;/+X'@_[.+EN?VJWV)X#L>>=;C7WO?&7UQM_;G6\
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MPKVA]@9K1H 63@P"(&9DDJPI@XMA7J*Y>,C&&MR8/ZXMDUC:31L59UA?"YV
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M($B'P)5C#@I-&@.&Q;'A\*.0A"1(SZ-3!HLW,NCN/6C+ACD+5%5P)/$#QSU
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M)1<B8I2A0G6S5XPSM9 J8^54DZ"$Q=:B,L0S<UER2X("O1>*.+ON5H7FQ);
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MB?0\7_S8[?K1?+)S PG]>2%S_;B6OKGZ+8\:ZCD^CF0,+%J9BT$R(SYEU:L
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M1:;\DJDR3/F:*@4SUF\ " %K\C06&EOPHV*H:Q;<L!0I\3$,$<>QOZUB_RH
M;*1B[:-&?>]&U"]KSO.QH(V';;=SR]9A^6WI7QY;\P/0]9YXRKPT,ME^.,70
ML[(2[& 6+.B:)4U4U%&WHX26@KW91$17(JI1&$[H2T\O%Y8F 3%XI(JG<=<N
M+J1[J^D4C7F8^J1E J(F*<ZH"N8F3S O%I_("34A[?%!\WCF9]NR4E.Y_!QI
M3=*/PG-Q+>/$"@:7HQIA(.B/R[%MU],(RRW/(S0Y!%E8& 4ACDI6,S+@D&F!
MZP*OH>NF45P(V :>&81L)!4UP6!7ZW!E<58Y.J:JWC/N=YX\9!=1+@2#YV=
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M  !M96DM,C R,# Y,C=?;&%B+GAM;%!+ 0(4 Q0    ( !2;/%%_,:-V_P0
M * K   4              "  2,,  !M96DM,C R,# Y,C=?<')E+GAM;%!+
M 0(4 Q0    ( !2;/%&S5"OQ8!T  ,$D 0 3              "  501  !M
M96DM.&M?,C R,# Y,C<N:'1M4$L! A0#%     @ %)L\42,2-./T,P  BYX!
M !               ( !Y2X  &UE:2UE>#$P,5\S."YH=&U02P$"% ,4
M"  4FSQ1TC\VFLDT  #\I@$ $               @ $'8P  ;65I+65X,3 R
M7S,W+FAT;5!+ 0(4 Q0    ( !2;/%% V!BI*2X  $PO 0 0
M  "  ?Z7  !M96DM97@Q,#-?,S8N:'1M4$L! A0#%     @ %)L\42)C^UQG
M(P  \.D  !               ( !5<8  &UE:2UE>#$P-%\S-2YH=&U02P$"
M% ,4    "  4FSQ1/%\LLBDC  "<Z   $               @ 'JZ0  ;65I
M+65X,3 U7S,T+FAT;5!+ 0(4 Q0    ( !2;/%'\MQ\VC2$  #W0   0
M          "  4$- 0!M96DM97@Q,#9?,S,N:'1M4$L%!@     *  H =P(
' /PN 0

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
